CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Current assets: | ||
| Accounts receivable, reserves (in dollars) | $ 90 | $ 78 |
| Stockholders' equity: | ||
| Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
| Preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 |
| Preferred stock, shares outstanding (in shares) | 0 | 0 |
| Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
| Common stock, shares authorized (in shares) | 480,000,000 | 480,000,000 |
| Common stock, shares issued (in shares) | 115,771,149 | 124,155,884 |
| Common stock, shares outstanding (in shares) | 115,771,149 | 124,155,884 |
| Variable Interest Entity, Primary Beneficiary [Member] | Recourse [Member] | ||
| Liabilities of VIE | $ 390 | $ 150 |
| Asset Pledged As Collateral [Member] | Variable Interest Entity, Primary Beneficiary [Member] | ||
| Pledged assets | $ 491 | $ 241 |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Income Statement [Abstract] | |||
| Net sales | $ 13,184 | $ 12,673 | $ 12,339 |
| Cost of sales | 9,079 | 8,657 | 8,479 |
| Gross profit | 4,105 | 4,016 | 3,860 |
| Operating expenses: | |||
| Selling, general and administrative | 3,084 | 3,034 | 2,956 |
| Depreciation and amortization | 263 | 251 | 209 |
| Restructuring and related costs | 105 | 110 | |
| Operating income | 653 | 621 | 615 |
| Other income (expense): | |||
| Interest income | 33 | 24 | 17 |
| Interest expense | (150) | (131) | (87) |
| Other, net | (3) | (1) | (3) |
| Income before taxes, equity in earnings of affiliates and noncontrolling interests | 533 | 513 | 542 |
| Income taxes | (126) | (128) | (120) |
| Equity in earnings of affiliates, net of tax | 12 | 13 | 14 |
| Net Income | 419 | 398 | 436 |
| Less: Net income attributable to noncontrolling interests | (21) | (8) | (20) |
| Net income attributable to Henry Schein, Inc. | $ 398 | $ 390 | $ 416 |
| Earnings per share attributable to Henry Schein, Inc.: | |||
| Basic (in dollars per share) | $ 3.29 | $ 3.07 | $ 3.18 |
| Diluted (in dollars per share) | $ 3.27 | $ 3.05 | $ 3.16 |
| Weighted-average common shares outstanding: | |||
| Basic (in shares) | 120,813,977 | 126,788,997 | 130,618,990 |
| Diluted (in shares) | 121,717,876 | 127,779,228 | 131,748,171 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Statement of Comprehensive Income [Abstract] | |||
| Net Income | $ 419 | $ 398 | $ 436 |
| Other comprehensive income, net of tax: | |||
| Foreign currency translation gain (loss) | 207 | (207) | 53 |
| Unrealized gain (loss) from hedging activities | (24) | 13 | (18) |
| Pension adjustment gain (loss) | 2 | (3) | (3) |
| Other comprehensive income (loss), net of tax | 185 | (197) | 32 |
| Comprehensive income | 604 | 201 | 468 |
| Comprehensive income attributable to noncontrolling interests: | |||
| Net income | (21) | (8) | (20) |
| Foreign currency translation loss (gain) | (32) | 24 | (5) |
| Comprehensive loss (income) attributable to noncontrolling interests | (53) | 16 | (25) |
| Comprehensive income attributable to Henry Schein, Inc. | $ 551 | $ 217 | $ 443 |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions |
Total |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Accumulated Other Comprehensive Income (Loss) [Member] |
Noncontrolling Interests [Member] |
|---|---|---|---|---|---|---|
| Beginning Balance at Dec. 31, 2022 | $ 4,095 | $ 1 | $ 0 | $ 3,678 | $ (233) | $ 649 |
| Beginning Balance (in shares) at Dec. 31, 2022 | 131,792,817 | |||||
| Net income (excluding amounts attributable to Redeemable noncontrolling interests) | 430 | 416 | 14 | |||
| Foreign currency translation gain (loss) (excluding amounts attributable to Redeemable noncontrolling interests) | 48 | 48 | ||||
| Unrealized gain (loss) from hedging activities, net of tax expense (benefit) | (18) | (18) | ||||
| Pension adjustment gain (loss), net of tax impact | (3) | (3) | ||||
| Distributions to noncontrolling shareholders | (27) | (27) | ||||
| Change in fair value of redeemable securities | 11 | 11 | ||||
| Noncontrolling interests and adjustments related to business acquisitions | (2) | (2) | ||||
| Repurchase and retirement of common stock - Value | (252) | (33) | (219) | |||
| Repurchase and retirement of common stock - Shares | (3,214,136) | |||||
| Stock issued upon exercise of stock options - Value | 1 | 1 | ||||
| Stock issued upon exercise of stock options - Shares | 21,068 | |||||
| Stock-based compensation expense - Value | 39 | 39 | ||||
| Stock-based compensation expense - Shares | 1,065,319 | |||||
| Shares withheld for payroll taxes - Value | (34) | (34) | ||||
| Shares withheld for payroll taxes - Shares | (416,605) | |||||
| Settlement of stock-based compensation awards | 1 | 1 | ||||
| Settlement of stock-based compensation awards, shares | (698) | |||||
| Transfer of charges in excess of capital | 15 | (15) | ||||
| Ending Balance at Dec. 30, 2023 | 4,289 | $ 1 | 0 | 3,860 | (206) | 634 |
| Ending Balance (in shares) at Dec. 30, 2023 | 129,247,765 | |||||
| Net income (excluding amounts attributable to Redeemable noncontrolling interests) | 399 | 390 | 9 | |||
| Foreign currency translation gain (loss) (excluding amounts attributable to Redeemable noncontrolling interests) | (183) | (183) | ||||
| Unrealized gain (loss) from hedging activities, net of tax expense (benefit) | 13 | 13 | ||||
| Pension adjustment gain (loss), net of tax impact | (3) | (3) | ||||
| Distributions to noncontrolling shareholders | (6) | (6) | ||||
| Purchase of noncontrolling interests | (8) | (7) | (1) | |||
| Change in fair value of redeemable securities | (119) | (119) | ||||
| Noncontrolling interests and adjustments related to business acquisitions | 1 | (1) | 2 | |||
| Repurchase and retirement of common stock - Value | (388) | (52) | (336) | |||
| Repurchase and retirement of common stock - Shares | (5,419,649) | |||||
| Stock issued upon exercise of stock options - Value | 6 | 6 | ||||
| Stock issued upon exercise of stock options - Shares | 98,755 | |||||
| Stock-based compensation expense - Value | 39 | 39 | ||||
| Stock-based compensation expense - Shares | 340,722 | |||||
| Shares withheld for payroll taxes - Value | (9) | (9) | ||||
| Shares withheld for payroll taxes - Shares | (111,815) | |||||
| Settlement of stock-based compensation awards, shares | 106 | |||||
| Transfer of charges in excess of capital | 143 | (143) | ||||
| Ending Balance at Dec. 28, 2024 | $ 4,031 | $ 1 | 0 | 3,771 | (379) | 638 |
| Ending Balance (in shares) at Dec. 28, 2024 | 124,155,884 | 124,155,884 | ||||
| Net income (excluding amounts attributable to Redeemable noncontrolling interests) | $ 424 | 398 | 26 | |||
| Foreign currency translation gain (loss) (excluding amounts attributable to Redeemable noncontrolling interests) | 177 | 175 | 2 | |||
| Unrealized gain (loss) from hedging activities, net of tax expense (benefit) | (24) | (24) | ||||
| Pension adjustment gain (loss), net of tax impact | 2 | 2 | ||||
| Distributions to noncontrolling shareholders | (11) | (11) | ||||
| Purchase of noncontrolling interests | (2) | (1) | (1) | |||
| Change in fair value of redeemable securities | (72) | (72) | ||||
| Noncontrolling interests and adjustments related to business acquisitions | (46) | (46) | ||||
| Issuance of common stock - Value | 250 | 250 | ||||
| Issuance of common stock - Shares | 3,285,151 | |||||
| Repurchase and retirement of common stock - Value | (856) | (94) | (762) | |||
| Repurchase and retirement of common stock - Shares | (12,062,174) | |||||
| Stock issued upon exercise of stock options - Value | $ 2 | 2 | ||||
| Stock issued upon exercise of stock options - Shares | 24,945 | 24,172 | ||||
| Stock-based compensation expense - Value | $ 39 | 39 | ||||
| Stock-based compensation expense - Shares | 578,536 | |||||
| Shares withheld for payroll taxes - Value | (15) | (15) | ||||
| Shares withheld for payroll taxes - Shares | (203,951) | |||||
| Settlement of stock-based compensation awards, shares | (6,469) | |||||
| Transfer of charges in excess of capital | 114 | (114) | ||||
| Ending Balance at Dec. 27, 2025 | $ 3,899 | $ 1 | $ 177 | $ 3,293 | $ (226) | $ 654 |
| Ending Balance (in shares) at Dec. 27, 2025 | 115,771,149 | 115,771,149 |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Statement of Stockholders' Equity [Abstract] | |||
| Net income attributable to redeemable noncontrolling interests | $ (5) | $ (1) | $ 6 |
| Foreign currency translation (gain) loss | (30) | 24 | (5) |
| Unrealized gain (loss) from foreign currency hedging activities, tax benefit (expense) | 9 | (5) | 7 |
| Pension adjustment gain (loss), net of tax impact, (expense) benefit | $ (3) | $ 2 | $ 0 |
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Cash flows from operating activities: | |||
| Net Income | $ 419 | $ 398 | $ 436 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 311 | 297 | 248 |
| Impairment charge on intangible assets | 16 | 0 | 7 |
| Impairment of capitalized software | 0 | 12 | 27 |
| Non-cash restructuring and related charges | 8 | 32 | 27 |
| Stock-based compensation expense | 39 | 39 | 39 |
| Provision for losses on trade and other accounts receivable | 16 | 14 | 18 |
| Provision for (benefit from) deferred income taxes | 5 | (61) | (20) |
| Equity in earnings of affiliates | (12) | (13) | (14) |
| Distributions from equity affiliates | 11 | 12 | 15 |
| Changes in unrecognized tax benefits | 4 | 5 | 10 |
| Other | (57) | (27) | (3) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Accounts receivable | (124) | 315 | (327) |
| Inventories | (95) | (59) | 231 |
| Other current assets | (45) | 47 | (138) |
| Accounts payable and accrued expenses | 216 | (163) | (56) |
| Net cash provided by operating activities | 712 | 848 | 500 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (139) | (148) | (147) |
| Payments related to equity investments and business acquisitions, net of cash acquired | (199) | (230) | (955) |
| Proceeds from loan to affiliate | 3 | 4 | 6 |
| Settlements for net investment hedges | 0 | 0 | 22 |
| Capitalized software costs | (52) | (39) | (40) |
| Other | (13) | (17) | (21) |
| Net cash used in investing activities | (400) | (430) | (1,135) |
| Cash flows from financing activities: | |||
| Net change in bank credit lines | 108 | 387 | 153 |
| Proceeds from issuance of long-term debt | 489 | 120 | 1,368 |
| Principal payments for long-term debt | (44) | (318) | (468) |
| Debt issuance costs | (2) | 0 | (3) |
| Issuance of common stock | 250 | 0 | 0 |
| Proceeds from issuance of stock upon exercise of stock options | 2 | 6 | 1 |
| Payments for repurchases and retirement of common stock | (850) | (385) | (250) |
| Payments for taxes related to shares withheld for employee taxes | (15) | (9) | (34) |
| Distributions to noncontrolling shareholders | (30) | (54) | (47) |
| Payments for contingent consideration | (19) | (2) | 0 |
| Acquisitions of noncontrolling interests in subsidiaries | (77) | (255) | (19) |
| Net cash provided by (used in) financing activities | (188) | (510) | 701 |
| Effect of exchange rate changes on cash and cash equivalents | (90) | 43 | (12) |
| Net change in cash and cash equivalents | 34 | (49) | 54 |
| Cash and cash equivalents, beginning of period | 122 | 171 | 117 |
| Cash and cash equivalents, end of period | $ 156 | $ 122 | $ 171 |
Basis of Presentation and Significant Accounting Policies |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Basis of Presentation and Significant Accounting Policies [Abstract] | |
| Basis of Presentation and Significant Accounting Policies | Note 1 – Basis of Presentation and Significant Accounting Policies Nature of Operations We distribute health care products and value-added services primarily to office-based dental and medical practitioners, across dental practices, laboratories, physician practices, government, institutional health care clinics, home health providers, and alternate software and technology services to health care practitioners. practitioners, dental laboratories, schools, government and other institutions. physician offices, urgent care centers, ambulatory care sites, emergency medical technicians, dialysis centers, health, federal and state governments and large enterprises, such as group practices networks, among other providers across a wide range of specialties. We have significant operations in the United States, Germany, France, Canada, and Brazil. meaningful market presence in several other European countries and the Asia-Pacific Basis of Presentation Our consolidated financial statements include the accounts of Henry subsidiaries and VIE. unconsolidated affiliates for which we have the ability to influence the operating or accounted for under the equity method. current period presentation. impact on our consolidated financial condition, results of operations The primary beneficiary of a VIE is required to consolidate the assets and be the primary beneficiary of the VIE when we have the power to direct activities economic performance and have the obligation to absorb the majority that could potentially be significant to the VIE. consider factors such as ownership interest, debt investments, management decisions, and contractual and substantive participating rights of each party. accounts receivable securitization as discussed in the trade accounts receivable transferred to the VIE are pledged as collateral to the related debt. accounts receivable. only be used to settle obligations of this VIE were $ 491 241 this VIE where the creditors have recourse to us were $ 390 150 Fair Value Fair value is defined as the price that would be received to sell an asset or transaction between market participants at the measurement date. (1) market participant assumptions developed based on market data obtained inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the in active markets for identical assets or liabilities (Level 1) and the lowest priority The three levels of the fair value hierarchy are described as follows: • measurement date. • either directly or indirectly. quoted prices for identical or similar assets or liabilities in markets prices that are observable for the asset or liability; and inputs that are observable market data by correlation or other means. • Use of Estimates The preparation of consolidated financial statements in conformity with the United States requires us to make estimates and assumptions that liabilities and disclosure of contingent assets and liabilities at the date of amounts of revenues and expenses during the reporting period. Our consolidated financial statements reflect estimates and assumptions our goodwill, long-lived asset and definite-lived intangible asset valuation; valuation; assessment of the annual effective tax rate; valuation of deferred income contingencies; the allowance for credit losses; fair value of contingent rebates; measurement of compensation cost for certain share-based pension plan assumptions. Fiscal Year We report our results of operations and cash flows on a 52 53 Saturday of December. consisted of 52 Revenue Recognition Revenue is recognized when a customer obtains control of promised goods consideration that we expect to receive for those goods or services. • • • • • We generate revenue from the sale of dental and medical consumable products, equipment, and services such as equipment repair and financial services (Global Distribution and Value-Added Services revenues), company- manufactured specialty products (Global Specialty Products revenue), and software (Global Technology revenues). revenue adjustments are included in the transaction price at contract based upon historical data and estimates and are provided for in the recognized. Revenue derived from the sale of consumable products and company-manufactured recognized at the point in time when control transfers to the customer, (e.g. when legal title and risks and of ownership transfer to the customer, we have no post-shipment obligations, and we have an enforceable payment). common carriers. Revenue derived from the sale of equipment is recognized when control when the equipment is delivered. equipment service technicians. time of delivery. Our merchandise and equipment products generally carry standard warranty however, in instances where we provide a warranty on company-manufactured products or labor services, warranty costs are accrued in accordance with Accounting Standards Codification At December 27, 2025 and December 28, 2024, we had accrued approximately 8 8 respectively, for warranty costs. Revenue derived from the sale of software products is recognized when made available electronically. training. training, is generally recognized over time using time elapsed as the input method control to the customer. over the subscription period as control is transferred to the customer. Revenue derived from other sources, including freight charges, equipment repairs recognized when the related product revenue is recognized or when practical expedient to treat shipping and handling activities performed after fulfillment activities, rather than a separate performance obligation in the Sales, value-add and other taxes we collect concurrent with revenue-producing revenue. Some of our revenue is derived from bundled arrangements that include which are accounted for separately. and technical support), we allocate the transaction price to each estimated standalone selling price for each performance obligation. that are not considered software consist primarily of equipment and the related revenue for such arrangements based on the relative selling prices of the goods price is not available (i.e., because we or others do not sell the goods or following techniques to estimate the standalone selling price: adjusted approach; or the residual method. selling price reflects our best estimate of what the selling prices of each deliverable regularly on a standalone basis taking into consideration the cost structure customer location and other market conditions. Sales Returns Sales returns are recognized as a reduction of revenue by the amount liability within accrued expenses-other within our consolidated balance sheets. liability based on historical data for specific products, adjusted as necessary returns is presented gross as a refund liability and we record a right of to cost of sales) for any products that we expect to be returned and resaleable. Cost of Sales The primary components of cost of sales include the cost of the product chargebacks and rebates) and inbound and outbound freight charges. Costs related to purchasing, receiving, inspections, warehousing, distribution network are included in selling, general and administrative Total distribution network costs were $ 107 105 105 27, 2025, December 28, 2024 and December 30, 2023, respectively. Supplier Rebates Supplier rebates are included as a reduction of cost of sales and are recognized factors we consider in estimating supplier rebate accruals include forecasted rebate contract terms, which generally provide for increasing rebates based volumes. Direct Shipping and Handling Costs Freight and other direct shipping costs are included in cost of sales. primarily direct compensation costs of employees who pick, pack and otherwise for shipment to our customers are reflected in selling, general and administrative were $ 105 106 98 December 30, 2023, respectively. Advertising and Promotional Costs We expense advertising and promotional costs as incurred. 46 million, $ 43 47 30, 2023, respectively. Stock-Based Compensation Costs We measure stock-based compensation at the grant date, based on the estimated recognize the cost (net of estimated forfeitures) as compensation expense on service period for certain time-based restricted stock units with cliff vesting and on a accelerated option awards and certain time-based restricted stock units with graded each reporting date, we reassess whether achievement of the performance condition compensation expense when achievement of the performance condition is expense is reflected in selling, general and administrative expenses. Employment Benefit Plans and other Postretirement Benefit Plans Some of our employees in our international markets participate We recognize the funded status, measured as the difference between the fair value of plan assets and the projected benefit obligation. asset or liability based on its funded status. Net periodic pension costs and valuations are dependent on assumptions those amounts. compensation levels, retirement rates, mortality rates, and other factors. net pension cost in selling, general and administrative expenses within Gains and losses that result from changes in actuarial assumptions or actuarial assumptions are recognized in and then amortized from accumulated Cash and Cash Equivalents We consider all highly liquid short-term investments with an original maturity of three months or less to be cash equivalents. fair value. 25 33 payments for inventory, were classified as accounts payable as of December 27, 2025 and December 28, 2024. Accounts Receivable and Allowance for Credit Losses Accounts receivable are generally recognized when revenues are recognized. credit loss” model, the carrying amount of accounts receivable is reduced best estimate of the amounts that we do not expect to collect. receivable, we consider many factors in estimating our reserve, including worthiness, experience and historical data adjusted for current conditions We record allowances for credit losses based upon a specific review of all those invoices not specifically reviewed, provisions are provided at differing rates, receivable, the collection history associated with the geographic region economic trends and reasonable supportable forecasts. We write off accounts receivable and charge it against its recorded allowance when we deem it uncollectible. Our net accounts receivable balance was $ 1,651 1,482 1,863 December 28, 2024 and December 30, 2023, respectively. The following table presents our allowances for credit losses: As of Description December 27, 2025 December 28, 2024 December 30, 2023 Balance at beginning of year $ 78 $ 83 $ 65 Provision for credit losses 20 14 17 Adjustments to existing allowances for late fees, foreign currency exchange rates, and write-offs (8) (19) 1 Balance at end of year $ 90 $ 78 $ 83 Contract Assets Contract assets include amounts related to any conditional right to consideration as of the reporting date. unconditional. consumables and sales of term software licenses. other and the non-current contract assets are included in investments and other sheets. material. Contract Liabilities Contract liabilities are comprised of advance payments and upfront payments over time that are accounted for as deferred revenue amounts. the performance obligation has been satisfied. and the non-current contract liabilities are included in other liabilities During the years ended December 27, 2025, December 28, 2024, and December substantially all of the current contract liability amounts that were previously year. The following table presents our contract liabilities: As of Description December 27, 2025 December 28, 2024 December 30, 2023 Current contract liabilities $ 81 $ 81 $ 89 Non-current contract liabilities 9 8 9 Total contract $ 90 $ 89 $ 98 Inventories and Reserves Inventories consist primarily of finished goods, raw materials and cost or net realizable value. for large equipment, high-technology equipment and drop-shipments. include direct materials, labor, and an allocation of related fixed and variable overhead. inventory carrying values requires management to make significant for inventory reserves and evaluating net realizable value, we consider condition, on-hand quantities, historical and forecasted sales, product economic conditions. Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation or computed under the straight-line method using estimated useful lives Amortization of leasehold improvements is computed using the straight-line over the lesser of the useful life of the assets or the remaining lease term. Capitalized Software Development Costs Capitalized software costs consist of costs to purchase and develop customers. application development stage and include such costs within property balance sheets. costs when technological feasibility is reached, and for cloud-based applications capitalize costs incurred during the application development stage, other within our consolidated balance sheets. Leases We determine if an arrangement contains a lease at inception. explicitly identifies an asset to be used and conveys the right to control for consideration. operating lease liabilities, and non-current operating lease liabilities in leases are included in property and equipment, current maturities of consolidated balance sheets. ROU assets represent our right to use an underlying asset for the lease obligation to make lease payments arising from the lease. upon commencement of the lease based on the present value of the lease payments our leases do not provide an implicit interest rate, we generally use our incremental estimated rate of interest for fully collateralized and fully amortizing borrowings payments at commencement date to determine the present value of use the implicit rate. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. over the lease term. and administrative and interest expense, respectively within our consolidated leases with a term of 12 months or less are not capitalized. We have lease agreements with lease and non-lease components, which are lease component, except non-lease components for leases of vehicles, which vehicle lease contains both lease and non-lease components, we allocate the standalone selling price. Business Acquisitions We account for business acquisitions under the acquisition method of accounting, under which the net assets of acquired businesses are recorded at their fair value at the acquisition include the acquired businesses’ results of operations from that date. Certain prior owners of acquired subsidiaries are eligible to receive additional we may be entitled to recoup a portion of purchase price cash consideration goals are met. the time of the acquisition, using the income approach, including a probability-weighted method or an option pricing method, where applicable. selling, general and administrative within our consolidated statements of While we use our best estimates and assumptions to accurately value liabilities assumed at the acquisition date, our estimates are inherently uncertain result, within 12 months to consideration transferred, assets acquired and liabilities assumed with within our consolidated balance sheets. of such assets acquired or liabilities assumed, whichever comes first, our consolidated statements of operations. Goodwill Any excess of acquisition consideration over the fair value of identifiable goodwill. business combination that are not individually identified and separately technology, as well as the assembled workforce. Goodwill is subject to impairment analysis at least once annually as event occurs or circumstances change that would more likely than carrying value. units by assessing whether two or more components are economically Our reporting units are identified as our operating segments. purposes of our impairment analyses. (i) Global Distribution and Value-Added Services reportable segment, which included the following operating segments (a) US Distribution Group; (b) Europe, Middle East, (c) Americas Non-US Distribution Group; and (d) Asia-Pacific and Australia (ii) Global Specialty Products reportable segment, which included the following Oral Reconstruction Group; and (b) Healthcare Specialty Group; (iii) Global Technology, Application of the goodwill impairment test requires judgment, including assignment of assets and liabilities that are considered shared services determination of the fair value of each reporting unit. applying the discounted cash flow methodology and confirming with uncertainties, however, related to fair value models, the inputs and our judgments in applying them The most significant inputs include estimation of detailed future cash flows determination of comparable companies to develop a weighted average In January 2025, we performed a geographical realignment within Services reportable segment intended to provide increased transparency distribution businesses and to reflect evolving management oversight realignment and the change in reporting units, we reallocated goodwill to each relative fair value approach. quantitative valuation analysis that considered projected cash flows, valuation inputs. Services reportable segment were tested for impairment as of January 1, values of our reporting units more likely than not exceeded their carrying January 1, 2025 under both structures. In connection with our restructuring initiatives, during the year ended 11 million impairment of goodwill in the Global Specialty Products segment, business; such impairment was calculated based on the relative fair value Intangible Assets In connection with our business acquisitions, we recognize assets acquired value estimates as of the date of acquisition. customer relationships and lists, trademarks and trade names, product development based on critical judgments and assumptions derived from analysis of projected revenue growth rates (which are based on historical trends estimated customer attrition and projected cash flows. the multi-period excess earnings method, the relief-from-royalty method, applicable. conditions. Intangible assets, other than goodwill, are evaluated for impairment whenever indicate that the carrying amount of the assets may not be recoverable expected to be derived from such asset or asset group. Definite and indefinite-lived intangible assets primarily consist of customer trademarks, trade names, product development and non-compete agreements. operations, impairment losses are only recorded if the asset or asset groups through its undiscounted future cash flows. carrying amount and the estimated fair value. fair value. During the years ended December 27, 2025, December 28, 2024 impairment charges within the selling, general and administrative line of our consolidated statements intangible assets of $ 16 0 7 During the years ended December 27, 2025, December 28, 2024 December 30, 2023, we recorded impairment charges, within the restructuring and related consolidated statements of income, of $ 0 14 , million, and $ 12 Income Taxes We account for income taxes under an asset and liability approach that requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events financial statements or tax returns. events other than expected enactments of changes in tax laws or rates. liabilities of a change in tax rates is recognized as income or expense in We file a consolidated U.S. federal income tax return with our 80% or greater owned U.S. subsidiaries. Redeemable Noncontrolling Interests Some minority stockholders in certain of our consolidated subsidiaries have to acquire their ownership interest in those entities at fair value. outside permanent equity on our consolidated balance sheets and are The redemption amounts have been estimated based on recent transactions and, if such earnings and cash flows are not achieved, the value of the impacted. reflected at each reporting period with a corresponding adjustment in the carrying amounts are subject to a “floor” amount that is equal noncontrolling interests at the time they were originally recorded. noncontrolling interests cannot go below the floor level. interests to reflect a fair value redemption feature do not impact the income is reduced by the portion of the subsidiaries’ net income interests. Noncontrolling Interests Noncontrolling interest represents the ownership interests of certain subsidiaries. noncontrolling interests. Comprehensive Income Comprehensive income includes certain gains and losses that, under accounting United States, are excluded from net income as such amounts are recorded stockholders’ equity. translation gain (loss), unrealized gain (loss) from hedging activities Risk Management and Derivative Financial Instruments We use derivative instruments to minimize our exposure to fluctuations in foreign currency exchange rates, interest rates, and our unfunded non-qualified supplemental retirement plan (“SERP”) (“DCP”). recognized asset and liability fair values, earnings and cash flows, as well subsidiaries, the interest rate risk on variable rate debt, and the returns on management policy requires that derivative contracts used as hedges be with the exposure being hedged and be designated hedges at inception derivative instruments for speculative purposes. forward contracts, total return swaps, and interest rate swaps. Foreign currency forward agreements related to forecasted inventory foreign currency swaps related to foreign currency denominated debt, and debt are designated as cash flow hedges. changes in the fair value of the derivatives are recorded as a income in stockholders’ equity and subsequently reclassified into transactions affect earnings. consolidated statements of cash flows as the cash flows related Foreign currency forward contracts related to our euro-denominated investment hedges. value of the derivatives are recorded in the foreign currency translation gain other comprehensive income in stockholders’ equity until the net Interest swap agreements are entered into for the purpose of hedging loan. Our foreign currency forward agreements related to foreign currency hedges but are not designated as hedges for accounting purposes. For agreements not designated as hedges, changes in the value of the derivative, loss on the hedged item, are recorded in other, net, within our consolidated statements of income. Total return swaps are entered into for the purpose of economically hedging our SERP and DCP. expected to be renewed on an annual basis. selling, general, and administrative expenses within our consolidated changes in the fair values of our SERP and DCP liabilities. Foreign Currency Translation The financial position and results of operations of our foreign subsidiaries the functional currencies. each year-end. Translation adjustments arising from the use of differing exchange rates from period to period are included Accumulated other comprehensive income in stockholders’ equity. currency transactions are included in earnings. Accounting Pronouncements Recently Adopted During the year ended December 27, 2025, we adopted Accounting Standards Update Income Taxes (Topic ,” which requires public business entities to disclose additional information in specified categories with respect to statutory rate for federal, state and foreign income taxes. items in the rate reconciliation to the extent the impact of those items new disclosures associated with the rate reconciliation, this ASU requires of refunds received) to be disaggregated for federal, state and foreign jurisdictions to the extent the related amounts exceed a quantitative threshold. need to be disaggregated based on their nature, which is determined by essential characteristics, such as the transaction or event that triggered the activity with which the reconciling item is associated. entities disclose information concerning unrecognized tax benefits having increasing or decreasing in the 12 months following the reporting date. basis, which resulted in the required additional disclosures included During the year ended December 28, 2024, we adopted ASU 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segments ” (“Topic 280”), disclosure of incremental segment information on an annual and investors to develop more decision-useful financial analyses. public entity identifies its operating segments, aggregates those operating thresholds to determine its reportable segments. the required additional disclosures included in our consolidated Recently Issued Accounting Pronouncements In December 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-11, “ Interim Reporting (Topic 270): Narrow ,” which is intended to improve navigability of the guidance 270, Interim Reporting, and clarify when it applies. statements and interim disclosure requirements, and establishes a principle events since the end of the last annual reporting period that have a effective for annual reporting periods beginning after December 15, 2027, and interim those annual reporting periods, with early adoption permitted. 2025-11 will have on our consolidated financial statements and related disclosures. In December 2025, the FASB issued ASU 2025-10, “ Government Grants (Topic 832) - Accounting for Government Grants Received by Business Entities, ” which establishes guidance on the recognition, measurement, and presentation of government grants received by business entities. beginning after December 15, 2028, and interim reporting periods within adoption permitted. financial statements and related disclosures. In November 2025, the FASB issued ASU 2025-09, “ Derivatives and Hedging (Topic 815): Hedge Accounting Improvements, ” which is intended to more closely align financial reporting with management activities, including expanded eligibility of forecasted hedge effectiveness, and clarifications related to hedging non-financial items. reporting periods beginning June 1, 2027, and interim reporting early adoption permitted, and should be applied prospectively. 2025-09 will have on our consolidated financial statements and related In September 2025, the FASB issued ASU 2025-06, “ Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements ,” which removes all references to software development project stages. when management authorizes and commits to funding the software project, be completed and the software will be used for its intended purpose. periods beginning after December 15, 2027, and interim reporting periods with early adoption permitted. modified transition approach. consolidated financial statements. In July 2025, the FASB issued ASU 2025-05, “ Financial Instruments - Credit Losses (Subtopic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, ” which introduces a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged asset when estimating expected credit losses on current accounts 606 on revenue from contracts with customers. This ASU is effective for annual December 15, 2025, with early adoption permitted. our consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, “ Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosure (Subtopic 220-40) : Disaggregation of Income Statement Expenses ,” which requires additional disclosure about the specific expense categories in and annual reporting periods. requirements, but affect where this information appears in the notes to financial statements. for annual reporting periods beginning after December 15, 2026, and December 15, 2027, with early adoption permitted. retrospectively. statements. |
Cyber Incident |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Cyber Incident [Abstract] | |
| Cyber Incident | Note 2 – Cyber Incident In October 2023 Henry Schein experienced a cyber incident that primarily American and European dental and medical distribution businesses. software, revenue cycle management and patient relationship management our manufacturing businesses were mostly unaffected. ecommerce platform and related applications, which was remediated. With respect to the October 2023 cyber incident, we had a $ 60 5 retention. 0 million, $ 9 11 professional fees. 40 representing a partial insurance recovery of losses related to the cyber incident. 27, 2025, we received insurance proceeds of $ 20 losses related to the cyber incident. included in the selling, general and administrative line in our consolidated |
Net Sales from Contracts with Customers |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Net Sales from Contracts with Customers [Abstract] | |
| Net Sales from Contracts with Customers | Note 3 – Net Sales from Contracts with Customers Net sales are recognized in accordance with policies disclosed Disaggregation of Net Sales The following table disaggregates our net sales by reportable segment: Years December 27, 2025 December 28, 2024 December 30, 2023 Net Sales: Global Distribution and Value Global Dental merchandise $ 4,831 $ 4,723 $ 4,783 Global Dental equipment 1,799 1,723 1,675 Global Value 238 233 191 Global Dental 6,868 6,679 6,649 Global Medical 4,270 4,081 3,912 Total Global Distribution 11,138 10,760 10,561 Global Specialty Products 1,544 1,446 1,331 Global Technology 675 630 602 Eliminations (173) (163) (155) Total $ 13,184 $ 12,673 $ 12,339 |
Segment and Geographic Data |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Segment and Geographic Data [Abstract] | |
| Segment and Geographic Data | Note 4 – Segment and Geographic Data We conduct our business through three Global Specialty Products; and (iii) Global Technology. We aggregate operating segments into these reportable segments based on economic similarities, the nature of their products, customer base and methods of distribution. Global Distribution and Value-Added Services includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related also includes value-added services such as financial services, continuing services. quality consumable merchandise. implant and biomaterial products; and endodontic, orthodontic and orthopedic related products and services. software, e-services and other products, which are distributed to health Our organizational structure also includes Corporate, which consists primarily of with support functions and projects. Our chief operating decision maker (“CODM”) is our Chairman adjusted operating income as the profitability metric for purposes of making to each segment and assessing performance of each segment. underlying segment results that is in line with our approach to risk and performance adjusted operating income as operating income adjusted to exclude insurance recovery proceeds, (b) amortization of acquisition intangibles, expenses, (d) impairment of intangible assets, (e) changes in fair value settlements, and (g) costs associated with shareholder advisory These adjustments are either: (i) non-cash or non-recurring in nature; (ii) not or (iii) not tied to the operational performance of the segment. the performance of the Company by CODM and thus are not reported The accounting policies of the reportable segments are generally Sales and transfers between reportable segments are eliminated in consolidation. Segment adjusted operating income is presented in the following presented on the consolidated statement of operations. taxes and equity in earnings of affiliates is presented on our consolidated statements Years Ended December 27, December 28, December 30, 2025 2024 2023 Gross Sales: Global Distribution and Value (1) $ 11,138 $ 10,760 $ 10,561 Global Specialty Products (2) 1,544 1,446 1,331 Global Technology (3) 675 630 602 Total Gross Sales 13,357 12,836 12,494 Less: Eliminations: Global Distribution and Value (18) (31) (36) Global Specialty Products (155) (132) (119) Global Technology - - - Total Eliminations (173) (163) (155) Net Sales: Global Distribution and Value 11,120 10,729 10,525 Global Specialty Products 1,389 1,314 1,212 Global Technology 675 630 602 Total Net Sales $ 13,184 $ 12,673 $ 12,339 Segment Cost of Sales: (4) Global Distribution and Value $ 8,352 $ 7,984 $ 7,862 Global Specialty Products 697 644 611 Global Technology 218 206 185 Segment Operating Expenses: (5) Global Distribution and Value $ 2,106 $ 2,080 $ 2,034 Global Specialty Products 605 624 545 Global Technology 277 272 275 Operating Income: Global Distribution and Value $ 680 $ 696 $ 665 Global Specialty Products 242 178 175 Global Technology 180 152 142 Total Segment Operating Income 1,102 1,026 982 Corporate, net (130) (77) (92) Adjustments (6) (319) (328) (275) Total Operating Income $ 653 $ 621 $ 615 Years Ended December 27, December 28, December 30, 2025 2024 2023 Depreciation and Amortization: Global Distribution and Value $ 27 $ 25 $ 26 Global Specialty Products 36 29 23 Global Technology 36 35 31 Total Segment Depreciation and Amortization 99 89 80 Corporate 33 24 18 Acquisition intangible amortization within adjustments (6) 179 184 150 Total Depreciation and Amortization $ 311 $ 297 $ 248 Global Distribution and Value impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X- ray supplies and equipment, high-tech and digital restoration equipment, equipment repair services, financial services on a non- recourse basis, continuing education services for practitioners, consulting and other services. under our own corporate brand a portfolio of cost-effective, high-quality consumable merchandise. (2) Global Specialty Products: Includes manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. (3) Global Technology: Includes development and distribution of practice management software, e-services and other products, which are distributed to health care providers. (4) Cost of goods sold in our Global Distribution and Value-Added Services segment and our Global Specialty Products segment includes product cost and inbound and outbound freight charges. primarily of software development and third-party provider costs, including technology use and hosting fees. (5) Significant segment operating expenses for our reportable segments and Corporate include primarily compensation costs, and to a lesser extent, rent, depreciation and maintenance costs related to operating our facilities. Adjustments represent items excluded from segment operating income to enable comparison of financial results between periods. The following table presents a breakdown of such adjustments: Years Ended December 27, December 28, December 30, 2025 2024 2023 Adjustments: Restructuring and related costs $ (105) $ (110) $ (80) Acquisition intangible amortization (179) (184) (150) Cyber incident-insurance proceeds, net of third-party advisory expenses 20 31 (11) Change in contingent consideration 2 (45) - Litigation settlements (5) (6) - Impairment of capitalized assets - (12) (27) Impairment of intangible assets (16) - (7) Costs associated with shareholder advisory matters and select value creation consulting costs (36) (2) - Total adjustments $ (319) $ (328) $ (275) The following table presents information about our operations by geographic December 27, 2025, December 28, 2024 and December 30, 2023. respective locations of our subsidiaries. 10 % of consolidated net sales. there were no material amounts of export sales. 2025 2024 2023 Net Sales Long-Lived Assets Net Sales Long-Lived Assets Net Sales Long-Lived Assets United States $ 9,096 $ 4,033 $ 8,825 $ 3,683 $ 8,662 $ 3,479 Other 4,088 2,120 3,848 2,051 3,677 2,135 Consolidated total $ 13,184 $ 6,153 $ 12,673 $ 5,734 $ 12,339 $ 5,614 |
Business Acquisitions |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Business Acquisitions [Abstract] | |
| Business Acquisitions | Note 5 – Business Acquisitions Our acquisition strategy is focused on investments in companies, including aligned with our BOLD+1 strategy, that add new customers and sales teams, increase our geographic footprint (whether entering a new country, such as emerging markets, or building scale where we have already invested in businesses), and finally, those that enable us to access new products and technologies. 2025 Acquisitions During the year ended December 27, 2025, we acquired companies within Added Services, these companies range from 60 % to 100 %. The following table aggregates the preliminary estimated fair value, as of consideration paid and net assets acquired for acquisitions during the year ended Preliminary Allocation as of December 27, 2025 Acquisition consideration: Cash $ 194 Deferred consideration 3 Estimated fair value of contingent consideration payable 19 Fair value of previously held equity method investments 91 Redeemable noncontrolling interests 85 Total consideration $ 392 Identifiable assets acquired and liabilities assumed: Current assets $ 59 Intangible assets 150 Other noncurrent assets 42 Current liabilities (26) Long-term debt (1) Deferred income taxes (23) Other noncurrent liabilities (8) Total identifiable 193 Goodwill 199 Total net assets acquired $ 392 The accounting for acquisitions in the year ended December 27, 2025 has not been including, but not limited to, pending assessment of certain assets, certain equity method investments, and certain liabilities, primarily year ended December 27, 2025, we did not record any material measurement Goodwill is a result of the synergies and cross-selling opportunities that these acquisitions for us, as well as the expected growth potential. purposes. The following table summarizes the intangible assets acquired during the year 2025 Weighted Average Lives (in years) Customer relationships and lists $ 98 11 Trademarks / Tradenames 32 7 Product development 18 10 Non-compete agreements 2 5 Total $ 150 During the year ended December 27, 2025, in connection with acquisitions recognized gains of approximately $ 38 equity investments. defined in which was recorded in selling, general and administrative consolidated statements of income. The impact of these acquisitions, individually and in the aggregate, was financial statements. Pro forma financial information since the acquisition date has not been presented acquisitions was immaterial to our consolidated financial statements. 2024 Acquisitions Acquisition of TriMed On April 1, 2024, we acquired a 60 % voting equity interest in TriMed Inc. (“TriMed”), a global developer of solutions for the orthopedic treatment of lower and upper extremities, headquartered of $ 315 aggregates the final fair value, as of the date of the acquisition, of consideration TriMed acquisition: Final Allocation Acquisition consideration: Cash $ 141 Deferred consideration 21 Redeemable noncontrolling interests 153 Total consideration $ 315 Identifiable assets acquired and liabilities assumed: Current assets $ 35 Intangible assets 221 Other noncurrent assets 10 Current liabilities (7) Deferred income taxes (62) Other noncurrent liabilities (6) Total identifiable 191 Goodwill 124 Total net assets acquired $ 315 Goodwill is a result of synergies that are expected to originate from the acquisition as well as potential of TriMed. The intangible assets acquired consisted of product development of $ 204 9 million, and in-process research and development of $ 8 intangible assets were 9 7 development (“IPR&D”), intangible assets acquired as a result of the TriMed acquisition are being their estimated useful lives using the straight-line method of amortization. indefinite-lived intangible asset and is not amortized until completion or and development efforts. exists during the period until completion. Pro forma financial information and TriMed’s revenue and earnings since the acquisition date have not been presented because the impact of the TriMed acquisition was immaterial to our consolidated Other 2024 Acquisitions During the year ended December 28, 2024, we acquired companies within Added Services and Global Specialty Products segments. range from 51 % to 100 %. 113 62 million, fair value of previously held equity investment of $ 30 18 estimated fair value of contingent consideration payable of $ 2 1 Net assets acquired primarily consisted of $ 60 64 intangible assets acquired consisted of customer relationships and lists of 33 of $ 24 5 2 useful lives for these acquired intangible assets were 11 years , 7 years , 9 years 5 years , respectively. We completed the accounting for all other acquisitions that occurred during the year ended December 28, 2024 and we did not record any material measurement period adjustments December 27, 2025. Goodwill is a result of the synergies and cross-selling opportunities that these acquisitions for us, as well as the expected growth potential. purposes. During the year ended December 28, 2024, in connection with the acquisition affiliate, we recognized a gain of approximately $ 19 previously held equity investment, using a discounted cash flow model based which was recorded in selling, general and administrative statements of income. Pro forma financial information for our 2024 acquisitions has not been acquisitions was immaterial to our consolidated financial statements. 2023 Acquisitions Acquisition of Shield Healthcare On October 2, 2023, we acquired a 90 % voting equity interest in Shield Healthcare, Inc. (“Shield”), a homecare medical products delivered directly to patients in their homes, 348 acquisition is reported in our Global Distribution and Value-Added Services segment. medical business by delivering a diverse range of products, including enteral nutrition, advanced wound care and diabetes supplies. monitoring devices directly to patients in their homes. The following table aggregates the final fair value, as of the date of the acquisition, assets acquired in the Shield acquisition: Final Allocation Acquisition consideration: Cash $ 289 Deferred consideration 22 Redeemable noncontrolling interests 37 Total consideration $ 348 Identifiable assets acquired and liabilities assumed: Current assets $ 41 Intangible assets 166 Other noncurrent assets 16 Current liabilities (24) Deferred income taxes (43) Other noncurrent liabilities (7) Total identifiable 149 Goodwill 199 Total net assets acquired $ 348 Goodwill is a result of synergies that are expected to originate from the acquisition as well as potential of Shield. The following table summarizes the identifiable intangible assets acquired 2023 Weighted Average Lives (in years) Customer relationships and lists $ 156 12 Trademarks / Tradenames 10 5 Total $ 166 Pro forma financial information and Shield’s revenue and earnings from the acquisition date have statements. Acquisition of S.I.N. Implant System On July 5, 2023, we acquired a 100 % voting equity interest in S.I.N. Implant System (“S.I.N.”) for consideration $ 329 manufactures an extensive line of products to perform dental implant procedures development of value-priced dental implants. United States and other international markets. The following table aggregates the final fair value, as of the date of acquisition, acquired in the S.I.N. acquisition: Final Allocation Acquisition consideration: Cash $ 329 Total consideration $ 329 Identifiable assets acquired and liabilities assumed: Current assets $ 73 Intangible assets 87 Other noncurrent assets 48 Current liabilities (33) Long-term debt (22) Deferred income taxes (38) Other noncurrent liabilities (27) Total identifiable 88 Goodwill 241 Total net assets acquired $ 329 Goodwill is a result of synergies that are expected to originate from the acquisition as well as potential of S.I.N. The following table summarizes the identifiable intangible assets acquired 2023 Weighted Average Lives (in years) Customer relationships and lists $ 38 7 Product development 36 8 Trademarks / Tradenames 13 10 Total $ 87 Pro forma financial information and S.I.N.’s revenue and earnings from the acquisition date have not been presented because the impact of the S.I.N. acquisition was immaterial Acquisition of Biotech Dental On April 5, 2023, we acquired a 57 % voting equity interest in Biotech Dental, a provider of dental implants, aligners, individualized prosthetics and innovative digital dental software based consideration of $ 423 Dental has several important solutions for dental practices and dental integrated suite of planning and diagnostic software using open architecture to create a digital view of the patient, offering greater diagnostic accuracy and an The following table aggregates the final fair value, as of the date of acquisition, acquired in the Biotech Dental acquisition: Final Allocation Acquisition consideration: Cash $ 216 Fair value of contributed equity share in a controlled subsidiary 25 Redeemable noncontrolling interests 182 Total consideration $ 423 Identifiable assets acquired and liabilities assumed: Current assets $ 74 Intangible assets 189 Other noncurrent assets 69 Current liabilities (60) Long-term debt (73) Deferred income taxes (53) Other noncurrent liabilities (20) Total identifiable 126 Goodwill 297 Total net assets acquired $ 423 Goodwill is a result of synergies that are expected to originate from the acquisition as well as potential of Biotech Dental. The following table summarizes the identifiable intangible assets acquired Dental: 2023 Weighted Average Lives (in years) Product development $ 124 10 Customer relationships and lists 47 9 Trademarks / Tradenames 18 7 Total $ 189 Pro forma financial information and Biotech’s revenues and earnings from the acquisition date have not been presented because the impact of the Biotech Dental acquisition was immaterial statements. Other 2023 Acquisitions During the year ended December 30, 2023, in addition to those noted above, Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments for total consideration of $ 284 51 % to 100 %. year ended December 30, 2023, in connection with the acquisition of recognized a gain of approximately $ 18 equity investment, using a discounted cash flow model based on Level Goodwill of $ 171 these acquisitions are expected to provide for us, as well as the expected acquired goodwill is deductible for tax purposes. 116 79 customer relationships and lists, $ 8 7 other of $ 22 two years ten years . Pro forma financial information for our 2023 acquisitions has not been acquisitions was immaterial to our consolidated financial statements. Acquisition Costs During the years ended December 27, 2025, December 28, 2024 6 6 million and $ 22 administrative in our consolidated statements of income. |
Inventories, Net |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Inventories, Net [Abstract] | |
| Inventories, Net | Note 6 – Inventories, Net Inventories, net consisted of the following as of: Description December 27, 2025 December 28, 2024 Finished goods $ 1,889 $ 1,710 Raw materials 70 61 Work-in process 43 39 Inventories, net $ 2,002 $ 1,810 Our inventory reserve was $ 131 132 respectively. |
Property and Equipment, Net |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Property, Plant and Equipment [Abstract] | |
| Property and Equipment, Net | Note 7 – Property and Equipment, Net Property and equipment, including related estimated useful lives, consisted December 27, December 28, 2025 2024 Land $ 22 $ 20 Buildings and permanent improvements 187 164 Leasehold improvements 125 109 Machinery and warehouse equipment 307 257 Furniture, fixtures and other 137 128 Computer equipment and software 602 523 1,380 1,201 Less accumulated depreciation and amortization (759) (670) Property and equipment, net $ 621 $ 531 Estimated Useful Lives (in years) Buildings and permanent improvements 40 Machinery and warehouse equipment 5 - 15 Furniture, fixtures and other 3 - 10 Computer equipment and software 3 - 10 Leasehold improvements are amortized on a straight-line basis over remaining lease term. Property and equipment related depreciation expense for the years and December 30, 2023, was $ 101 83 70 for finance lease amounts included in property and equipment, net within our During the year ended December 30, 2023 we recorded a $ 27 the Global Distribution and Value-Added Services segment. |
Leases |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Leases [Abstract] | |
| Leases | Note 8 – Leases We have operating and finance leases for corporate offices, office space, distribution and other facilities, vehicles and certain equipment. 23 which may include options to extend the leases for up to 10 follows: Years December 27, December 28, December 30, 2025 2024 2023 Operating lease cost: $ 94 $ 107 $ 99 Variable 11 12 12 Short-term lease cost 10 11 10 Total operating lease cost 115 130 121 Finance lease cost 3 4 5 Total lease cost $ 118 $ 134 $ 126 (1) Total operating lease cost for the years ended December 27, 2025, December 28, 2024 and December 30, 2023, included costs of $ 3 million, $ 17 11 consolidated statements of income. Further, for the year ended December 27, 2025 we recognized a gain of $ 4 related to facility leases which was recorded in restructuring and related costs income. operating lease right-of-use assets of $ 0 3 restructuring and related costs within our consolidated statement of Supplemental balance sheet information related to leases is as follows: Years December 27, December 28, 2025 2024 Operating Leases: Operating lease right-of-use assets $ 301 $ 293 Current operating lease liabilities 78 75 Non-current operating lease liabilities 251 259 Total operating lease liabilities $ 329 $ 334 Finance Leases: Property and equipment, at cost $ 14 $ 16 Accumulated depreciation (7) (9) Property and equipment, net of accumulated depreciation $ 7 $ 7 Current maturities of long-term debt $ 3 $ 3 Long-term debt 4 $ 3 Total finance $ 7 $ 6 Weighted Average Operating leases 5.6 5.9 Finance leases 2.9 2.7 Weighted Average Operating leases 4.5 % 4.2 % Finance leases 4.5 % 4.4 % Supplemental cash flow information related to leases is as follows: Years December 27, December 28, 2025 2024 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 99 $ 94 Financing cash flows for finance leases 3 4 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 71 $ 76 Finance leases 3 2 Maturities of lease liabilities are as follows: December 27, 2025 Operating Finance Leases Leases 2026 $ 91 $ 3 2027 74 2 2028 59 1 2029 47 1 2030 37 - Thereafter 63 - Total future 371 7 Less imputed interest 42 - Total $ 329 $ 7 As of December 27, 2025, we have additional operating leases that have payments of $ 23 2025, with lease terms of less than one year to ten years . Certain of our facilities related to our acquisitions are leased from leases are classified as operating leases and have a remaining lease term 12 years . As of December 27, 2025, current and non-current liabilities associated 5 million and $ 22 6.6 % and 8.7 % of the total current and non-current operating lease liabilities, respectively. non-current liabilities associated with related party operating leases were 6 20 At December 28, 2024 related party leases represented 7.6 % and 7.8 % of the total current and non-current operating lease liabilities, respectively. |
Goodwill and Other Intangibles, Net |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Goodwill and Other Intangibles, Net [Abstract] | |
| Goodwill and Other Intangibles, Net | Note 9 – Goodwill and Other Intangibles, Net Changes in the carrying amounts as follows: Global Distribution and Value-Added Services Global Specialty Products Global Technology Total Balance as of December 30, 2023 $ 2,007 $ 1,077 $ 791 $ 3,875 Adjustments to goodwill: Acquisitions 41 107 - 148 Impairment - (11) (2) (13) Foreign currency translation (39) (80) (4) (123) Balance as of December 28, 2024 2,009 1,093 785 3,887 Adjustments to goodwill: Acquisitions 49 124 26 199 Disposal (1) - (2) (3) Foreign currency translation 49 74 7 130 Balance as of December 27, 2025 $ 2,106 $ 1,291 $ 816 $ 4,213 In January 2025, we performed a geographical realignment within Services reportable segment intended to provide increased transparency distribution businesses and to reflect evolving management oversight realignment and the change in reporting units, we reallocated goodwill relative fair value approach. quantitative valuation analysis that considered projected cash flows, valuation inputs. Services reportable segment were tested for impairment as of January 1, values of our reporting units more likely than not exceeded their carrying January 1, 2025 under both structures. In connection with our restructuring initiatives, during the year ended 11 million impairment of goodwill in the Global Specialty Products segment, business; such impairment was calculated based on the relative fair value Other intangible assets consisted of the following: December 27, 2025 Accumulated Weighted Average Cost Amortization Net Life (in years) Customer relationships and lists $ 971 $ (408) $ 563 10 Trademarks / Tradenames 205 (96) 109 8 Product development 438 (120) 318 9 Non-compete agreements 18 (5) 13 5 Other 24 (9) 15 15 Total $ 1,656 $ (638) $ 1,018 December 28, 2024 Accumulated Weighted Average Cost Amortization Net Life (in years) Customer relationships and lists $ 915 $ (356) $ 559 10 Trademarks / Tradenames 188 (89) 99 8 Product development 403 (71) 332 9 Non-compete agreements 21 (6) 15 4 Other 28 (10) 18 15 Total $ 1,555 $ (532) $ 1,023 Trademarks, trade names, customer lists and customer relationships were established through and are amortized on a straight-line basis over their respective asset life. amounts paid primarily to prior owners of acquired businesses and certain restrictions on their ability to pose a competitive risk to us. over the respective non-compete period, which generally commences upon separation from us. Amortization expense, excluding impairment charges, related to definite-lived intangible assets December 27, 2025, December 28, 2024 and December 30, 2023, was $ 180 185 152 respectively. During the year ended December 27, 2025, we recorded $ 16 our Global Distribution and Value-Added Services segment. 14 primarily related to customer lists and relationships attributable businesses. 2 During the year ended December 28, 2024, we recorded $ 4 our Global Distribution and Value-Added Services segment. 2 calculated using the relative fair value, related to a disposal of a business, and 1 impairment due to business integration in connection with our restructuring 1 impairment charges related to trade names and non-compete agreements. During the year ended December 30, 2023, we recorded $ 19 our Global Distribution and Value-Added Services segment, consisting of $ 7 lists and relationships attributable to lower than anticipated operating 12 million charge related to the planned exit of a business in connection with our restructuring The impairment charges for the years ended December 27, 2025, December 28, 2024, measured as the excess of the carrying values over the estimated fair values determined using discounted estimates of future cash flows and the The above intangible asset impairment charges were recorded within selling, general and in restructuring and related costs in our consolidated statement of The annual amortization expense expected to be recorded for existing 2030 is $ 172 159 142 128 118 |
Investments and Other |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Investments and Other [Abstract] | |
| Investments and Other | Note 10 – Investments and Other Investments and other consisted of the following: December 27, December 28, 2025 2024 Investments in unconsolidated affiliates $ 174 $ 170 Non-current deferred foreign, state and local income taxes 92 47 Notes receivable (1) 56 63 Capitalized costs for software and cloud based applications for external use 112 90 Security deposits 4 4 Acquisition-related indemnification assets 39 39 Non-current pension assets 11 9 Non-current inventory 38 27 Other 72 52 Total $ 598 $ 501 (1) Long-term notes receivable carry interest rates ranging from 3.0 % to 11.8 % and are due in varying installments through May 31, 2031 . Amortization expense, related to capitalized costs for software to be sold, for cloud-based applications used to deliver our services, for the years 2024 and December 30, 2023, was $ 30 29 26 selling, general and administrative line within our consolidated statements During the year ended December 28, 2024 we recorded a $ 12 related to the Global Technology segment. |
Fair Value Measurements |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Fair Value Measurements [Abstract] | |
| Fair Value Measurements | Note 11 – Fair Value The following section describes the fair values of our financial instruments measure their fair values. Investments and notes receivable There are no quoted market prices available for investments in unconsolidated Certain of our notes receivable contain variable interest rates. receivable are a reasonable estimate of fair value based on the interest rates receivable fair value is based on Level 3 inputs within the fair value Debt The fair value of our debt (including bank credit lines, current maturities based on Level 3 inputs within the fair value hierarchy, and as of December 27, 2025 and December 28, 2024 was estimated at $ 3,107 2,536 value of our debt include market conditions, such as interest rates and credit Derivative contracts Derivative contracts are valued using quoted market prices and instruments primarily include foreign currency forward contracts, interest The fair values for the majority of our foreign currency derivative contracts rate to a published forward price of the underlying market rates, which transactions that are classified within Level 2 of the fair value hierarchy. The fair value of the interest rate swap, which is classified within Level 2 by comparing our contract rate to a forward market rate as of the The fair value of total return swaps is determined by valuing the underlying using market-on-close pricing by industry providers as of the valuation fair value hierarchy. Redeemable noncontrolling interests The values for redeemable noncontrolling interests are based on recent earnings that are classified within Level 3 of the fair value hierarchy. Intangible Assets Assets measured on a non-recurring basis at fair value include intangibles. classified as Level 3 within the fair value hierarchy. Defined Benefit Plans Assets of our defined benefit plans are measured on a recurring basis value hierarchy. Contingent Consideration We estimate the fair value of contingent consideration payments as part of the acquisition price and record the estimated fair value of contingent consideration as a liability on our accounted for as business combinations, subsequent changes in the payments are included in selling, general and administrative expenses For transactions involving changes in our ownership in consolidated without a change in our control, subsequent changes in the estimated fair payments are recognized in additional paid-in capital in our consolidated consideration at the fair value on a recurring basis using significant unobservable fair value hierarchy. weighted scenarios, to determine the fair value of the contingent consideration at each reporting period. risk-free rates, and credit spread. Contingent consideration is remeasured to fair value at each reporting 2025, we updated the fair value of contingent consideration in connection acquisitions, which resulted in expense of $ 9 11 ended December 28, 2024, we updated the fair value of contingent business acquisitions, which resulted in expense of $ 38 7 recorded in selling, general and administrative in the consolidated December 27, 2025, we also updated the fair value of contingent consideration These changes were recorded within additional paid-in-capital in the consolidated The components of the change in the fair value of contingent consideration and December 28, 2024 are presented in the following table: Years December 27, December 28, 2025 2024 Balance, beginning of period $ 30 $ 6 Increase in contingent consideration due to business acquisitions and acquisitions of noncontrolling interests in subsidiaries 103 10 Decrease in contingent consideration due to payments (19) (31) Change in fair value of contingent consideration in connection with business acquisitions (2) 45 Change in fair value of contingent consideration in connection with changes in ownership in consolidated subsidiaries (15) - Balance, end of period $ 97 $ 30 The following table presents our assets and liabilities that are measured and basis classified under the appropriate level of the fair value hierarchy as of 2024: December 27, 2025 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 1 $ - $ 1 Derivative contracts undesignated - 1 - 1 Total return - 1 - 1 Total assets $ - $ 3 $ - $ 3 Liabilities: Derivative contracts designated as hedges $ - $ 23 $ - $ 23 Derivative contracts undesignated - 2 - 2 Contingent consideration - - 97 97 Total liabilities $ - $ 25 $ 97 $ 122 Redeemable noncontrolling interests $ - $ - $ 895 $ 895 December 28, 2024 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 10 $ - $ 10 Derivative contracts undesignated - 7 - 7 Total assets $ - $ 17 $ - $ 17 Liabilities: Derivative contracts designated as hedges $ - $ 5 $ - $ 5 Derivative contracts undesignated - 4 - 4 Total return - 3 - 3 Contingent consideration - - 30 30 Total liabilities $ - $ 12 $ 30 $ 42 Redeemable noncontrolling interests $ - $ - $ 806 $ 806 |
Concentrations of Risk |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Concentrations of Risk [Abstract] | |
| Concentrations of Risk | Note 12 – Concentrations of Risk Certain financial instruments potentially subject us to concentrations of consist primarily of cash equivalents, trade receivables, long-term investments, instruments. instruments. not experienced any loss in such accounts and we manage this risk through highly liquid investments in high quality financial institutions. such losses, which have been within our expectations. financial instruments subject to credit risk, except for long-term notes receivable. We limit credit risk with respect to our cash equivalents, short-term and long-term investments and derivative instruments, by monitoring the credit worthiness of the financial institutions financial instruments. utilizing numerous investment grade counterparties. With respect to our trade receivables, credit risk is somewhat limited due to a relatively large customer base dispersion across different types of health care professionals and geographic areas. for more than 2 % of our net sales in each of the years ended December 27, 2025, 30, 2023. suppliers and our single largest supplier accounted for approximately 24 % and 4 %, respectively, of our aggregate purchases for the year ended December 27, 2025 and approximately 25 % and 4 %, respectively, of our aggregate purchases for the year ended December 28, 2024. Our long-term notes receivable primarily represent strategic financing arrangements Generally, these notes are secured by certain assets of the counterparty; however, in most cases our security is subordinate to the rights of other commercial financial institutions. event of non-performance by these counterparties, we conduct ongoing assessments operational performance. |
Derivatives and Hedging Activities |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Derivatives and Hedging Activities [Abstract] | |
| Derivatives and Hedging Activities | Note 13 – Derivatives and Hedging Activities We are exposed to market risks and changes in foreign currency exchange rates against the U.S. dollar and each other, and changes to the credit risk of the derivative counterparties. foreign currency forward contracts and by maintaining counter-party credit limits. only limited protection against currency exchange and credit risks. our hedging programs include currency markets and availability of hedging markets. anticipated currency exposure. and we manage our credit risks by diversifying our counterparties, multiple sources of capital. return swaps, and interest rate swaps. During 2019 we entered foreign currency forward contracts that we portion of our euro-denominated foreign operations. value of our investments in certain euro-functional currency subsidiaries due Gains and losses related to these net investment hedges are recorded within our consolidated balance sheets. in interest expense within our consolidated statements of income. investment hedges, which matured on November 16, 2023 , was approximately € 200 2023 we entered into new foreign currency forward contracts to operations which are designated as net investment hedges. hedge, which matures on November 3, 2028 , is approximately € 300 2025, December 28, 2024, and December 30, 2023, we recorded an (33) 10 million, and $ (32) forward contracts. On March 20, 2020 , we entered a total return swap to economically hedge our unfunded our DCP. value of the investments in these plans was $ 43 investments in these plans was $ 117 based on the Secured Overnight Financing Rate (“SOFR”) of 3.79 % plus 0.75 %, for a combined rate of 4.54 %. the years ended December 27, 2025, December 28, 2024, general and administrative expenses in our consolidated statement of income, 11 8 $ 10 On July 11, 2023, we entered into interest rate swap agreements to hedge the cash flow of our variable 750 million floating debt term loan facility, with three years our obligation to a fixed rate. payments based on the one-month Term SOFR rate and pay interest at a fixed rate. notional value of the interest rate swap agreements was $ 675 December 28, 2024, we recorded, within accumulated other comprehensive sheets, a loss of $ 3 3 swap agreements, since we have designated these swap agreements as cash Fluctuations in the value of certain foreign currencies as compared affect our revenues, gross margins, operating expenses and retained earnings, all of which are expressed dollars. contracts aimed at limiting the impact of foreign currency exchange short-term (i.e., generally 18 months or less) foreign currency forward contracts exchange risks associated with intercompany loans due from our international merchandise purchases to our foreign suppliers. U.S. dollars, as we consider foreign currency translation to be an accounting exposure. expenses: other within our consolidated balance sheets. The following table summarizes the terms and fair value of our outstanding derivative December 27, 2025 and December 28, 2024: December 27, 2025 Notional Amount Classification Fair Value Maturity Date Derivatives used in cash flow hedges: Foreign currency forward contracts $ 98 Prepaid expenses and other $ - December 24, 2026 Interest rate swaps 675 Accrued expenses, other (3) July 13, 2026 Derivatives used in net investment hedges: Foreign currency forward contracts 365 Accrued expenses, other (19) November 3, 2028 Undesignated hedging relationships: Total return 116 Prepaid expenses and other 1 December 30, 2025 Total $ 1,254 $ (21) December 28, 2024 Notional Amount Classification Fair Value Maturity Date Derivatives used in cash flow hedges: Foreign currency forward contracts $ 84 Prepaid expenses and other $ - October 30, 2025 Interest rate swaps 713 Accrued expenses, other (3) July 13, 2026 Derivatives used in net investment hedges: Foreign currency forward contracts 336 Prepaid expenses and other 9 November 3, 2028 Undesignated hedging relationships: Total return 106 Accrued expenses, other (3) December 30, 2024 Total $ 1,239 $ 3 The following table summarizes the effect of cash flow hedges and net investment hedges statements of income for the years ended December 27, 2025, December Years December 27, December 28, December 30, 2025 2024 2023 Derivatives used in cash flow hedges: Foreign currency forward contracts $ - $ - $ (1) Interest rate swaps - 6 (7) Derivatives used in net investment hedges: Foreign currency forward contracts (24) 7 (10) Total $ (24) $ 13 $ (18) The amount of gains or losses reclassified from accumulated other comprehensive material for the years ended December 27, 2025, December 28, 2024, |
Debt |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Debt [Abstract] | |
| Debt | Note 14 – Debt Bank Credit Lines Bank credit lines consisted of the following: December 27, December 28, 2025 2024 Revolving credit agreement $ 100 $ - Other short-term bank credit lines 664 650 Total $ 764 $ 650 Revolving Credit Agreement On August 20, 2021 , we entered into a $ 1.0 which was amended and restated on July 11, 2023 July 11, 2028 interest rate provisions to reflect the current market approach for a amended and restated the Revolving Credit Agreement to, among other and covenants. Rate (“ Term SOFR ”) plus a spread based on our leverage ratio at the end December 27, 2025 the interest rate on this revolving credit facility 3.78 % plus 1.08 % for a combined rate of 4.86 %. 4.45 % plus 1.18 % for a combined rate of 5.63 %. The Revolving Credit Agreement requires, among other things, that we Additionally, the Revolving Credit Agreement contains customary representations, warranties and affirmative covenants as well as customary negative covenants, subject to negotiated significant corporate changes (including mergers), dispositions and certain restrictive 27, 2025 and December 28, 2024, we had $ 100 0 revolving credit facility. Revolving Credit Agreement was approximately $ 203 there were $ 10 11 Revolving Credit Agreement. Other Short-Term Bank Credit As of December 27, 2025 and December 28, 2024, we had various other various currencies, with a maximum borrowing capacity of $ 787 790 December 27, 2025 and December 28, 2024, $ 664 650 During the year ended December 27, 2025, the average outstanding balances bank credit lines was approximately $ 680 under other short-term bank credit lines had weighted average interest 4.68 % and 5.35 %, respectively. Long-term debt Long-term debt consisted of the following: December 27, December 28, 2025 2024 Private placement facilities $ 1,149 $ 975 Term loan 749 712 U.S. trade accounts receivable securitization 390 150 Various in varying installments through 2031 at interest rates from 0.00 % to 6.75 % at December 27, 2025 and from 0.00 % to 9.42 % at December 28, 2024 48 43 Finance lease obligations 7 6 Total 2,343 1,886 Less current maturities (33) (56) Total long-term debt $ 2,310 $ 1,830 As of December 27, 2025, deferred debt issuance costs, maturing in each of the next five years 2026 $ 33 2027 534 2028 221 2029 143 2030 810 Thereafter 602 Total $ 2,343 Private Placement Facilities Our private placement facilities provided by four 1.5 and are available on an uncommitted basis at fixed rate economic terms from time to time through December 19, 2028 . lenders at a fixed rate based on an agreed upon spread over applicable treasury term of each possible issuance will be selected by us and can range from five 15 years longer than 12 years ). purposes, including working capital and capital expenditures, to refinance potential acquisitions. other things, (i) extend the scheduled facility termination dates to December 19, 2028 financial definitions and covenants. maximum leverage ratios, and contain restrictions relating to subsidiary disposal of assets and certain changes in ownership. that we pay off the facilities prior to the applicable due dates. The components of our private placement facility borrowings as of December average interest rate of 3.93 % are presented in the following table: Amount of Date of Borrowing Borrowing Borrowing Outstanding Rate Due Date June 16, 2017 $ 100 3.42 % June 16, 2027 September 15, 2017 100 3.52 September 15, 2029 January 2, 2018 100 3.32 January 2, 2028 September 2, 2020 100 2.35 September 2, 2030 June 2, 2021 100 2.48 June 2, 2031 June 2, 2021 100 2.58 June 2, 2033 May 4, 2023 75 4.79 May 4, 2028 May 4, 2023 75 4.84 May 4, 2030 May 4, 2023 75 4.96 May 4, 2033 May 4, 2023 150 4.94 May 4, 2033 December 15, 2025 100 5.23 December 15, 2032 December 15, 2025 75 5.28 December 15, 2032 Less: Deferred debt issuance costs (1) Total $ 1,149 The components of our private placement facility borrowings as of December average interest rate of 3.70 % are presented in the following table: Amount of Date of Borrowing Borrowing Borrowing Outstanding Rate Due Date June 16, 2017 $ 100 3.42 % June 16, 2027 September 15, 2017 100 3.52 September 15, 2029 January 2, 2018 100 3.32 January 2, 2028 September 2, 2020 100 2.35 September 2, 2030 June 2, 2021 100 2.48 June 2, 2031 June 2, 2021 100 2.58 June 2, 2033 May 4, 2023 75 4.79 May 4, 2028 May 4, 2023 75 4.84 May 4, 2030 May 4, 2023 75 4.96 May 4, 2033 May 4, 2023 150 4.94 May 4, 2033 Total $ 975 Term Loan On July 11, 2023, we entered into a three-year 750 Agreement”), which was originally scheduled to mature on July 11, 2026 . amended and restated to, among other things, (i) extend the maturity date June 6, 2030 , and (ii) modify certain financial definitions and covenants. Term SOFR based on our leverage ratio at the end of each financial reporting quarter. through June 2027, we are required to make quarterly payments of $ 5 payment amount increases to $ 9 2030. 749 27, 2025, the interest rate under the Term Credit Agreement was 3.76 % plus 1.25 % for a combined rate of 5.01 %. As of December 28, 2024, the borrowings outstanding under this term 712 2024, the interest rate under the Term Credit Agreement was 4.45 % plus 1.60 % for a combined rate of 6.05 %. However, at December 28, 2024, we had a hedge in place creating an effective fixed rate of 6.04 %. the Term Credit Agreement in June of 2025, our hedged portion of the Term Credit Agreement is now approximately 90 % of the notional total. 5.69 % and the floating rate was 5.01 %, resulting in a weighted average rate of 5.62 %. among other things, that we maintain certain maximum leverage ratios. contains customary representations, warranties and affirmative covenants as well subject to negotiated exceptions, on liens, indebtedness, significant corporate dispositions and certain restrictive agreements. U.S. Trade Accounts Receivable Securitization We have a facility agreement based on our U.S. trade accounts receivable that is structured as an asset-backed securitization program with pricing committed for up to three years . expiration date of this facility agreement to December 6, 2027 December 15, 2025 ). This facility agreement has a purchase limit of $ 450 two As of December 27, 2025 and December 28, 2024, the borrowings outstanding were $ 390 150 this facility was based on the asset-backed commercial paper rate 4.06 % plus 0.75 %, for a combined rate of 4.81 %. commercial paper rate of 4.73 % plus 0.75 %, for a combined rate of 5.48 %. If our accounts receivable collection pattern changes due to customers our ability to borrow under this facility may be reduced. We are required to pay a commitment fee of 30 35 |
Income Taxes |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Income Taxes [Abstract] | |
| Income Taxes | Note 15 – Income Taxes Income before taxes and equity in earnings of affiliates was as follows: Years December 27, December 28, December 30, 2025 2024 2023 Domestic $ 384 $ 338 $ 424 Foreign 149 175 118 Total $ 533 $ 513 $ 542 The provisions for income taxes were as follows: Years December 27, December 28, December 30, 2025 2024 2023 Current income tax expense: U.S. Federal $ 42 $ 100 $ 72 State and local 15 33 28 Foreign 64 56 40 Total current 121 189 140 Deferred income tax expense (benefit): U.S. Federal 33 (29) 9 State and local 3 (12) (3) Foreign (31) (20) (26) Total deferred 5 (61) (20) Total provision $ 126 $ 128 $ 120 The tax effects of temporary differences that give rise to our deferred income tax asset (liability) were Years December 27, December 28, 2025 2024 Deferred income tax asset: Net operating losses $ 105 $ 91 Other carryforwards 52 37 Inventory, premium valuation allowances 38 37 Operating lease liability 75 76 Capitalization of research and development costs 10 27 Other asset 62 49 Total deferred income 342 317 Valuation (1) (53) (38) Net deferred income tax asset 289 279 Deferred income tax liability Intangibles amortization (266) (260) Operating lease right-of-use asset (70) (67) Property and equipment (7) (7) Total deferred tax (343) (334) Net deferred income tax asset (liability) $ (54) $ (55) (1) Primarily relates to operating losses, the benefits of which are uncertain. reflected as a reduction of income tax expense. The assessment of the amount of value assigned to our deferred tax assets under judgmental. We are required to consider all available positive and negative evidence that we will be able to realize the benefit of our deferred tax assets in the future. of deferred tax liabilities and projected future taxable income. events that may occur some years into the future, there is an element of deferred tax assets is dependent on generating sufficient taxable income in future periods. We believe that it is more likely than not that future taxable income will be sufficient to allow us to recover assigned to our deferred tax assets. not that we will be able to recover the value assigned to our deferred tax assets, we valuation allowance accordingly. As of December 27, 2025, we had federal, state and foreign net operating 86 million, $ 62 366 will begin to expire in various years from 2026 through 2045. operating losses that can be carried-forward indefinitely are $ 86 21 358 respectively. The effective income tax rate for the year ended December 27, 2025 differs from the statutory federal rate as follows: Year $ % Income tax provision at federal statutory rate $ 112 21.0 % State income tax provision, net of federal income tax effect 10 2.0 Foreign Tax effects Cayman Islands: Foreign partnership loss 8 1.5 Other (1) (0.1) Other foreign jurisdictions: Equity investment remeasurement gain (6) (1.1) Notional interest deduction (6) (1.1) Other 19 3.5 Effects of changes in tax laws or rates enacted in current period - - Cross-border tax laws 1 0.1 Tax credits (2) (0.4) Changes in valuation allowance 3 0.6 Nontaxable and nondeductible items 3 0.5 Worldwide changes 4 0.7 Other adjustments: Previously held non-controlling equity investment (9) (1.7) Other (10) (1.8) Effective tax rate $ 126 23.7 % State taxes in California, Illinois, Massachusetts, New Jersey, and New York in this category. As previously disclosed for the years ended December 28, 2024 and December ASU 2023-09, the tax provisions differ from the amount computed using the federal follows: Years December 28, December 30, 2024 2023 Income tax provision at federal statutory rate $ 108 $ 114 State income tax provision, net of federal income tax effect 11 15 Foreign income tax provision 10 5 Pass-through noncontrolling interest 1 (8) Valuation 6 (3) Unrecognized tax benefits and audit settlements 5 9 Interest expense related to loans (14) (13) Effect of cross border tax laws 12 7 Other (11) (6) Total income $ 128 $ 120 For the year ended December 27, 2025 our effective tax rate was 23.7 %, compared to 24.9 % for the prior year period. 22.1 %. rates primarily relates to state and foreign income taxes and interest expense, with the acquisition of a controlling interest of a previously held non-controlling On July 4, 2025, President Trump signed the reconciliation tax bill, commonly known as the “One Big Beautiful Bill Act” (OBBBA), into law. research and experimental expenditures, limitations on certain deductions provisions. The OECD issued technical and administrative guidance on Pillar Two rules in December 2021, which provides for a global minimum tax rate on the earnings of large multinational businesses on a country-by-country Effective January 1, 2024, the minimum global tax rate is 15% for various jurisdictions pursuant rules. which may adversely impact our effective tax rate going forward or result in higher cash December 27, 2025, the impact of the Pillar Two rules to our financial statements was immaterial. Due to the one-time transition tax and the imposition of the GILTI provisions, all previously unremitted earnings will no longer be subject to U.S. federal income tax; however, there could be U.S., state and/or foreign withholding taxes upon distribution of such unremitted earnings. liability with respect to such earnings is not practicable. ASC Topic 740 prescribes the accounting for uncertainty in income taxes recognized in accordance with other provisions contained within its guidance. for the financial statement recognition and measurement of tax positions taken or return. examination by the taxing authorities. a greater than 50% likelihood of being realized upon ultimate audit settlement. our tax returns are subject to examination by various taxing authorities. and interest assessments by these taxing authorities for uncertain tax positions matters. The total amount of unrecognized tax benefits, which are included in “other balance sheets, as of December 27, 2025 and December 28, 2024 was $ 112 108 of which $ 104 100 All tax returns audited by the IRS are officially closed through 2021. IRS include years 2022 and forward. examination. The amount of tax interest expense included as a component of the provision 4 2 and $ 4 respectively. sheets, and was $ 22 18 penalties accrued for during the periods presented was not material to our The following table provides a reconciliation of unrecognized tax benefits: December 27, December 28, December 30, 2025 2024 2023 Balance, beginning of period $ 89 $ 98 $ 82 Additions based on current year tax positions 5 5 9 Additions based on prior year tax positions 5 10 26 Reductions based on prior year tax positions (2) (14) (2) Reductions resulting from settlements with taxing authorities - - (3) Reductions resulting from lapse in statutes of limitations (7) (10) (14) Balance, end of period $ 90 $ 89 $ 98 |
Plans of Restructuring and Related Costs |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Plans of Restructuring and Related Costs [Abstract] | |
| Plans of Restructuring and Related Costs | Note 16 – Plans of Restructuring and Related Costs On August 6, 2024, we committed to a restructuring plan (the “2024 operations and further increase efficiencies. During the years ended December 27, 2025 and December 28, 2024, we recorded associated with the 2024 Plan of $ 105 73 these periods primarily related to severance and employee-related costs, accelerated assets and fixed assets, and other exit costs. the 2024 Plan through the end of 2027; however, an estimate of the amount of these charges for 2026 through 2027 has not yet been determined. During the year ended December 27, 2025, in connection with the 2024 Plan, 1 $ 12 Specialty Product segments, respectively, and a net gain related to disposal of a business in the Global Technology segment. 105 During the year ended December 28, 2024, in connection with the 2024 Plan, goodwill and intangible assets of $ 13 Specialty Products segment. 73 discussed above. On August 1, 2022, we committed to a restructuring plan (the “2022 BOLD+1 strategic plan, streamlining operations and other initiatives to completed as of July 31, 2024. with our 2022 Plan, we recorded restructuring and related costs of $ 37 80 primarily related to severance and employee-related costs, accelerated amortization assets, and other exit costs. During the year ended December 30, 2023, in connection with the 2022 Plan, intangible asset of $ 12 impairment is included in the $ 80 completed during the first quarter of 2024. Restructuring and related costs recorded for the fiscal years ended 2025, 2024 Plan and 2022 Plan, respectively, consisted of the following: Year Ended Global Distribution and Value-Added Services Global Specialty Products Global Technology Corporate Total 2024 Plan Severance and employee-related costs $ 40 $ 22 $ 4 $ 20 $ 86 Impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets (3) 6 (1) - 2 Exit and other related costs 5 4 - - 9 Loss/(Gain) on disposal of a business 1 12 (5) - 8 Restructuring and related costs-2024 Plan $ 43 $ 44 $ (2) $ 20 $ 105 Year Ended Global Distribution and Value-Added Services Global Specialty Products Global Technology Corporate Total 2024 Plan Severance and employee-related costs $ 31 $ 5 $ 6 $ 2 $ 44 Impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets 5 3 4 - 12 Exit and other related costs 2 - - - 2 Loss on disposal of a business - 15 - - 15 Restructuring and related costs-2024 Plan $ 38 $ 23 $ 10 $ 2 $ 73 2022 Plan Severance and employee-related costs $ 18 $ 5 $ 1 $ - $ 24 Accelerated depreciation and amortization 10 - - (3) 7 Exit and other related costs 2 2 - 2 6 Loss on disposal of a business - - - - - Restructuring and related costs-2022 Plan $ 30 $ 7 $ 1 $ (1) $ 37 Total restructuring and related costs $ 68 $ 30 $ 11 $ 1 $ 110 Year Ended Global Distribution and Value-Added Services Global Specialty Products Global Technology Corporate Total 2022 Plan Severance and employee-related costs $ 29 $ 5 $ 5 $ 7 $ 46 Impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets 13 - 2 - 15 Exit and other related costs 3 1 - 2 6 Loss on disposal of a business - 13 - - 13 Restructuring and related costs-2022 Plan $ 45 $ 19 $ 7 $ 9 $ 80 The following table summarizes, by plan year, the activity related to the liabilities associated with initiatives under the 2022 Plan and the 2024 Plan for the year ended December balance of restructuring and related costs as of December 27, 2025, which employee-related costs, is included in accrued expenses: other within related to exited leased facilities are recorded within our current and non-current our consolidated balance sheets. 2022 Plan 2024 Plan Total Balance, December 30, 2023 $ 23 $ - $ 23 Restructuring and related costs 37 73 110 Non-cash impairment, accelerated depreciation and amortization (7) (12) (19) Non-cash impairment on disposal of a business - (13) (13) Cash payments and other adjustments (41) (20) (61) Balance, December 28, 2024 12 28 40 Restructuring and related costs - 105 105 Non-cash impairment, accelerated depreciation and amortization - (2) (2) Non-cash charges related to disposal of a business - (6) (6) Cash payments and other adjustments (11) (77) (88) Balance, December 27, 2025 $ 1 $ 48 $ 49 |
Commitments and Contingencies |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Commitments and Contingencies Disclosure [Abstract] | |
| Commitments and Contingencies | Note 17 – Commitments and Contingencies Purchase Commitments In our Global Distribution and Value-Added Services business, we sometimes enter into long-term purchase commitments to ensure the availability of products for distribution. inventory purchase commitments as of December 27, 2025 were: 2026 $ 8 2027 1 2028 - 2029 - 2030 - Thereafter - Total minimum $ 9 Employment, Consulting and Non-Compete Agreements We have employment, consulting and non-compete agreements that have varying base aggregate annual payments for the years 2026 through 2030 and thereafter of approximately $ 13 3 0 0 0 million, and $ 0 compensation of four-hundred thousand next increase in 2027. Legal Proceedings Henry Schein, Inc. was named as a defendant in multiple opioid related 10 ); one or more of Henry Schein, Inc.’s subsidiaries was also named as a defendant in a number of those cases). the lawsuits allege that the manufacturers of prescription opioid drugs expand the market for such drugs and their own market share and that Henry Schein, Inc. and its subsidiaries) reaped financial rewards by refusing appropriately and restrict the improper distribution of those drugs. within the MultiDistrict Litigation (“MDL”) proceeding In Re National 2804; Case No. 17-md-2804) and are currently stayed. 13.2 billion, sales of opioids represented less than four -tenths of 1 percent. business. From time to time, we may become a party to other legal proceedings, liability claims, employment matters, commercial disputes, governmental in some cases involve our entering into settlement arrangements or consent of the ordinary course of our business. in our opinion none of these other pending matters are currently consolidated financial position, liquidity or results of operations. As of December 27, 2025, we had accrued our best estimate of potential to result in liability and for which we were able to reasonably estimate related expenses, was not material to our financial position, results of operations determining estimated losses considers currently available factors, including probable recoveries from third parties. |
Stock Based Compensation |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Stock Based Compensation [Abstract] | |
| Stock Based Compensation | Note 18 – Stock-Based Compensation Stock-based awards are provided to certain employees under our 2024 Stock Incentive 2020 Stock Incentive Plan) and to non-employee directors under our 2023 Non-Employee Plan (together, the “Plans”). “Compensation Committee”). form of time-based and performance-based restricted stock units (“RSUs”) in which non-qualified stock options were issued in place of performance-based granted time-based and performance-based RSUs, as well as non-qualified directors receive equity-based awards solely in the form of time-based RSUs with 12 -month cliff vesting. Starting with our 2023 plan year, we returned to granting our employees equity-based awards solely in time-based RSUs (which vest solely based on the recipient’s continued service over time) and performance-based RSUs (which vest based on achieving specified performance over time). In our 2025 plan year, stock awards issued to our Chief Executive Officer were allocated 35 % to time-based RSU awards with four-year 65 % to performance-based RSU awards with three-year 2025 plan year, stock awards issued to members of our Executive Management Committee were allocated 50 % to time-based RSU awards with four-year 50 % to performance-based RSU awards with three-year cliff vesting. In our 2025 plan year, stock awards issued to our eligible vice-presidents were allocated 80 % to time-based RSU awards and 20 % to performance-based RSU awards with three-year based awards will vest 50 % on the third anniversary of the grant date with the remaining 50 % vesting on the fourth anniversary of the grant date. In our 2025 plan year, we began granting only time-based RSU awards to our eligible director level employees. Our director level time-based RSU awards will vest 50 % on the third anniversary of the grant date with the remaining 50 % vesting on the fourth anniversary of the grant date. For the performance-based RSUs and the time-based RSUs with cliff vesting (issued recognize the cost as compensation expense on a straight-line basis. (issued in the 2025 plan year), we recognize the cost as compensation As of December 27, 2025, there were 75,742,657 9,081,164 under the 2025 Stock Incentive Plan and 2,075,000 324,753 under the 2023 Non-Employee Director Stock Incentive Plan. For all RSUs, we estimate the fair value based on our closing stock performance-based RSUs, the number of shares that ultimately vest and our performance as measured against specified targets over a specified period, as Committee. performance-based RSUs based on our closing stock price at time of grant. Each of the Plans provide for certain adjustments to the performance the Plans. performance measurement adjustments relate to significant events, including, divestitures, new business ventures, changes in fair value of contingent performance-based RSUs granted in the 2024 and 2025 plan years), repurchases), differences in budgeted average outstanding shares (other transactions referred to above), restructuring and related costs, amortization related intangible assets, certain litigation settlements or payments, applicable laws or regulations, changes in income tax rates in certain financial impact either positive or negative, of the difference in projected earnings (solely with respect to performance-based RSUs granted in the 2023 plan costs related to shareholder advisory matters (solely with respect to performance-based plan year). Over the performance period, the number of performance-based RSUs that will the related compensation expense is adjusted upward or downward based upon performance targets. recognized as an expense is based on our actual performance against each case as adjusted). Stock options are awards that allow the recipient to purchase shares of our price set at the time of grant. date of grant. service, subject to the terms and conditions of the 2020 Stock Incentive Plan, three years grant date and have a contractual term of ten years term acceleration upon certain events. basis. ended December 27, 2025, we did no t grant any stock options. Our consolidated statements of income reflect pre-tax share-based compensation 39 39 million and $ 39 respectively. Total unrecognized compensation cost related to unvested awards as of December 27, 2025 was $ 63 is expected to be recognized over a weighted-average period of approximately 2.5 The weighted-average grant date fair value of stock-based awards granted 75.78 , $ 75.12 76.43 during the years ended December 27, 2025, December 28, 2024 and December We record deferred income tax assets for awards that will result in amount of compensation cost recognized and our statutory tax rate in the deduction. Our consolidated statements of cash flows present our stock-based compensation adjustment between net income and net cash provided by operating no cash benefits associated with tax deductions in excess of recognized December 27, 2025, December 28, 2024 and December 30, 2023. The following table summarizes the stock option activity for the year Stock Options Weighted Average Aggregate Weighted Average Remaining Contractual Intrinsic Shares Exercise Price Life (in years) Value Outstanding at beginning of year 963,491 $ 72.16 Granted - - Exercised (24,945) 62.71 Forfeited (15,831) 81.75 Outstanding at end of year 922,715 $ 72.26 5.6 $ 7 Options exercisable at end of year 922,715 $ 72.26 5.6 $ 7 The following tables summarize the activity of our unvested RSUs for Time-Based Restricted Stock Units Performance-Based Restricted Stock Units Weighted Average Weighted Average Grant Date Fair Grant Date Fair Shares/Units Value Per Share Shares/Units Value Per Share Outstanding at beginning of period 1,685,550 $ 72.90 389,111 $ 75.98 Granted 592,716 75.18 251,287 75.30 Performance adjustment n/a n/a (31,313) 76.20 Vested (564,037) 66.54 (14,499) 84.04 Forfeited (107,687) 77.10 (206,626) 77.33 Outstanding at end of period 1,606,542 $ 75.69 387,960 $ 75.89 The fair value of time and performance RSUs that vested was $ 38 1 ended December 27, 2025; $ 21 1 $ 27 38 |
Employee Benefit Plans |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Employee Benefit Plans [Abstract] | |
| Employee Benefit Plans | Note 19 – Employee Benefit Plans Defined benefit plans Certain of our employees in our international markets participate These plans are managed to provide pension benefits to covered employees and practices. liabilities within our consolidated balance sheets. obligations, plan assets, and the funded status of our defined benefit Years December 27, December 28, 2025 2024 Obligation and funded status: Change in benefit obligation Projected benefit obligation, beginning of period $ 129 $ 125 Service costs 4 4 Interest cost 3 3 Past service cost (credit) - (1) Actuarial gain (loss) (2) 6 Benefits paid 1 - Participant contributions 2 2 Settlements and curtailments (7) (1) Effect of foreign currency translation 16 (9) Projected benefit obligation, end of period $ 146 $ 129 Change in plan assets Fair value of plan assets at beginning of period $ 90 $ 86 Actual return on plan assets 1 3 Employer contributions 3 3 Plan participant contributions 2 2 Expected return on plan assets 3 3 Benefit received 4 1 Settlements (6) (2) Effect of foreign currency translation 9 (6) Fair value of plan assets at end of period $ 106 $ 90 Unfunded status at end of period $ 40 $ 39 The majority of our defined benefit plans are unfunded, with the exception amount of assets exceeds the projected benefit obligation by approximately 8 8 December 27, 2025 and December 28, 2024, respectively. accumulated benefit obligations were $ 142 125 The following table provides the amounts recognized in our consolidated pension plans: Years December 27, December 28, 2025 2024 Non-current assets $ 37 $ 28 Current liabilities (1) (1) Non-current liabilities (76) (68) Accumulated other comprehensive loss, pre-tax 8 10 The following table provides the components of net periodic pension cost Years December 27, December 28, December 30, 2025 2024 2023 Service cost $ 4 $ 4 $ 3 Interest cost 3 3 3 Expected return on plan assets (3) (3) (3) Employee contributions (1) (1) (1) Settlements (1) - - Net periodic pension cost $ 2 $ 3 $ 2 The following tables present the weighted-average actuarial assumptions obligation and our net periodic pension cost for the periods presented: Years December 27, December 28, Pension Benefit Obligation 2025 2024 Weighted average 2.75 % 2.23 % Years December 27, December 28, December 30, Net Periodic Pension Cost 2025 2024 2023 Discount rate-pension benefit 2.05 % 1.70 % 1.50 % Expected return on plan assets 0.92 % 1.13 % 0.51 % Rate of compensation increase 2.00 % 1.98 % 1.64 % Pension increase rate 0.74 % 0.63 % 0.80 % The following table presents the estimated pension benefit payments that December 27, 2025: Year 2026 $ 8 2027 9 2028 9 2029 7 2030 8 2031 to 2035 52 Total $ 93 401(k) Plans We offer matching contributions to these plans generally do not exceed 100 % of the participants’ contributions up to 5 % of their base compensation, subject to applicable legal limits. allocated consistent with the participants’ investment elections on file, subject 20 % allocation limit to the Henry Schein Stock Fund. fully vested are reallocated as part of our ongoing matching contributions the 401(k) plans. Assets of the 401(k) and other defined contribution plans are held choose from various investment fund options. during the years ended December 27, 2025, December 28, 2024 and December 42 $ 48 50 36 40 and $ 42 6 8 8 included in cost of goods sold for the years ended December 27, 2025, December 2023, respectively. Supplemental Executive Retirement Plan We offer highly compensated employees after they have reached the maximum limit. base compensation for the portion of the year in which such employees are contributions to the 401(k) plan. December 28, 2024 and December 30, 2023 amounted to $ 3 2 3 charges are included in selling, general and administrative within our consolidated Deferred Compensation Plan We offer DCP to a select group of management or highly compensated employees subsidiaries. eligible employees. 2024 and December 30, 2023 were approximately $ 12 12 12 charges are included in selling, general and administrative within our consolidated |
Redeemable Noncontrolling Interests |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Redeemable Noncontrolling Interests [Abstract] | |
| Redeemable Noncontrolling Interests | Note 20 – Redeemable Noncontrolling Interests Some minority stockholders in certain of our subsidiaries have the right, their ownership interest in those entities at fair value. where we are or may be required to purchase all or a portion of the from the noncontrolling interest holder under the terms of a put option contained components of the change in the redeemable noncontrolling interests for the December 28, 2024 and December 30, 2023, are presented in the following table: December 27, December 28, December 30, 2025 2024 2023 Balance, beginning of period $ 806 $ 864 $ 576 Decrease in redeemable noncontrolling interests due to acquisitions of noncontrolling interests in subsidiaries (76) (273) (19) Increase in redeemable noncontrolling interests due to business acquisitions 86 171 326 Net income (loss) attributable to redeemable noncontrolling interests (5) (1) 6 Distributions declared, net of capital contributions (18) (50) (19) Effect of foreign currency translation gain (loss) attributable redeemable noncontrolling interests 30 (24) 5 Change in fair value of redeemable securities 72 119 (11) Balance, end of period $ 895 $ 806 $ 864 |
Comprehensive Income |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Comprehensive Income [Abstract] | |
| Comprehensive Income | Note 21 – Comprehensive Income Comprehensive income includes certain gains and losses that, under U.S. are recorded directly to stockholders’ equity. The following table summarizes our Accumulated other comprehensive loss, net December 27, December 28, December 30, 2025 2024 2023 Attributable to redeemable noncontrolling interests: Foreign currency translation adjustment $ (26) $ (56) $ (32) Attributable to noncontrolling interests: Foreign currency translation adjustment $ 1 $ (1) $ (1) Attributable to Henry Schein, Inc.: Foreign currency translation adjustment $ (196) $ (371) $ (188) Unrealized gain loss from hedging activities (24) - (13) Pension adjustment loss (6) (8) (5) Accumulated other comprehensive loss $ (226) $ (379) $ (206) Total Accumulated $ (251) $ (436) $ (239) The following table summarizes the components of comprehensive income, net December 27, December 28, December 30, 2025 2024 2023 Net income $ 419 $ 398 $ 436 Foreign currency translation gain (loss) 207 (207) 53 Tax effect - - - Foreign currency translation gain (loss) 207 (207) 53 Unrealized gain (loss) from hedging activities (33) 18 (25) Tax effect 9 (5) 7 Unrealized gain (loss) from hedging activities (24) 13 (18) Pension adjustment gain (loss) 5 (5) (3) Tax effect (3) 2 - Pension adjustment gain (loss) 2 (3) (3) Comprehensive income $ 604 $ 201 $ 468 Our financial statements are denominated in U.S. Dollars. compared to the U.S. Dollar may have a significant impact on our translation gain (loss) during the years ended December 27, 2025, December 28, primarily due to changes in foreign currency exchange rates of the Brazilian Franc, Israel Shekel, Canadian Dollar, Australian Dollar, and New Zealand Dollar. The hedging gain (loss) during the years ended December 27, 2025, December was attributable to a net investment hedge. The following table summarizes our total comprehensive income, net of December 27, December 28, December 30, 2025 2024 2023 Comprehensive income attributable to Henry Schein, Inc. $ 551 $ 217 $ 443 Comprehensive income attributable to noncontrolling interests 28 9 14 Comprehensive income (loss) attributable to Redeemable noncontrolling interests 25 (25) 11 Comprehensive income $ 604 $ 201 $ 468 |
Earnings Per Share |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Earnings Per Share [Abstract] | |
| Earnings Per Share | Note 22 – Earnings Per Share Basic earnings per share is computed by dividing net income attributable average number of common shares outstanding for the period. to basic earnings per share, except that it reflects the effect of common shares issuable exercise of stock options using the treasury stock method in periods A reconciliation of shares used in calculating earnings per basic and Years December 27, December 28, December 30, 2025 2024 2023 Basic 120,813,977 126,788,997 130,618,990 Effect of dilutive securities: Stock options and restricted stock units 903,899 990,231 1,129,181 Diluted 121,717,876 127,779,228 131,748,171 The number of antidilutive securities that were excluded from the calculation shares outstanding are as follows: Years December 27, December 28, December 30, 2025 2024 2023 Stock options 396,052 406,676 424,695 Restricted stock units 6,200 9,287 15,040 Total anti-dilutive computation 402,252 415,963 439,735 |
Supplemental Cash Flow Information |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Supplemental Cash Flow Elements [Abstract] | |
| Supplemental Cash Flow Information | Note 23 – Supplemental Cash Flow Information Cash paid for interest and income taxes was: Years December 27, December 28, December 30, 2025 2024 2023 Cash paid for interest $ 151 $ 132 $ 84 Cash paid for income taxes, net of refunds: U.S. Federal $ 67 U.S. State and local 15 Foreign: Switzerland 8 Other 38 Total $ 128 Years December 28, December 30, 2024 2023 Cash paid during the period for income taxes (prior to ASU 2023-09) $ 144 $ 218 For the years ended December 27, 2025, December 28, 2024 and December (33) 18 million and $ (25) There was approximately $ 3 0 143 the years ended December 27, 2025, December 28, 2024 and December 30, 2023, during the year ended December 30, 2023 primarily relates to the acquisitions |
Related Party Transactions |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Related Party Transactions | |
| Related Party Transactions | Note 24 – Related Party Transactions During 2018, we entered into a joint venture with Internet Brands to create Henry Brands initially held a 26 % noncontrolling interest, which has since increased to a 33.6 % noncontrolling interest in Henry Schein One, LLC, and a freestanding and separately exercisable right Henry Schein, Inc. for fair value following the fifth anniversary of the effective date of the venture. extend the time-based trigger for the exercise of our call option to July 1, 2032 Brands of its put option for a period of four years , to January 29, 2029. In connection with the formation of Henry Schein One, LLC we entered ten-year Internet Brands whereby we will pay Internet Brands approximately $ 31 intellectual property. recorded $ 31 31 31 consolidated statements of income, 2025 and December 28, 2024, Henry Schein One, LLC had a net payable balance 9 and $ 1 components of this payable are recorded within accrued expenses: other within We have interests in entities that we account for under the equity accounting business, during the years ended December 27, 2025, December 28, 2024 sales of $ 56 52 47 27, 2025, December 28, 2024 and December 30, 2023, we purchased 19 10 10 respectively, from such entities. 39 and $ 35 6 6 equity affiliates. Certain of our facilities related to our acquisitions are leased from employees |
KKR Investment and Accelerated Share Repurchase Program |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| KKR Investment and Accelerated Share Repurchase Program [Abstract] | |
| KKR Investment and Accelerated Share Repurchase Program | Note 25 – KKR Investment and Accelerated Share Repurchase Program On January 29, 2025, Henry Schein, Inc. announced a strategic investment global investment firm, and entered into a Strategic Partnership Agreement 16, 2025, we issued 3,285,151 250 million, at approximately $ 76.10 two joined our Board of Directors. On May 19, 2025, we executed an accelerated share repurchase program 250 our outstanding common stock based on volume-weighted average prices. 3,122,832 shares at an estimated fair value of $ 224 368,651 estimated fair value of $ 26 share repurchase program. On November 4, 2025, the Company and KKR entered into an amendment beneficial ownership limit from 14.9 % to 19.9 % of the outstanding shares of the Company’s common stock that KKR is permitted to acquire during the standstill period. ownership limit, continue in effect for a period of six months following the later Agreement and the date on which no KKR director appointed pursuant Directors. |
Insider Trading Arrangements |
3 Months Ended |
|---|---|
Dec. 28, 2024 | |
| Insider Trading Arr [Line Items] | |
| No Insider Trading Flag | true |
Insider Trading Policies and Procedures |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Insider Trading Policies Proc [Line Items] | |
| Insider Trading Policies and Procedures Adopted | true |
Cybersecurity Risk Management Strategy And Governance |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Cybersecurity Risk Management Strategy And Governance [Line Items] | |
| Cybersecurity Risk Management Processes For Assessing Identifying And Managing Threats [Text Block] | Cybersecurity Risk Management and Strategy We have developed and implemented a cybersecurity risk mitigation strategy intended to protect our information systems. aligned with generally accepted cybersecurity standards and frameworks, Framework, or “NIST CSF,” and our Company is externally audited, or certified, with ISO27001 partial scope. We maintain an Office of Cybersecurity (“OCS”), led by our Chief Information Security Officer (“CISO”), which oversees management team, which continuously evaluates our global cybersecurity on maintaining and protecting our information systems. strategy, the OCS partners with our Global Technology Solutions team, which is led by our Chief Technology Officer (“CTO”) and is comprised of over one hundred professionals that support our information operations. monitoring the Company’s information systems, as well as at our third-party partners. Our CISO reports to our CTO. experience leading large-scale global IT organizations and received a Bachelor of Business Administration Business Computer Information Systems and a Master of Business Administration Our Vice President, Global CISO, who also serves as Vice President and Head of the Office of Cyber Security, has over 30 years of experience leading global cybersecurity and technology programs in large and complex corporations, and holds a Certified Professional and a Certified Information Systems Auditor certification. Technology and Security from Baker College. managers who are members of our Executive Steering Committee, comprised technology, legal and internal auditing officers. developments, and our Board oversees our risk mitigation strategy principally Regulatory, Compliance and Cybersecurity Committee, as described in more detail below. Our cybersecurity risk management program includes, among other • risk assessments designed to help identify material cybersecurity risks • a security team principally responsible for managing our (i) cybersecurity (ii) defining cybersecurity control standards; • the use of expert external service providers to assess, test or otherwise assist cybersecurity controls, and to respond to specific cybersecurity threats; • the review and assessment of past cybersecurity incidents with a view to further strengthen our cyber risk mitigation strategy; • a written cybersecurity incident response plan that includes procedures incidents; and • a Global Information Security Policy, together with more detailed information security policies, procedures, standards, and guidelines. In addition, all employees with systems access are required to participate anti-phishing courses, along with compliance programs. also receive additional mandatory annual data security training specific security threats. Our cybersecurity risk strategy is integrated into our overall enterprise cybersecurity team is supported by and connected with the enterprise risk management Cyber Incidents In addition to immaterial and unrelated incidents at certain of our subsidiaries, experienced a cyber incident that primarily affected the operations of our North American medical distribution businesses. and patient relationship management solutions business was not affected, and mostly unaffected. financial results for the fourth quarter and full year 2023, diverted Company to incur significant remediation costs. |
| Cybersecurity Risk Management Processes Integrated [Flag] | true |
| Cybersecurity Risk Management Processes Integrated [Text Block] | We have developed and implemented a cybersecurity risk mitigation strategy intended to protect our information systems. aligned with generally accepted cybersecurity standards and frameworks, Framework, or “NIST CSF,” and our Company is externally audited, or certified, with ISO27001 partial scope. |
| Cybersecurity Risk Management Third Party Engaged [Flag] | true |
| Cybersecurity Risk Third Party Oversight And Identification Processes [Flag] | true |
| Cybersecurity Risk Materially Affected Or Reasonably Likely To Materially Affect Registrant [Flag] | true |
| Cybersecurity Risk Materially Affected Or Reasonably Likely To Materially Affect Registrant [Text Block] | In addition to immaterial and unrelated incidents at certain of our subsidiaries, experienced a cyber incident that primarily affected the operations of our North American medical distribution businesses. and patient relationship management solutions business was not affected, and mostly unaffected. financial results for the fourth quarter and full year 2023, diverted Company to incur significant remediation costs. |
| Cybersecurity Risk Board Of Directors Oversight [Text Block] | Cybersecurity Governance Our Board has a Regulatory, Compliance and Cybersecurity Committee that focuses on cybersecurity oversight, together with other board committees, principally the Audit Committee. The purpose of the Regulatory, Compliance and Cybersecurity Committee is to assist the Board by providing Company’s senior management responsible for assessing and managing Company-wide regulatory, corporate compliance and cybersecurity risk management programs. Compliance and Cybersecurity Committee are to (i) discuss cybersecurity opportunities relating thereto, (ii) provide expertise to guide assessment regulatory, corporate compliance and cybersecurity risk management budgeting, spending and capital investment, (iii) monitor progress and status of the Company’s regulatory, corporate compliance and cybersecurity risk management programs, (iv) review and evaluate major regulatory, corporate compliance and cybersecurity risk management initiatives to identify emerging and future opportunities for synergy or to corporate compliance and cybersecurity risk management investments (v) report to the Audit Committee on regulatory, corporate compliance and cybersecurity risk management matters reviewed by the Regulatory, Compliance and Cybersecurity Committee that may impact the Company’s financial reporting and (vi) be generally available to, and communicate with, inform the Board in the areas described above. Our CISO and CTO, along with other key executives who are part of our Executive strategy, policy, Board’s Regulatory, Committee on at least a bi-annual basis. meets regular basis as well as in connection with specific cybersecurity issues or |
| Cybersecurity Risk Board Committee Or Subcommittee Responsible For Oversight [Text Block] | The purpose of the Regulatory, Compliance and Cybersecurity Committee is to assist the Board by providing Company’s senior management responsible for assessing and managing Company-wide regulatory, corporate compliance and cybersecurity risk management programs. |
| Cybersecurity Risk Process For Informing Board Committee Or Subcommittee Responsible For Oversight [Text Block] | Our Board has a Regulatory, Compliance and Cybersecurity Committee that focuses on cybersecurity oversight, together with other board committees, principally the Audit Committee. The purpose of the Regulatory, Compliance and Cybersecurity Committee is to assist the Board by providing Company’s senior management responsible for assessing and managing Company-wide regulatory, corporate compliance and cybersecurity risk management programs. Compliance and Cybersecurity Committee are to (i) discuss cybersecurity opportunities relating thereto, (ii) provide expertise to guide assessment regulatory, corporate compliance and cybersecurity risk management budgeting, spending and capital investment, (iii) monitor progress and status of the Company’s regulatory, corporate compliance and cybersecurity risk management programs, (iv) review and evaluate major regulatory, corporate compliance and cybersecurity risk management initiatives to identify emerging and future opportunities for synergy or to corporate compliance and cybersecurity risk management investments (v) report to the Audit Committee on regulatory, corporate compliance and cybersecurity risk management matters reviewed by the Regulatory, Compliance and Cybersecurity Committee that may impact the Company’s financial reporting and (vi) be generally available to, and communicate with, inform the Board in the areas described above. |
| Cybersecurity Risk Role Of Management [Text Block] | We maintain an Office of Cybersecurity (“OCS”), led by our Chief Information Security Officer (“CISO”), which oversees management team, which continuously evaluates our global cybersecurity on maintaining and protecting our information systems. strategy, the OCS partners with our Global Technology Solutions team, which is led by our Chief Technology Officer (“CTO”) and is comprised of over one hundred professionals that support our information operations. monitoring the Company’s information systems, as well as at our third-party partners. |
| Cybersecurity Risk Management Positions Or Committees Responsible [Flag] | true |
| Cybersecurity Risk Management Positions Or Committees Responsible [Text Block] | We maintain an Office of Cybersecurity (“OCS”), led by our Chief Information Security Officer (“CISO”), which oversees |
| Cybersecurity Risk Management Expertise Of Management Responsible [Text Block] | Our CISO reports to our CTO. experience leading large-scale global IT organizations and received a Bachelor of Business Administration Business Computer Information Systems and a Master of Business Administration Our Vice President, Global CISO, who also serves as Vice President and Head of the Office of Cyber Security, has over 30 years of experience leading global cybersecurity and technology programs in large and complex corporations, and holds a Certified Professional and a Certified Information Systems Auditor certification. Technology and Security from Baker College. managers who are members of our Executive Steering Committee, comprised technology, legal and internal auditing officers. developments, and our Board oversees our risk mitigation strategy principally Regulatory, Compliance and Cybersecurity Committee, as described in more detail below. |
| Cybersecurity Risk Process For Informing Management Or Committees Responsible [Text Block] | Our CISO and CTO, along with other key executives who are part of our Executive strategy, policy, Board’s Regulatory, Committee on at least a bi-annual basis. meets regular basis as well as in connection with specific cybersecurity issues or |
| Cybersecurity Risk Management Positions Or Committees Responsible Report To Board [Flag] | true |
Basis of Presentation and Significant Accounting Policies (Policies) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Basis of Presentation and Significant Accounting Policies [Abstract] | |
| Nature of Operations | Nature of Operations We distribute health care products and value-added services primarily to office-based dental and medical practitioners, across dental practices, laboratories, physician practices, government, institutional health care clinics, home health providers, and alternate software and technology services to health care practitioners. practitioners, dental laboratories, schools, government and other institutions. physician offices, urgent care centers, ambulatory care sites, emergency medical technicians, dialysis centers, health, federal and state governments and large enterprises, such as group practices networks, among other providers across a wide range of specialties. We have significant operations in the United States, Germany, France, Canada, and Brazil. meaningful market presence in several other European countries and the Asia-Pacific |
| Basis of Presentation | Basis of Presentation Our consolidated financial statements include the accounts of Henry subsidiaries and VIE. unconsolidated affiliates for which we have the ability to influence the operating or accounted for under the equity method. current period presentation. impact on our consolidated financial condition, results of operations The primary beneficiary of a VIE is required to consolidate the assets and be the primary beneficiary of the VIE when we have the power to direct activities economic performance and have the obligation to absorb the majority that could potentially be significant to the VIE. consider factors such as ownership interest, debt investments, management decisions, and contractual and substantive participating rights of each party. accounts receivable securitization as discussed in the trade accounts receivable transferred to the VIE are pledged as collateral to the related debt. accounts receivable. only be used to settle obligations of this VIE were $ 491 241 this VIE where the creditors have recourse to us were $ 390 150 |
| Fair Value Measurements | Fair Value Fair value is defined as the price that would be received to sell an asset or transaction between market participants at the measurement date. (1) market participant assumptions developed based on market data obtained inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the in active markets for identical assets or liabilities (Level 1) and the lowest priority The three levels of the fair value hierarchy are described as follows: • measurement date. • either directly or indirectly. quoted prices for identical or similar assets or liabilities in markets prices that are observable for the asset or liability; and inputs that are observable market data by correlation or other means. • |
| Use of Estimates | Use of Estimates The preparation of consolidated financial statements in conformity with the United States requires us to make estimates and assumptions that liabilities and disclosure of contingent assets and liabilities at the date of amounts of revenues and expenses during the reporting period. Our consolidated financial statements reflect estimates and assumptions our goodwill, long-lived asset and definite-lived intangible asset valuation; valuation; assessment of the annual effective tax rate; valuation of deferred income contingencies; the allowance for credit losses; fair value of contingent rebates; measurement of compensation cost for certain share-based pension plan assumptions. |
| Fiscal Year | Fiscal Year We report our results of operations and cash flows on a 52 53 Saturday of December. consisted of 52 |
| Revenue Recognition | Revenue Recognition Revenue is recognized when a customer obtains control of promised goods consideration that we expect to receive for those goods or services. • • • • • We generate revenue from the sale of dental and medical consumable products, equipment, and services such as equipment repair and financial services (Global Distribution and Value-Added Services revenues), company- manufactured specialty products (Global Specialty Products revenue), and software (Global Technology revenues). revenue adjustments are included in the transaction price at contract based upon historical data and estimates and are provided for in the recognized. Revenue derived from the sale of consumable products and company-manufactured recognized at the point in time when control transfers to the customer, (e.g. when legal title and risks and of ownership transfer to the customer, we have no post-shipment obligations, and we have an enforceable payment). common carriers. Revenue derived from the sale of equipment is recognized when control when the equipment is delivered. equipment service technicians. time of delivery. Our merchandise and equipment products generally carry standard warranty however, in instances where we provide a warranty on company-manufactured products or labor services, warranty costs are accrued in accordance with Accounting Standards Codification At December 27, 2025 and December 28, 2024, we had accrued approximately 8 8 respectively, for warranty costs. Revenue derived from the sale of software products is recognized when made available electronically. training. training, is generally recognized over time using time elapsed as the input method control to the customer. over the subscription period as control is transferred to the customer. Revenue derived from other sources, including freight charges, equipment repairs recognized when the related product revenue is recognized or when practical expedient to treat shipping and handling activities performed after fulfillment activities, rather than a separate performance obligation in the Sales, value-add and other taxes we collect concurrent with revenue-producing revenue. Some of our revenue is derived from bundled arrangements that include which are accounted for separately. and technical support), we allocate the transaction price to each estimated standalone selling price for each performance obligation. that are not considered software consist primarily of equipment and the related revenue for such arrangements based on the relative selling prices of the goods price is not available (i.e., because we or others do not sell the goods or following techniques to estimate the standalone selling price: adjusted approach; or the residual method. selling price reflects our best estimate of what the selling prices of each deliverable regularly on a standalone basis taking into consideration the cost structure customer location and other market conditions. Sales Returns Sales returns are recognized as a reduction of revenue by the amount liability within accrued expenses-other within our consolidated balance sheets. liability based on historical data for specific products, adjusted as necessary returns is presented gross as a refund liability and we record a right of to cost of sales) for any products that we expect to be returned and resaleable. Cost of Sales The primary components of cost of sales include the cost of the product chargebacks and rebates) and inbound and outbound freight charges. Costs related to purchasing, receiving, inspections, warehousing, distribution network are included in selling, general and administrative Total distribution network costs were $ 107 105 105 27, 2025, December 28, 2024 and December 30, 2023, respectively. Supplier Rebates Supplier rebates are included as a reduction of cost of sales and are recognized factors we consider in estimating supplier rebate accruals include forecasted rebate contract terms, which generally provide for increasing rebates based volumes. Direct Shipping and Handling Costs Freight and other direct shipping costs are included in cost of sales. primarily direct compensation costs of employees who pick, pack and otherwise for shipment to our customers are reflected in selling, general and administrative were $ 105 106 98 December 30, 2023, respectively. |
| Advertising and Promotional Costs | Advertising and Promotional Costs We expense advertising and promotional costs as incurred. 46 million, $ 43 47 30, 2023, respectively. |
| Stock-Based Compensation Costs | Stock-Based Compensation Costs We measure stock-based compensation at the grant date, based on the estimated recognize the cost (net of estimated forfeitures) as compensation expense on service period for certain time-based restricted stock units with cliff vesting and on a accelerated option awards and certain time-based restricted stock units with graded each reporting date, we reassess whether achievement of the performance condition compensation expense when achievement of the performance condition is expense is reflected in selling, general and administrative expenses. |
| Employment Benefit Plans and other Postretirement Benefit Plans | Employment Benefit Plans and other Postretirement Benefit Plans Some of our employees in our international markets participate We recognize the funded status, measured as the difference between the fair value of plan assets and the projected benefit obligation. asset or liability based on its funded status. Net periodic pension costs and valuations are dependent on assumptions those amounts. compensation levels, retirement rates, mortality rates, and other factors. net pension cost in selling, general and administrative expenses within Gains and losses that result from changes in actuarial assumptions or actuarial assumptions are recognized in and then amortized from accumulated |
| Cash and Cash Equivalents | Cash and Cash Equivalents We consider all highly liquid short-term investments with an original maturity of three months or less to be cash equivalents. fair value. 25 33 payments for inventory, were classified as accounts payable as of December 27, 2025 and December 28, 2024. |
| Accounts Receivable and Allowance for Credit Losses | Accounts Receivable and Allowance for Credit Losses Accounts receivable are generally recognized when revenues are recognized. credit loss” model, the carrying amount of accounts receivable is reduced best estimate of the amounts that we do not expect to collect. receivable, we consider many factors in estimating our reserve, including worthiness, experience and historical data adjusted for current conditions We record allowances for credit losses based upon a specific review of all those invoices not specifically reviewed, provisions are provided at differing rates, receivable, the collection history associated with the geographic region economic trends and reasonable supportable forecasts. We write off accounts receivable and charge it against its recorded allowance when we deem it uncollectible. Our net accounts receivable balance was $ 1,651 1,482 1,863 December 28, 2024 and December 30, 2023, respectively. The following table presents our allowances for credit losses: As of Description December 27, 2025 December 28, 2024 December 30, 2023 Balance at beginning of year $ 78 $ 83 $ 65 Provision for credit losses 20 14 17 Adjustments to existing allowances for late fees, foreign currency exchange rates, and write-offs (8) (19) 1 Balance at end of year $ 90 $ 78 $ 83 |
| Contract Assets and Contract Liabilities | Contract Assets Contract assets include amounts related to any conditional right to consideration as of the reporting date. unconditional. consumables and sales of term software licenses. other and the non-current contract assets are included in investments and other sheets. material. Contract Liabilities Contract liabilities are comprised of advance payments and upfront payments over time that are accounted for as deferred revenue amounts. the performance obligation has been satisfied. and the non-current contract liabilities are included in other liabilities During the years ended December 27, 2025, December 28, 2024, and December substantially all of the current contract liability amounts that were previously year. The following table presents our contract liabilities: As of Description December 27, 2025 December 28, 2024 December 30, 2023 Current contract liabilities $ 81 $ 81 $ 89 Non-current contract liabilities 9 8 9 Total contract $ 90 $ 89 $ 98 |
| Inventories and Reserves | Inventories and Reserves Inventories consist primarily of finished goods, raw materials and cost or net realizable value. for large equipment, high-technology equipment and drop-shipments. include direct materials, labor, and an allocation of related fixed and variable overhead. inventory carrying values requires management to make significant for inventory reserves and evaluating net realizable value, we consider condition, on-hand quantities, historical and forecasted sales, product economic conditions. |
| Property and Equipment | Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation or computed under the straight-line method using estimated useful lives Amortization of leasehold improvements is computed using the straight-line over the lesser of the useful life of the assets or the remaining lease term. |
| Capitalized Software Development Costs | Capitalized Software Development Costs Capitalized software costs consist of costs to purchase and develop customers. application development stage and include such costs within property balance sheets. costs when technological feasibility is reached, and for cloud-based applications capitalize costs incurred during the application development stage, other within our consolidated balance sheets. |
| Leases | Leases We determine if an arrangement contains a lease at inception. explicitly identifies an asset to be used and conveys the right to control for consideration. operating lease liabilities, and non-current operating lease liabilities in leases are included in property and equipment, current maturities of consolidated balance sheets. ROU assets represent our right to use an underlying asset for the lease obligation to make lease payments arising from the lease. upon commencement of the lease based on the present value of the lease payments our leases do not provide an implicit interest rate, we generally use our incremental estimated rate of interest for fully collateralized and fully amortizing borrowings payments at commencement date to determine the present value of use the implicit rate. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. over the lease term. and administrative and interest expense, respectively within our consolidated leases with a term of 12 months or less are not capitalized. We have lease agreements with lease and non-lease components, which are lease component, except non-lease components for leases of vehicles, which vehicle lease contains both lease and non-lease components, we allocate the standalone selling price. |
| Business Acquisitions | Business Acquisitions We account for business acquisitions under the acquisition method of accounting, under which the net assets of acquired businesses are recorded at their fair value at the acquisition include the acquired businesses’ results of operations from that date. Certain prior owners of acquired subsidiaries are eligible to receive additional we may be entitled to recoup a portion of purchase price cash consideration goals are met. the time of the acquisition, using the income approach, including a probability-weighted method or an option pricing method, where applicable. selling, general and administrative within our consolidated statements of While we use our best estimates and assumptions to accurately value liabilities assumed at the acquisition date, our estimates are inherently uncertain result, within 12 months to consideration transferred, assets acquired and liabilities assumed with within our consolidated balance sheets. of such assets acquired or liabilities assumed, whichever comes first, our consolidated statements of operations. |
| Goodwill | Goodwill Any excess of acquisition consideration over the fair value of identifiable goodwill. business combination that are not individually identified and separately technology, as well as the assembled workforce. Goodwill is subject to impairment analysis at least once annually as event occurs or circumstances change that would more likely than carrying value. units by assessing whether two or more components are economically Our reporting units are identified as our operating segments. purposes of our impairment analyses. (i) Global Distribution and Value-Added Services reportable segment, which included the following operating segments (a) US Distribution Group; (b) Europe, Middle East, (c) Americas Non-US Distribution Group; and (d) Asia-Pacific and Australia (ii) Global Specialty Products reportable segment, which included the following Oral Reconstruction Group; and (b) Healthcare Specialty Group; (iii) Global Technology, Application of the goodwill impairment test requires judgment, including assignment of assets and liabilities that are considered shared services determination of the fair value of each reporting unit. applying the discounted cash flow methodology and confirming with uncertainties, however, related to fair value models, the inputs and our judgments in applying them The most significant inputs include estimation of detailed future cash flows determination of comparable companies to develop a weighted average In January 2025, we performed a geographical realignment within Services reportable segment intended to provide increased transparency distribution businesses and to reflect evolving management oversight realignment and the change in reporting units, we reallocated goodwill to each relative fair value approach. quantitative valuation analysis that considered projected cash flows, valuation inputs. Services reportable segment were tested for impairment as of January 1, values of our reporting units more likely than not exceeded their carrying January 1, 2025 under both structures. In connection with our restructuring initiatives, during the year ended 11 million impairment of goodwill in the Global Specialty Products segment, business; such impairment was calculated based on the relative fair value |
| Intangible Assets | Intangible Assets In connection with our business acquisitions, we recognize assets acquired value estimates as of the date of acquisition. customer relationships and lists, trademarks and trade names, product development based on critical judgments and assumptions derived from analysis of projected revenue growth rates (which are based on historical trends estimated customer attrition and projected cash flows. the multi-period excess earnings method, the relief-from-royalty method, applicable. conditions. Intangible assets, other than goodwill, are evaluated for impairment whenever indicate that the carrying amount of the assets may not be recoverable expected to be derived from such asset or asset group. Definite and indefinite-lived intangible assets primarily consist of customer trademarks, trade names, product development and non-compete agreements. operations, impairment losses are only recorded if the asset or asset groups through its undiscounted future cash flows. carrying amount and the estimated fair value. fair value. During the years ended December 27, 2025, December 28, 2024 impairment charges within the selling, general and administrative line of our consolidated statements intangible assets of $ 16 0 7 During the years ended December 27, 2025, December 28, 2024 December 30, 2023, we recorded impairment charges, within the restructuring and related consolidated statements of income, of $ 0 14 , million, and $ 12 |
| Income Taxes | Income Taxes We account for income taxes under an asset and liability approach that requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events financial statements or tax returns. events other than expected enactments of changes in tax laws or rates. liabilities of a change in tax rates is recognized as income or expense in We file a consolidated U.S. federal income tax return with our 80% or greater owned U.S. subsidiaries. |
| Redeemable Noncontrolling Interests | Redeemable Noncontrolling Interests Some minority stockholders in certain of our consolidated subsidiaries have to acquire their ownership interest in those entities at fair value. outside permanent equity on our consolidated balance sheets and are The redemption amounts have been estimated based on recent transactions and, if such earnings and cash flows are not achieved, the value of the impacted. reflected at each reporting period with a corresponding adjustment in the carrying amounts are subject to a “floor” amount that is equal noncontrolling interests at the time they were originally recorded. noncontrolling interests cannot go below the floor level. interests to reflect a fair value redemption feature do not impact the income is reduced by the portion of the subsidiaries’ net income interests. |
| Noncontrolling Interests | Noncontrolling Interests Noncontrolling interest represents the ownership interests of certain subsidiaries. noncontrolling interests. |
| Comprehensive Income | Comprehensive Income Comprehensive income includes certain gains and losses that, under accounting United States, are excluded from net income as such amounts are recorded stockholders’ equity. translation gain (loss), unrealized gain (loss) from hedging activities |
| Risk Management and Derivative Financial Instruments | Risk Management and Derivative Financial Instruments We use derivative instruments to minimize our exposure to fluctuations in foreign currency exchange rates, interest rates, and our unfunded non-qualified supplemental retirement plan (“SERP”) (“DCP”). recognized asset and liability fair values, earnings and cash flows, as well subsidiaries, the interest rate risk on variable rate debt, and the returns on management policy requires that derivative contracts used as hedges be with the exposure being hedged and be designated hedges at inception derivative instruments for speculative purposes. forward contracts, total return swaps, and interest rate swaps. Foreign currency forward agreements related to forecasted inventory foreign currency swaps related to foreign currency denominated debt, and debt are designated as cash flow hedges. changes in the fair value of the derivatives are recorded as a income in stockholders’ equity and subsequently reclassified into transactions affect earnings. consolidated statements of cash flows as the cash flows related Foreign currency forward contracts related to our euro-denominated investment hedges. value of the derivatives are recorded in the foreign currency translation gain other comprehensive income in stockholders’ equity until the net Interest swap agreements are entered into for the purpose of hedging loan. Our foreign currency forward agreements related to foreign currency hedges but are not designated as hedges for accounting purposes. For agreements not designated as hedges, changes in the value of the derivative, loss on the hedged item, are recorded in other, net, within our consolidated statements of income. Total return swaps are entered into for the purpose of economically hedging our SERP and DCP. expected to be renewed on an annual basis. selling, general, and administrative expenses within our consolidated changes in the fair values of our SERP and DCP liabilities. |
| Foreign Currency Translation and Transactions | Foreign Currency Translation The financial position and results of operations of our foreign subsidiaries the functional currencies. each year-end. Translation adjustments arising from the use of differing exchange rates from period to period are included Accumulated other comprehensive income in stockholders’ equity. currency transactions are included in earnings. |
| Accounting Pronouncements Adopted and Recently Issued Accounting Standards | Accounting Pronouncements Recently Adopted During the year ended December 27, 2025, we adopted Accounting Standards Update Income Taxes (Topic ,” which requires public business entities to disclose additional information in specified categories with respect to statutory rate for federal, state and foreign income taxes. items in the rate reconciliation to the extent the impact of those items new disclosures associated with the rate reconciliation, this ASU requires of refunds received) to be disaggregated for federal, state and foreign jurisdictions to the extent the related amounts exceed a quantitative threshold. need to be disaggregated based on their nature, which is determined by essential characteristics, such as the transaction or event that triggered the activity with which the reconciling item is associated. entities disclose information concerning unrecognized tax benefits having increasing or decreasing in the 12 months following the reporting date. basis, which resulted in the required additional disclosures included During the year ended December 28, 2024, we adopted ASU 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segments ” (“Topic 280”), disclosure of incremental segment information on an annual and investors to develop more decision-useful financial analyses. public entity identifies its operating segments, aggregates those operating thresholds to determine its reportable segments. the required additional disclosures included in our consolidated Recently Issued Accounting Pronouncements In December 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-11, “ Interim Reporting (Topic 270): Narrow ,” which is intended to improve navigability of the guidance 270, Interim Reporting, and clarify when it applies. statements and interim disclosure requirements, and establishes a principle events since the end of the last annual reporting period that have a effective for annual reporting periods beginning after December 15, 2027, and interim those annual reporting periods, with early adoption permitted. 2025-11 will have on our consolidated financial statements and related disclosures. In December 2025, the FASB issued ASU 2025-10, “ Government Grants (Topic 832) - Accounting for Government Grants Received by Business Entities, ” which establishes guidance on the recognition, measurement, and presentation of government grants received by business entities. beginning after December 15, 2028, and interim reporting periods within adoption permitted. financial statements and related disclosures. In November 2025, the FASB issued ASU 2025-09, “ Derivatives and Hedging (Topic 815): Hedge Accounting Improvements, ” which is intended to more closely align financial reporting with management activities, including expanded eligibility of forecasted hedge effectiveness, and clarifications related to hedging non-financial items. reporting periods beginning June 1, 2027, and interim reporting early adoption permitted, and should be applied prospectively. 2025-09 will have on our consolidated financial statements and related In September 2025, the FASB issued ASU 2025-06, “ Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements ,” which removes all references to software development project stages. when management authorizes and commits to funding the software project, be completed and the software will be used for its intended purpose. periods beginning after December 15, 2027, and interim reporting periods with early adoption permitted. modified transition approach. consolidated financial statements. In July 2025, the FASB issued ASU 2025-05, “ Financial Instruments - Credit Losses (Subtopic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, ” which introduces a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged asset when estimating expected credit losses on current accounts 606 on revenue from contracts with customers. This ASU is effective for annual December 15, 2025, with early adoption permitted. our consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, “ Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosure (Subtopic 220-40) : Disaggregation of Income Statement Expenses ,” which requires additional disclosure about the specific expense categories in and annual reporting periods. requirements, but affect where this information appears in the notes to financial statements. for annual reporting periods beginning after December 15, 2026, and December 15, 2027, with early adoption permitted. retrospectively. statements. |
Net Sales from Contracts with Customers (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Net Sales from Contracts with Customers [Abstract] | |
| Disaggregation of Net Sales | Years December 27, 2025 December 28, 2024 December 30, 2023 Net Sales: Global Distribution and Value Global Dental merchandise $ 4,831 $ 4,723 $ 4,783 Global Dental equipment 1,799 1,723 1,675 Global Value 238 233 191 Global Dental 6,868 6,679 6,649 Global Medical 4,270 4,081 3,912 Total Global Distribution 11,138 10,760 10,561 Global Specialty Products 1,544 1,446 1,331 Global Technology 675 630 602 Eliminations (173) (163) (155) Total $ 13,184 $ 12,673 $ 12,339 |
Segment and Geographic Data (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Segment and Geographic Data [Abstract] | |
| Business Segment Information | Years Ended December 27, December 28, December 30, 2025 2024 2023 Gross Sales: Global Distribution and Value (1) $ 11,138 $ 10,760 $ 10,561 Global Specialty Products (2) 1,544 1,446 1,331 Global Technology (3) 675 630 602 Total Gross Sales 13,357 12,836 12,494 Less: Eliminations: Global Distribution and Value (18) (31) (36) Global Specialty Products (155) (132) (119) Global Technology - - - Total Eliminations (173) (163) (155) Net Sales: Global Distribution and Value 11,120 10,729 10,525 Global Specialty Products 1,389 1,314 1,212 Global Technology 675 630 602 Total Net Sales $ 13,184 $ 12,673 $ 12,339 Segment Cost of Sales: (4) Global Distribution and Value $ 8,352 $ 7,984 $ 7,862 Global Specialty Products 697 644 611 Global Technology 218 206 185 Segment Operating Expenses: (5) Global Distribution and Value $ 2,106 $ 2,080 $ 2,034 Global Specialty Products 605 624 545 Global Technology 277 272 275 Operating Income: Global Distribution and Value $ 680 $ 696 $ 665 Global Specialty Products 242 178 175 Global Technology 180 152 142 Total Segment Operating Income 1,102 1,026 982 Corporate, net (130) (77) (92) Adjustments (6) (319) (328) (275) Total Operating Income $ 653 $ 621 $ 615 Years Ended December 27, December 28, December 30, 2025 2024 2023 Depreciation and Amortization: Global Distribution and Value $ 27 $ 25 $ 26 Global Specialty Products 36 29 23 Global Technology 36 35 31 Total Segment Depreciation and Amortization 99 89 80 Corporate 33 24 18 Acquisition intangible amortization within adjustments (6) 179 184 150 Total Depreciation and Amortization $ 311 $ 297 $ 248 Global Distribution and Value impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X- ray supplies and equipment, high-tech and digital restoration equipment, equipment repair services, financial services on a non- recourse basis, continuing education services for practitioners, consulting and other services. under our own corporate brand a portfolio of cost-effective, high-quality consumable merchandise. (2) Global Specialty Products: Includes manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. (3) Global Technology: Includes development and distribution of practice management software, e-services and other products, which are distributed to health care providers. (4) Cost of goods sold in our Global Distribution and Value-Added Services segment and our Global Specialty Products segment includes product cost and inbound and outbound freight charges. primarily of software development and third-party provider costs, including technology use and hosting fees. (5) Significant segment operating expenses for our reportable segments and Corporate include primarily compensation costs, and to a lesser extent, rent, depreciation and maintenance costs related to operating our facilities. Adjustments represent items excluded from segment operating income to enable comparison of financial results between periods. The following table presents a breakdown of such adjustments: Years Ended December 27, December 28, December 30, 2025 2024 2023 Adjustments: Restructuring and related costs $ (105) $ (110) $ (80) Acquisition intangible amortization (179) (184) (150) Cyber incident-insurance proceeds, net of third-party advisory expenses 20 31 (11) Change in contingent consideration 2 (45) - Litigation settlements (5) (6) - Impairment of capitalized assets - (12) (27) Impairment of intangible assets (16) - (7) Costs associated with shareholder advisory matters and select value creation consulting costs (36) (2) - Total adjustments $ (319) $ (328) $ (275) |
| Operations by Geographic Area | 2025 2024 2023 Net Sales Long-Lived Assets Net Sales Long-Lived Assets Net Sales Long-Lived Assets United States $ 9,096 $ 4,033 $ 8,825 $ 3,683 $ 8,662 $ 3,479 Other 4,088 2,120 3,848 2,051 3,677 2,135 Consolidated total $ 13,184 $ 6,153 $ 12,673 $ 5,734 $ 12,339 $ 5,614 |
Business Acquisitions (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Acquisitions 2025 [Member] | |
| Business Acquisition [Line Items] | |
| Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired | Preliminary Allocation as of December 27, 2025 Acquisition consideration: Cash $ 194 Deferred consideration 3 Estimated fair value of contingent consideration payable 19 Fair value of previously held equity method investments 91 Redeemable noncontrolling interests 85 Total consideration $ 392 Identifiable assets acquired and liabilities assumed: Current assets $ 59 Intangible assets 150 Other noncurrent assets 42 Current liabilities (26) Long-term debt (1) Deferred income taxes (23) Other noncurrent liabilities (8) Total identifiable 193 Goodwill 199 Total net assets acquired $ 392 |
| Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives | 2025 Weighted Average Lives (in years) Customer relationships and lists $ 98 11 Trademarks / Tradenames 32 7 Product development 18 10 Non-compete agreements 2 5 Total $ 150 |
| TriMed, Inc. [Member] | |
| Business Acquisition [Line Items] | |
| Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired | Final Allocation Acquisition consideration: Cash $ 141 Deferred consideration 21 Redeemable noncontrolling interests 153 Total consideration $ 315 Identifiable assets acquired and liabilities assumed: Current assets $ 35 Intangible assets 221 Other noncurrent assets 10 Current liabilities (7) Deferred income taxes (62) Other noncurrent liabilities (6) Total identifiable 191 Goodwill 124 Total net assets acquired $ 315 |
| Shield Healthcare, Inc. [Member] | |
| Business Acquisition [Line Items] | |
| Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired | Final Allocation Acquisition consideration: Cash $ 289 Deferred consideration 22 Redeemable noncontrolling interests 37 Total consideration $ 348 Identifiable assets acquired and liabilities assumed: Current assets $ 41 Intangible assets 166 Other noncurrent assets 16 Current liabilities (24) Deferred income taxes (43) Other noncurrent liabilities (7) Total identifiable 149 Goodwill 199 Total net assets acquired $ 348 |
| Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives | 2023 Weighted Average Lives (in years) Customer relationships and lists $ 156 12 Trademarks / Tradenames 10 5 Total $ 166 |
| S.I.N. Implant System [Member] | |
| Business Acquisition [Line Items] | |
| Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired | Final Allocation Acquisition consideration: Cash $ 329 Total consideration $ 329 Identifiable assets acquired and liabilities assumed: Current assets $ 73 Intangible assets 87 Other noncurrent assets 48 Current liabilities (33) Long-term debt (22) Deferred income taxes (38) Other noncurrent liabilities (27) Total identifiable 88 Goodwill 241 Total net assets acquired $ 329 |
| Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives | 2023 Weighted Average Lives (in years) Customer relationships and lists $ 38 7 Product development 36 8 Trademarks / Tradenames 13 10 Total $ 87 |
| Biotech Dental [Member] | |
| Business Acquisition [Line Items] | |
| Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired | Final Allocation Acquisition consideration: Cash $ 216 Fair value of contributed equity share in a controlled subsidiary 25 Redeemable noncontrolling interests 182 Total consideration $ 423 Identifiable assets acquired and liabilities assumed: Current assets $ 74 Intangible assets 189 Other noncurrent assets 69 Current liabilities (60) Long-term debt (73) Deferred income taxes (53) Other noncurrent liabilities (20) Total identifiable 126 Goodwill 297 Total net assets acquired $ 423 |
| Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives | 2023 Weighted Average Lives (in years) Product development $ 124 10 Customer relationships and lists 47 9 Trademarks / Tradenames 18 7 Total $ 189 |
Inventories, Net (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Inventories, Net [Abstract] | |
| Schedule of Inventory, Net | Description December 27, 2025 December 28, 2024 Finished goods $ 1,889 $ 1,710 Raw materials 70 61 Work-in process 43 39 Inventories, net $ 2,002 $ 1,810 |
Property and Equipment, Net (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Property, Plant and Equipment [Abstract] | |
| Property and Equipment, Including Related Estimated Useful Lives | December 27, December 28, 2025 2024 Land $ 22 $ 20 Buildings and permanent improvements 187 164 Leasehold improvements 125 109 Machinery and warehouse equipment 307 257 Furniture, fixtures and other 137 128 Computer equipment and software 602 523 1,380 1,201 Less accumulated depreciation and amortization (759) (670) Property and equipment, net $ 621 $ 531 Estimated Useful Lives (in years) Buildings and permanent improvements 40 Machinery and warehouse equipment 5 - 15 Furniture, fixtures and other 3 - 10 Computer equipment and software 3 - 10 |
Leases (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Leases [Abstract] | |
| Components of Lease Expense, Supplemental Cash Flow and Supplemental Balance Sheet Information | Years December 27, December 28, December 30, 2025 2024 2023 Operating lease cost: $ 94 $ 107 $ 99 Variable 11 12 12 Short-term lease cost 10 11 10 Total operating lease cost 115 130 121 Finance lease cost 3 4 5 Total lease cost $ 118 $ 134 $ 126 (1) Total operating lease cost for the years ended December 27, 2025, December 28, 2024 and December 30, 2023, included costs of $ 3 million, $ 17 11 consolidated statements of income. Years December 27, December 28, 2025 2024 Operating Leases: Operating lease right-of-use assets $ 301 $ 293 Current operating lease liabilities 78 75 Non-current operating lease liabilities 251 259 Total operating lease liabilities $ 329 $ 334 Finance Leases: Property and equipment, at cost $ 14 $ 16 Accumulated depreciation (7) (9) Property and equipment, net of accumulated depreciation $ 7 $ 7 Current maturities of long-term debt $ 3 $ 3 Long-term debt 4 $ 3 Total finance $ 7 $ 6 Weighted Average Operating leases 5.6 5.9 Finance leases 2.9 2.7 Weighted Average Operating leases 4.5 % 4.2 % Finance leases 4.5 % 4.4 % Years December 27, December 28, 2025 2024 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 99 $ 94 Financing cash flows for finance leases 3 4 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 71 $ 76 Finance leases 3 2 |
| Maturities of Finance and Operating Lease Liabilities | December 27, 2025 Operating Finance Leases Leases 2026 $ 91 $ 3 2027 74 2 2028 59 1 2029 47 1 2030 37 - Thereafter 63 - Total future 371 7 Less imputed interest 42 - Total $ 329 $ 7 |
Goodwill and Other Intangibles, Net (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Goodwill and Other Intangibles, Net [Abstract] | |
| Changes in the Carrying Amount of Goodwill | Global Distribution and Value-Added Services Global Specialty Products Global Technology Total Balance as of December 30, 2023 $ 2,007 $ 1,077 $ 791 $ 3,875 Adjustments to goodwill: Acquisitions 41 107 - 148 Impairment - (11) (2) (13) Foreign currency translation (39) (80) (4) (123) Balance as of December 28, 2024 2,009 1,093 785 3,887 Adjustments to goodwill: Acquisitions 49 124 26 199 Disposal (1) - (2) (3) Foreign currency translation 49 74 7 130 Balance as of December 27, 2025 $ 2,106 $ 1,291 $ 816 $ 4,213 |
| Other Intangible Assets - Finite-Lived | December 27, 2025 Accumulated Weighted Average Cost Amortization Net Life (in years) Customer relationships and lists $ 971 $ (408) $ 563 10 Trademarks / Tradenames 205 (96) 109 8 Product development 438 (120) 318 9 Non-compete agreements 18 (5) 13 5 Other 24 (9) 15 15 Total $ 1,656 $ (638) $ 1,018 December 28, 2024 Accumulated Weighted Average Cost Amortization Net Life (in years) Customer relationships and lists $ 915 $ (356) $ 559 10 Trademarks / Tradenames 188 (89) 99 8 Product development 403 (71) 332 9 Non-compete agreements 21 (6) 15 4 Other 28 (10) 18 15 Total $ 1,555 $ (532) $ 1,023 |
Investments and Other (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Investments and Other [Abstract] | |
| Investments and Other | December 27, December 28, 2025 2024 Investments in unconsolidated affiliates $ 174 $ 170 Non-current deferred foreign, state and local income taxes 92 47 Notes receivable (1) 56 63 Capitalized costs for software and cloud based applications for external use 112 90 Security deposits 4 4 Acquisition-related indemnification assets 39 39 Non-current pension assets 11 9 Non-current inventory 38 27 Other 72 52 Total $ 598 $ 501 (1) Long-term notes receivable carry interest rates ranging from 3.0 % to 11.8 % and are due in varying installments through May 31, 2031 . |
Fair Value Measurements (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Fair Value Measurements [Abstract] | |
| Components of Change in Fair Value of Contingent Consideration | Years December 27, December 28, 2025 2024 Balance, beginning of period $ 30 $ 6 Increase in contingent consideration due to business acquisitions and acquisitions of noncontrolling interests in subsidiaries 103 10 Decrease in contingent consideration due to payments (19) (31) Change in fair value of contingent consideration in connection with business acquisitions (2) 45 Change in fair value of contingent consideration in connection with changes in ownership in consolidated subsidiaries (15) - Balance, end of period $ 97 $ 30 |
| Assets and Liabilities Measured and Recognized on a Recurring Basis | December 27, 2025 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 1 $ - $ 1 Derivative contracts undesignated - 1 - 1 Total return - 1 - 1 Total assets $ - $ 3 $ - $ 3 Liabilities: Derivative contracts designated as hedges $ - $ 23 $ - $ 23 Derivative contracts undesignated - 2 - 2 Contingent consideration - - 97 97 Total liabilities $ - $ 25 $ 97 $ 122 Redeemable noncontrolling interests $ - $ - $ 895 $ 895 December 28, 2024 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 10 $ - $ 10 Derivative contracts undesignated - 7 - 7 Total assets $ - $ 17 $ - $ 17 Liabilities: Derivative contracts designated as hedges $ - $ 5 $ - $ 5 Derivative contracts undesignated - 4 - 4 Total return - 3 - 3 Contingent consideration - - 30 30 Total liabilities $ - $ 12 $ 30 $ 42 Redeemable noncontrolling interests $ - $ - $ 806 $ 806 |
Derivatives and Hedging Activities (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Derivatives and Hedging Activities [Abstract] | |
| Summary of Terms and Fair Value of Derivative Instruments | December 27, 2025 Notional Amount Classification Fair Value Maturity Date Derivatives used in cash flow hedges: Foreign currency forward contracts $ 98 Prepaid expenses and other $ - December 24, 2026 Interest rate swaps 675 Accrued expenses, other (3) July 13, 2026 Derivatives used in net investment hedges: Foreign currency forward contracts 365 Accrued expenses, other (19) November 3, 2028 Undesignated hedging relationships: Total return 116 Prepaid expenses and other 1 December 30, 2025 Total $ 1,254 $ (21) December 28, 2024 Notional Amount Classification Fair Value Maturity Date Derivatives used in cash flow hedges: Foreign currency forward contracts $ 84 Prepaid expenses and other $ - October 30, 2025 Interest rate swaps 713 Accrued expenses, other (3) July 13, 2026 Derivatives used in net investment hedges: Foreign currency forward contracts 336 Prepaid expenses and other 9 November 3, 2028 Undesignated hedging relationships: Total return 106 Accrued expenses, other (3) December 30, 2024 Total $ 1,239 $ 3 |
| Summary of Effect of Cash Flow and Net Investment Hedges on Statements of Income | Years December 27, December 28, December 30, 2025 2024 2023 Derivatives used in cash flow hedges: Foreign currency forward contracts $ - $ - $ (1) Interest rate swaps - 6 (7) Derivatives used in net investment hedges: Foreign currency forward contracts (24) 7 (10) Total $ (24) $ 13 $ (18) |
Debt (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Debt [Abstract] | |
| Bank Credit Lines | December 27, December 28, 2025 2024 Revolving credit agreement $ 100 $ - Other short-term bank credit lines 664 650 Total $ 764 $ 650 |
| Schedule of Long-Term Debt | December 27, December 28, 2025 2024 Private placement facilities $ 1,149 $ 975 Term loan 749 712 U.S. trade accounts receivable securitization 390 150 Various in varying installments through 2031 at interest rates from 0.00 % to 6.75 % at December 27, 2025 and from 0.00 % to 9.42 % at December 28, 2024 48 43 Finance lease obligations 7 6 Total 2,343 1,886 Less current maturities (33) (56) Total long-term debt $ 2,310 $ 1,830 |
| Schedule of Long-Term Debt Maturities | 2026 $ 33 2027 534 2028 221 2029 143 2030 810 Thereafter 602 Total $ 2,343 |
| Schedule of Private Placement Facilities | The components of our private placement facility borrowings as of December average interest rate of 3.93 % are presented in the following table: Amount of Date of Borrowing Borrowing Borrowing Outstanding Rate Due Date June 16, 2017 $ 100 3.42 % June 16, 2027 September 15, 2017 100 3.52 September 15, 2029 January 2, 2018 100 3.32 January 2, 2028 September 2, 2020 100 2.35 September 2, 2030 June 2, 2021 100 2.48 June 2, 2031 June 2, 2021 100 2.58 June 2, 2033 May 4, 2023 75 4.79 May 4, 2028 May 4, 2023 75 4.84 May 4, 2030 May 4, 2023 75 4.96 May 4, 2033 May 4, 2023 150 4.94 May 4, 2033 December 15, 2025 100 5.23 December 15, 2032 December 15, 2025 75 5.28 December 15, 2032 Less: Deferred debt issuance costs (1) Total $ 1,149 The components of our private placement facility borrowings as of December average interest rate of 3.70 % are presented in the following table: Amount of Date of Borrowing Borrowing Borrowing Outstanding Rate Due Date June 16, 2017 $ 100 3.42 % June 16, 2027 September 15, 2017 100 3.52 September 15, 2029 January 2, 2018 100 3.32 January 2, 2028 September 2, 2020 100 2.35 September 2, 2030 June 2, 2021 100 2.48 June 2, 2031 June 2, 2021 100 2.58 June 2, 2033 May 4, 2023 75 4.79 May 4, 2028 May 4, 2023 75 4.84 May 4, 2030 May 4, 2023 75 4.96 May 4, 2033 May 4, 2023 150 4.94 May 4, 2033 Total $ 975 |
Income Taxes (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Income Taxes [Abstract] | |
| Income Before Taxes and Equity in Earnings of Affiliates | Years December 27, December 28, December 30, 2025 2024 2023 Domestic $ 384 $ 338 $ 424 Foreign 149 175 118 Total $ 533 $ 513 $ 542 |
| Provision for Income Taxes Attributable to Continuing Operations | The provisions for income taxes were as follows: Years December 27, December 28, December 30, 2025 2024 2023 Current income tax expense: U.S. Federal $ 42 $ 100 $ 72 State and local 15 33 28 Foreign 64 56 40 Total current 121 189 140 Deferred income tax expense (benefit): U.S. Federal 33 (29) 9 State and local 3 (12) (3) Foreign (31) (20) (26) Total deferred 5 (61) (20) Total provision $ 126 $ 128 $ 120 |
| Tax Effects of Temporary Differences to Deferred Income Tax Asset (Liability) | The tax effects of temporary differences that give rise to our deferred income tax asset (liability) were Years December 27, December 28, 2025 2024 Deferred income tax asset: Net operating losses $ 105 $ 91 Other carryforwards 52 37 Inventory, premium valuation allowances 38 37 Operating lease liability 75 76 Capitalization of research and development costs 10 27 Other asset 62 49 Total deferred income 342 317 Valuation (1) (53) (38) Net deferred income tax asset 289 279 Deferred income tax liability Intangibles amortization (266) (260) Operating lease right-of-use asset (70) (67) Property and equipment (7) (7) Total deferred tax (343) (334) Net deferred income tax asset (liability) $ (54) $ (55) (1) Primarily relates to operating losses, the benefits of which are uncertain. reflected as a reduction of income tax expense. |
| Reconciliation of Income Tax Provision at Federal Statutory Rate to Total Income Tax Provision | Year $ % Income tax provision at federal statutory rate $ 112 21.0 % State income tax provision, net of federal income tax effect 10 2.0 Foreign Tax effects Cayman Islands: Foreign partnership loss 8 1.5 Other (1) (0.1) Other foreign jurisdictions: Equity investment remeasurement gain (6) (1.1) Notional interest deduction (6) (1.1) Other 19 3.5 Effects of changes in tax laws or rates enacted in current period - - Cross-border tax laws 1 0.1 Tax credits (2) (0.4) Changes in valuation allowance 3 0.6 Nontaxable and nondeductible items 3 0.5 Worldwide changes 4 0.7 Other adjustments: Previously held non-controlling equity investment (9) (1.7) Other (10) (1.8) Effective tax rate $ 126 23.7 % State taxes in California, Illinois, Massachusetts, New Jersey, and New York in this category. Years December 28, December 30, 2024 2023 Income tax provision at federal statutory rate $ 108 $ 114 State income tax provision, net of federal income tax effect 11 15 Foreign income tax provision 10 5 Pass-through noncontrolling interest 1 (8) Valuation 6 (3) Unrecognized tax benefits and audit settlements 5 9 Interest expense related to loans (14) (13) Effect of cross border tax laws 12 7 Other (11) (6) Total income $ 128 $ 120 |
| Reconciliation of Unrecognized Tax Benefits Excluding the Effect of Deferred Taxes | December 27, December 28, December 30, 2025 2024 2023 Balance, beginning of period $ 89 $ 98 $ 82 Additions based on current year tax positions 5 5 9 Additions based on prior year tax positions 5 10 26 Reductions based on prior year tax positions (2) (14) (2) Reductions resulting from settlements with taxing authorities - - (3) Reductions resulting from lapse in statutes of limitations (7) (10) (14) Balance, end of period $ 90 $ 89 $ 98 |
Plans of Restructuring and Related Costs (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Plans of Restructuring and Related Costs [Abstract] | |
| Schedule of Restructuring Costs | Year Ended Global Distribution and Value-Added Services Global Specialty Products Global Technology Corporate Total 2024 Plan Severance and employee-related costs $ 40 $ 22 $ 4 $ 20 $ 86 Impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets (3) 6 (1) - 2 Exit and other related costs 5 4 - - 9 Loss/(Gain) on disposal of a business 1 12 (5) - 8 Restructuring and related costs-2024 Plan $ 43 $ 44 $ (2) $ 20 $ 105 Year Ended Global Distribution and Value-Added Services Global Specialty Products Global Technology Corporate Total 2024 Plan Severance and employee-related costs $ 31 $ 5 $ 6 $ 2 $ 44 Impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets 5 3 4 - 12 Exit and other related costs 2 - - - 2 Loss on disposal of a business - 15 - - 15 Restructuring and related costs-2024 Plan $ 38 $ 23 $ 10 $ 2 $ 73 2022 Plan Severance and employee-related costs $ 18 $ 5 $ 1 $ - $ 24 Accelerated depreciation and amortization 10 - - (3) 7 Exit and other related costs 2 2 - 2 6 Loss on disposal of a business - - - - - Restructuring and related costs-2022 Plan $ 30 $ 7 $ 1 $ (1) $ 37 Total restructuring and related costs $ 68 $ 30 $ 11 $ 1 $ 110 Year Ended Global Distribution and Value-Added Services Global Specialty Products Global Technology Corporate Total 2022 Plan Severance and employee-related costs $ 29 $ 5 $ 5 $ 7 $ 46 Impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets 13 - 2 - 15 Exit and other related costs 3 1 - 2 6 Loss on disposal of a business - 13 - - 13 Restructuring and related costs-2022 Plan $ 45 $ 19 $ 7 $ 9 $ 80 |
| Schedule of Restructuring Reserve Activity | 2022 Plan 2024 Plan Total Balance, December 30, 2023 $ 23 $ - $ 23 Restructuring and related costs 37 73 110 Non-cash impairment, accelerated depreciation and amortization (7) (12) (19) Non-cash impairment on disposal of a business - (13) (13) Cash payments and other adjustments (41) (20) (61) Balance, December 28, 2024 12 28 40 Restructuring and related costs - 105 105 Non-cash impairment, accelerated depreciation and amortization - (2) (2) Non-cash charges related to disposal of a business - (6) (6) Cash payments and other adjustments (11) (77) (88) Balance, December 27, 2025 $ 1 $ 48 $ 49 |
Commitments and Contingencies (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Commitments and Contingencies Disclosure [Abstract] | |
| Purchase Commitments | 2026 $ 8 2027 1 2028 - 2029 - 2030 - Thereafter - Total minimum $ 9 |
Stock Based Compensation (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Stock Based Compensation [Abstract] | |
| Summary of Stock Option Activity Under the Plans | Stock Options Weighted Average Aggregate Weighted Average Remaining Contractual Intrinsic Shares Exercise Price Life (in years) Value Outstanding at beginning of year 963,491 $ 72.16 Granted - - Exercised (24,945) 62.71 Forfeited (15,831) 81.75 Outstanding at end of year 922,715 $ 72.26 5.6 $ 7 Options exercisable at end of year 922,715 $ 72.26 5.6 $ 7 |
| Status of Non-Vested Restricted Shares/Units | Time-Based Restricted Stock Units Performance-Based Restricted Stock Units Weighted Average Weighted Average Grant Date Fair Grant Date Fair Shares/Units Value Per Share Shares/Units Value Per Share Outstanding at beginning of period 1,685,550 $ 72.90 389,111 $ 75.98 Granted 592,716 75.18 251,287 75.30 Performance adjustment n/a n/a (31,313) 76.20 Vested (564,037) 66.54 (14,499) 84.04 Forfeited (107,687) 77.10 (206,626) 77.33 Outstanding at end of period 1,606,542 $ 75.69 387,960 $ 75.89 |
Employee Benefit Plans (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Employee Benefit Plans [Abstract] | |
| Obligation and Funded Status | Years December 27, December 28, 2025 2024 Obligation and funded status: Change in benefit obligation Projected benefit obligation, beginning of period $ 129 $ 125 Service costs 4 4 Interest cost 3 3 Past service cost (credit) - (1) Actuarial gain (loss) (2) 6 Benefits paid 1 - Participant contributions 2 2 Settlements and curtailments (7) (1) Effect of foreign currency translation 16 (9) Projected benefit obligation, end of period $ 146 $ 129 Change in plan assets Fair value of plan assets at beginning of period $ 90 $ 86 Actual return on plan assets 1 3 Employer contributions 3 3 Plan participant contributions 2 2 Expected return on plan assets 3 3 Benefit received 4 1 Settlements (6) (2) Effect of foreign currency translation 9 (6) Fair value of plan assets at end of period $ 106 $ 90 Unfunded status at end of period $ 40 $ 39 |
| Balance Sheet | Years December 27, December 28, 2025 2024 Non-current assets $ 37 $ 28 Current liabilities (1) (1) Non-current liabilities (76) (68) Accumulated other comprehensive loss, pre-tax 8 10 |
| Net Periodic Pension Cost | Years December 27, December 28, December 30, 2025 2024 2023 Service cost $ 4 $ 4 $ 3 Interest cost 3 3 3 Expected return on plan assets (3) (3) (3) Employee contributions (1) (1) (1) Settlements (1) - - Net periodic pension cost $ 2 $ 3 $ 2 |
| Assumptions | Years December 27, December 28, Pension Benefit Obligation 2025 2024 Weighted average 2.75 % 2.23 % Years December 27, December 28, December 30, Net Periodic Pension Cost 2025 2024 2023 Discount rate-pension benefit 2.05 % 1.70 % 1.50 % Expected return on plan assets 0.92 % 1.13 % 0.51 % Rate of compensation increase 2.00 % 1.98 % 1.64 % Pension increase rate 0.74 % 0.63 % 0.80 % |
| Estimated Payments | Year 2026 $ 8 2027 9 2028 9 2029 7 2030 8 2031 to 2035 52 Total $ 93 |
Redeemable Noncontrolling Interests (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Redeemable Noncontrolling Interests [Abstract] | |
| Change in Fair Value of Redeemable Noncontrolling Interests | December 27, December 28, December 30, 2025 2024 2023 Balance, beginning of period $ 806 $ 864 $ 576 Decrease in redeemable noncontrolling interests due to acquisitions of noncontrolling interests in subsidiaries (76) (273) (19) Increase in redeemable noncontrolling interests due to business acquisitions 86 171 326 Net income (loss) attributable to redeemable noncontrolling interests (5) (1) 6 Distributions declared, net of capital contributions (18) (50) (19) Effect of foreign currency translation gain (loss) attributable redeemable noncontrolling interests 30 (24) 5 Change in fair value of redeemable securities 72 119 (11) Balance, end of period $ 895 $ 806 $ 864 |
Comprehensive Income (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Comprehensive Income [Abstract] | |
| Accumulated Other Comprehensive Income and Comprehensive Income Components | December 27, December 28, December 30, 2025 2024 2023 Attributable to redeemable noncontrolling interests: Foreign currency translation adjustment $ (26) $ (56) $ (32) Attributable to noncontrolling interests: Foreign currency translation adjustment $ 1 $ (1) $ (1) Attributable to Henry Schein, Inc.: Foreign currency translation adjustment $ (196) $ (371) $ (188) Unrealized gain loss from hedging activities (24) - (13) Pension adjustment loss (6) (8) (5) Accumulated other comprehensive loss $ (226) $ (379) $ (206) Total Accumulated $ (251) $ (436) $ (239) |
| Components of comprehensive income, net of applicable taxes | December 27, December 28, December 30, 2025 2024 2023 Net income $ 419 $ 398 $ 436 Foreign currency translation gain (loss) 207 (207) 53 Tax effect - - - Foreign currency translation gain (loss) 207 (207) 53 Unrealized gain (loss) from hedging activities (33) 18 (25) Tax effect 9 (5) 7 Unrealized gain (loss) from hedging activities (24) 13 (18) Pension adjustment gain (loss) 5 (5) (3) Tax effect (3) 2 - Pension adjustment gain (loss) 2 (3) (3) Comprehensive income $ 604 $ 201 $ 468 |
| Total Comprehensive Income | December 27, December 28, December 30, 2025 2024 2023 Comprehensive income attributable to Henry Schein, Inc. $ 551 $ 217 $ 443 Comprehensive income attributable to noncontrolling interests 28 9 14 Comprehensive income (loss) attributable to Redeemable noncontrolling interests 25 (25) 11 Comprehensive income $ 604 $ 201 $ 468 |
Earnings Per Share (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Earnings Per Share [Abstract] | |
| Reconciliation of Shares used in Calculating Earnings per Share Basic and Diluted | Years December 27, December 28, December 30, 2025 2024 2023 Basic 120,813,977 126,788,997 130,618,990 Effect of dilutive securities: Stock options and restricted stock units 903,899 990,231 1,129,181 Diluted 121,717,876 127,779,228 131,748,171 |
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Years December 27, December 28, December 30, 2025 2024 2023 Stock options 396,052 406,676 424,695 Restricted stock units 6,200 9,287 15,040 Total anti-dilutive computation 402,252 415,963 439,735 |
Supplemental Cash Flow Information (Tables) |
12 Months Ended |
|---|---|
Dec. 27, 2025 | |
| Supplemental Cash Flow Elements [Abstract] | |
| Cash Paid for Interest and Income Taxes | Years December 27, December 28, December 30, 2025 2024 2023 Cash paid for interest $ 151 $ 132 $ 84 Cash paid for income taxes, net of refunds: U.S. Federal $ 67 U.S. State and local 15 Foreign: Switzerland 8 Other 38 Total $ 128 Years December 28, December 30, 2024 2023 Cash paid during the period for income taxes (prior to ASU 2023-09) $ 144 $ 218 |
Basis of Presentation and Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
Dec. 31, 2022 |
|||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Fiscal year duration | 364 days | 364 days | 364 days | |||||
| Accrued warranty costs | $ 8 | $ 8 | ||||||
| Distribution network costs | 107 | 105 | $ 105 | |||||
| Costs of goods sold | 9,079 | 8,657 | 8,479 | |||||
| Advertising and promotional costs | 46 | 43 | 47 | |||||
| Outstanding checks in excess of funds on deposit classified as accounts payable | 25 | 33 | ||||||
| Contract liabilities, current | 81 | 81 | $ 89 | |||||
| Contract liabilities, noncurrent | $ 9 | 8 | 9 | |||||
| Lease option to extend | Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. | |||||||
| Short-term lease expense | $ 10 | 11 | 10 | |||||
| Accounts receivable balance | 1,651 | [1] | 1,482 | [1] | 1,863 | |||
| Allowance for doubtful accounts | 90 | 78 | 83 | $ 65 | ||||
| Goodwill impairment | 13 | |||||||
| Impairment charge on intangible assets | $ 16 | 0 | 7 | |||||
| Business combinations, measurement period | 12 months | |||||||
| Facility Closing [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Impairment charge on intangible assets | $ 0 | 14 | 12 | |||||
| Minimum [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Fiscal year duration | 364 days | |||||||
| Maximum [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Fiscal year duration | 371 days | |||||||
| Global Distribution and Value-Added Services [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Goodwill impairment | 0 | |||||||
| Global Specialty Products [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Goodwill impairment | 11 | |||||||
| Global Specialty Products [Member] | Facility Closing [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Goodwill impairment | 11 | |||||||
| Shipping and Handling [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Costs of goods sold | $ 105 | 106 | $ 98 | |||||
| Variable Interest Entity, Primary Beneficiary [Member] | Recourse [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Liabilities of VIE | 390 | 150 | ||||||
| Variable Interest Entity, Primary Beneficiary [Member] | Asset Pledged As Collateral [Member] | ||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Pledged assets | $ 491 | $ 241 | ||||||
| ||||||||
Basis of Presentation and Significant Accounting Policies (Allowance for Credit Losses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Basis of Presentation and Significant Accounting Policies [Abstract] | |||
| Balance at beginning of year | $ 78 | $ 83 | $ 65 |
| Provision for credit losses | 20 | 14 | 17 |
| Adjustments to existing allowances for late fees, foreign currency exchange rates, and write-offs | (8) | (19) | 1 |
| Balance at end of year | $ 90 | $ 78 | $ 83 |
Basis of Presentation and Significant Accounting Policies (Contract Liabilities) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|---|---|
| Basis of Presentation and Significant Accounting Policies [Abstract] | ||||
| Current contract liabilities | $ 81 | $ 81 | $ 89 | |
| Non-current contract liabilities | $ 9 | 8 | 9 | |
| Total contract liabilities | $ 90 | $ 89 | $ 98 |
Cyber Incident (Narrative) (Details) - Cyber Incident [Member] - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Unusual Or Infrequent Item [Line Items] | |||
| Insurance policy limitations | $ 60 | ||
| Insurance retention | 5 | ||
| Expenses related to cyber incident | 0 | $ 9 | $ 11 |
| Insurance proceeds related to cyber incident | $ 20 | $ 40 | |
Net Sales from Contracts with Customers (Disaggregation of Net Sales) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Disaggregation of Revenue [Abstract] | |||
| Net sales | $ 13,184 | $ 12,673 | $ 12,339 |
| Global Distribution and Value-Added Services [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 11,120 | 10,729 | 10,525 |
| Global Specialty Products [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 1,389 | 1,314 | 1,212 |
| Global Technology [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 675 | 630 | 602 |
| Operating Segments [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 13,357 | 12,836 | 12,494 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 11,138 | 10,760 | 10,561 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Dental [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 6,868 | 6,679 | 6,649 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Dental Merchandise [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 4,831 | 4,723 | 4,783 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Dental Equipment [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 1,799 | 1,723 | 1,675 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Value-Added Services [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 238 | 233 | 191 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Medical [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 4,270 | 4,081 | 3,912 |
| Operating Segments [Member] | Global Specialty Products [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 1,544 | 1,446 | 1,331 |
| Operating Segments [Member] | Global Technology [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | 675 | 630 | 602 |
| Intersegment Elimination [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | (173) | (163) | (155) |
| Intersegment Elimination [Member] | Global Distribution and Value-Added Services [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | (18) | (31) | (36) |
| Intersegment Elimination [Member] | Global Specialty Products [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | (155) | (132) | (119) |
| Intersegment Elimination [Member] | Global Technology [Member] | |||
| Disaggregation of Revenue [Abstract] | |||
| Net sales | $ 0 | $ 0 | $ 0 |
Segment and Geographic Data (Narrative) (Details) |
12 Months Ended |
|---|---|
|
Dec. 27, 2025
number
| |
| Segment Reporting Information [Line Items] | |
| Number of reportable segments | 3 |
| Minimum [Member] | United States [Member] | Geographic Concentration Risk [Member] | Sales Revenue, Net [Member] | |
| Segment Reporting Information [Line Items] | |
| Concentration risk percentage (as a percent) | 10.00% |
Segment and Geographic Data (Business Segment Information) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Segment Reporting Information [Line Items] | |||
| Net sales | $ 13,184 | $ 12,673 | $ 12,339 |
| Cost of sales | 9,079 | 8,657 | 8,479 |
| Operating income | 653 | 621 | 615 |
| Depreciation and amortization | 311 | 297 | 248 |
| Global Distribution and Value-Added Services [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 11,120 | 10,729 | 10,525 |
| Global Specialty Products [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 1,389 | 1,314 | 1,212 |
| Global Technology [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 675 | 630 | 602 |
| Operating Segments [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 13,357 | 12,836 | 12,494 |
| Operating income | 1,102 | 1,026 | 982 |
| Depreciation and amortization | 99 | 89 | 80 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 11,138 | 10,760 | 10,561 |
| Cost of sales | 8,352 | 7,984 | 7,862 |
| Operating expenses | 2,106 | 2,080 | 2,034 |
| Operating income | 680 | 696 | 665 |
| Depreciation and amortization | 27 | 25 | 26 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Dental [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 6,868 | 6,679 | 6,649 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Dental Merchandise [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 4,831 | 4,723 | 4,783 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Dental Equipment [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 1,799 | 1,723 | 1,675 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Value-Added Services [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 238 | 233 | 191 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Global Medical [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 4,270 | 4,081 | 3,912 |
| Operating Segments [Member] | Global Specialty Products [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 1,544 | 1,446 | 1,331 |
| Cost of sales | 697 | 644 | 611 |
| Operating expenses | 605 | 624 | 545 |
| Operating income | 242 | 178 | 175 |
| Depreciation and amortization | 36 | 29 | 23 |
| Operating Segments [Member] | Global Technology [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 675 | 630 | 602 |
| Cost of sales | 218 | 206 | 185 |
| Operating expenses | 277 | 272 | 275 |
| Operating income | 180 | 152 | 142 |
| Depreciation and amortization | 36 | 35 | 31 |
| Corporate Nonsegment [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Operating income | (130) | (77) | (92) |
| Depreciation and amortization | 33 | 24 | 18 |
| Intersegment Elimination [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | (173) | (163) | (155) |
| Operating income | (319) | (328) | (275) |
| Intersegment Elimination [Member] | Global Distribution and Value-Added Services [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | (18) | (31) | (36) |
| Intersegment Elimination [Member] | Global Specialty Products [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | (155) | (132) | (119) |
| Intersegment Elimination [Member] | Global Technology [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 0 | 0 | 0 |
| Eliminations and Reconciling Items [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Operating income | 319 | 328 | 275 |
| Depreciation and amortization | $ 179 | $ 184 | $ 150 |
Segment and Geographic Data (Business Segment Information - Adjustments) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Adjustments: | |||
| Restructuring costs and related costs | $ (105) | $ (110) | |
| Acquisition intangible amortization | (311) | (297) | $ (248) |
| Impairment of capitalized assets | 0 | (12) | (27) |
| Impairment of intangible assets | (16) | 0 | (7) |
| Total adjustments | (653) | (621) | (615) |
| Eliminations and Reconciling Items [Member] | |||
| Adjustments: | |||
| Restructuring costs and related costs | (105) | (110) | (80) |
| Acquisition intangible amortization | (179) | (184) | (150) |
| Cyber incident-third-party advisory expenses, net of insurance | 20 | 31 | (11) |
| Changes in contingent consideration | 2 | (45) | 0 |
| Litigation settlements | (5) | (6) | 0 |
| Impairment of capitalized assets | 0 | (12) | (27) |
| Impairment of intangible assets | (16) | 0 | (7) |
| Costs associated with shareholder advisory matters and select value creation consulting costs | (36) | (2) | 0 |
| Total adjustments | $ (319) | $ (328) | $ (275) |
Segment and Geographic Data (Operations by Geographic Area) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Net sales | $ 13,184 | $ 12,673 | $ 12,339 |
| Long-Lived Assets | 6,153 | 5,734 | 5,614 |
| United States [Member] | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Net sales | 9,096 | 8,825 | 8,662 |
| Long-Lived Assets | 4,033 | 3,683 | 3,479 |
| Other [Member] | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Net sales | 4,088 | 3,848 | 3,677 |
| Long-Lived Assets | $ 2,120 | $ 2,051 | $ 2,135 |
Business Acquisitions (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Apr. 01, 2024 |
Oct. 02, 2023 |
Jul. 05, 2023 |
Apr. 05, 2023 |
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Business Acquisition [Line Items] | |||||||
| Goodwill | $ 4,213 | $ 3,887 | $ 3,875 | ||||
| Acquisition costs | 6 | 6 | 22 | ||||
| 2025 Acquisitions [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Totalonsideration transferred | 392 | ||||||
| Consideration paid | 194 | ||||||
| Noncontrolling interests | 85 | ||||||
| Fair value of contributed equity share in a controlled subsidiary | 91 | ||||||
| Deferred consideration | 3 | ||||||
| Goodwill | 199 | ||||||
| Intangible Assets | 150 | ||||||
| Identifiable intangible assets acquired | 150 | ||||||
| 2025 Acquisitions [Member] | Product Development [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Identifiable intangible assets acquired | $ 18 | ||||||
| Weighted Average Useful Lives (in years) | 10 years | ||||||
| 2025 Acquisitions [Member] | Noncompete Agreements [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Identifiable intangible assets acquired | $ 2 | ||||||
| Weighted Average Useful Lives (in years) | 5 years | ||||||
| 2025 Acquisitions [Member] | Minimum [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 60.00% | ||||||
| 2025 Acquisitions [Member] | Maximum [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 100.00% | ||||||
| Acquisitions of Controlling Interests of Affiliates [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Recognized gain related to remeasurement to fair value of previously held equity investment | $ 38 | ||||||
| Business Combination Achieved In Stages Preacquisition Equity Interest In Acquiree Remeasurement Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration | Selling, General and Administrative Expense | ||||||
| Adjustments for provisional amounts | 18 | ||||||
| TriMed, Inc. [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 60.00% | ||||||
| Totalonsideration transferred | $ 315 | 315 | |||||
| Consideration paid | 141 | ||||||
| Noncontrolling interests | 153 | ||||||
| Deferred consideration | 21 | ||||||
| Goodwill | 124 | ||||||
| Intangible Assets | 221 | ||||||
| TriMed, Inc. [Member] | Product Development [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 204 | ||||||
| Weighted Average Useful Lives (in years) | 9 years | ||||||
| TriMed, Inc. [Member] | Trademarks and Trade Names [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 9 | ||||||
| Weighted Average Useful Lives (in years) | 7 years | ||||||
| TriMed, Inc. [Member] | In Process Research and Development [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 8 | ||||||
| Shield Healthcare, Inc. [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 90.00% | ||||||
| Totalonsideration transferred | $ 348 | ||||||
| Consideration paid | 289 | ||||||
| Noncontrolling interests | 37 | ||||||
| Deferred consideration | 22 | ||||||
| Goodwill | 199 | ||||||
| Intangible Assets | 166 | ||||||
| Identifiable intangible assets acquired | $ 166 | ||||||
| S.I.N. Implant System [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 100.00% | ||||||
| Totalonsideration transferred | $ 329 | ||||||
| Consideration paid | 329 | ||||||
| Goodwill | 241 | ||||||
| Intangible Assets | 87 | ||||||
| Identifiable intangible assets acquired | 87 | ||||||
| S.I.N. Implant System [Member] | Product Development [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Identifiable intangible assets acquired | $ 36 | ||||||
| Weighted Average Useful Lives (in years) | 8 years | ||||||
| Biotech Dental [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 57.00% | ||||||
| Totalonsideration transferred | $ 423 | ||||||
| Consideration paid | 216 | ||||||
| Noncontrolling interests | 182 | ||||||
| Fair value of contributed equity share in a controlled subsidiary | 25 | ||||||
| Goodwill | 297 | ||||||
| Intangible Assets | 189 | ||||||
| Identifiable intangible assets acquired | 189 | ||||||
| Biotech Dental [Member] | Product Development [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Identifiable intangible assets acquired | $ 124 | ||||||
| Weighted Average Useful Lives (in years) | 10 years | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Totalonsideration transferred | 113 | 284 | |||||
| Consideration paid | 62 | ||||||
| Noncontrolling interests | 18 | ||||||
| Estimated fair value of contingent consideration payable | 2 | ||||||
| Fair value of contributed equity share in a controlled subsidiary | 30 | ||||||
| Deferred consideration | 1 | ||||||
| Goodwill | 60 | 171 | |||||
| Intangible Assets | 64 | 116 | |||||
| Recognized gain related to remeasurement to fair value of previously held equity investment | $ 19 | ||||||
| Business Combination Achieved In Stages Preacquisition Equity Interest In Acquiree Remeasurement Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration | Selling, General and Administrative Expense | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Customer Relationships and Lists [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 33 | 79 | |||||
| Weighted Average Useful Lives (in years) | 11 years | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Product Development [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 5 | 7 | |||||
| Weighted Average Useful Lives (in years) | 9 years | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Trademarks and Trade Names [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 24 | 8 | |||||
| Weighted Average Useful Lives (in years) | 7 years | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Noncompete Agreements [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 2 | ||||||
| Weighted Average Useful Lives (in years) | 5 years | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Other Intangible Assets [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Intangible Assets | $ 22 | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Minimum [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 51.00% | 51.00% | |||||
| Weighted Average Useful Lives (in years) | 2 years | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | Maximum [Member] | |||||||
| Business Acquisition [Line Items] | |||||||
| Percentage of voting interest acquired | 100.00% | 100.00% | |||||
| Weighted Average Useful Lives (in years) | 10 years | ||||||
Business Acquisitions (Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Apr. 01, 2024 |
Oct. 02, 2023 |
Jul. 05, 2023 |
Apr. 05, 2023 |
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Identifiable assets acquired and liabilities assumed: | |||||||
| Goodwill | $ 4,213 | $ 3,887 | $ 3,875 | ||||
| Acquisitions 2025 [Member] | |||||||
| Acquisition consideration: | |||||||
| Cash | 194 | ||||||
| Deferred consideration | 3 | ||||||
| Estimated fair value of contingent consideration payable | 19 | ||||||
| Fair value of previously held equity method investment | 91 | ||||||
| Noncontrolling interests | 85 | ||||||
| Totalonsideration transferred | 392 | ||||||
| Identifiable assets acquired and liabilities assumed: | |||||||
| Current assets | 59 | ||||||
| Intangible Assets | 150 | ||||||
| Other noncurrent assets | 42 | ||||||
| Current liabilities | (26) | ||||||
| Long-term debt | (1) | ||||||
| Deferred income taxes | (23) | ||||||
| Other noncurrent liabilities | (8) | ||||||
| Total identifiable net assets | 193 | ||||||
| Goodwill | 199 | ||||||
| Total net assets acquired | $ 392 | ||||||
| TriMed, Inc. [Member] | |||||||
| Acquisition consideration: | |||||||
| Cash | 141 | ||||||
| Deferred consideration | 21 | ||||||
| Noncontrolling interests | 153 | ||||||
| Totalonsideration transferred | $ 315 | 315 | |||||
| Identifiable assets acquired and liabilities assumed: | |||||||
| Current assets | 35 | ||||||
| Intangible Assets | 221 | ||||||
| Other noncurrent assets | 10 | ||||||
| Current liabilities | (7) | ||||||
| Deferred income taxes | (62) | ||||||
| Other noncurrent liabilities | (6) | ||||||
| Total identifiable net assets | 191 | ||||||
| Goodwill | 124 | ||||||
| Total net assets acquired | 315 | ||||||
| Shield Healthcare, Inc. [Member] | |||||||
| Acquisition consideration: | |||||||
| Cash | $ 289 | ||||||
| Deferred consideration | 22 | ||||||
| Noncontrolling interests | 37 | ||||||
| Totalonsideration transferred | 348 | ||||||
| Identifiable assets acquired and liabilities assumed: | |||||||
| Current assets | 41 | ||||||
| Intangible Assets | 166 | ||||||
| Other noncurrent assets | 16 | ||||||
| Current liabilities | (24) | ||||||
| Deferred income taxes | (43) | ||||||
| Other noncurrent liabilities | (7) | ||||||
| Total identifiable net assets | 149 | ||||||
| Goodwill | 199 | ||||||
| Total net assets acquired | $ 348 | ||||||
| S.I.N. Implant System [Member] | |||||||
| Acquisition consideration: | |||||||
| Cash | $ 329 | ||||||
| Totalonsideration transferred | 329 | ||||||
| Identifiable assets acquired and liabilities assumed: | |||||||
| Current assets | 73 | ||||||
| Intangible Assets | 87 | ||||||
| Other noncurrent assets | 48 | ||||||
| Current liabilities | (33) | ||||||
| Long-term debt | (22) | ||||||
| Deferred income taxes | (38) | ||||||
| Other noncurrent liabilities | (27) | ||||||
| Total identifiable net assets | 88 | ||||||
| Goodwill | 241 | ||||||
| Total net assets acquired | $ 329 | ||||||
| Series of Individually Immaterial Business Acquisitions [Member] | |||||||
| Acquisition consideration: | |||||||
| Cash | 62 | ||||||
| Deferred consideration | 1 | ||||||
| Fair value of previously held equity method investment | 30 | ||||||
| Noncontrolling interests | 18 | ||||||
| Totalonsideration transferred | 113 | 284 | |||||
| Identifiable assets acquired and liabilities assumed: | |||||||
| Intangible Assets | 64 | 116 | |||||
| Goodwill | $ 60 | $ 171 | |||||
| Biotech Dental [Member] | |||||||
| Acquisition consideration: | |||||||
| Cash | $ 216 | ||||||
| Fair value of previously held equity method investment | 25 | ||||||
| Noncontrolling interests | 182 | ||||||
| Totalonsideration transferred | 423 | ||||||
| Identifiable assets acquired and liabilities assumed: | |||||||
| Current assets | 74 | ||||||
| Intangible Assets | 189 | ||||||
| Other noncurrent assets | 69 | ||||||
| Current liabilities | (60) | ||||||
| Long-term debt | (73) | ||||||
| Deferred income taxes | (53) | ||||||
| Other noncurrent liabilities | (20) | ||||||
| Total identifiable net assets | 126 | ||||||
| Goodwill | 297 | ||||||
| Total net assets acquired | $ 423 | ||||||
Business Acquisitions (Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Oct. 02, 2023 |
Jul. 05, 2023 |
Apr. 05, 2023 |
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Acquisitions 2025 [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 150 | |||||
| Acquisitions 2025 [Member] | Customer Relationships and Lists [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 98 | |||||
| Weighted Average Useful Lives (in years) | 11 years | |||||
| Acquisitions 2025 [Member] | Trademarks and Tradenames [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 32 | |||||
| Weighted Average Useful Lives (in years) | 7 years | |||||
| Acquisitions 2025 [Member] | Product Development [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 18 | |||||
| Weighted Average Useful Lives (in years) | 10 years | |||||
| Acquisitions 2025 [Member] | Noncompete Agreements [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 2 | |||||
| Weighted Average Useful Lives (in years) | 5 years | |||||
| TriMed, Inc. [Member] | Product Development [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Weighted Average Useful Lives (in years) | 9 years | |||||
| Shield Healthcare, Inc. [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 166 | |||||
| Shield Healthcare, Inc. [Member] | Customer Relationships and Lists [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 156 | |||||
| Weighted Average Useful Lives (in years) | 12 years | |||||
| Shield Healthcare, Inc. [Member] | Trademarks and Tradenames [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 10 | |||||
| Weighted Average Useful Lives (in years) | 5 years | |||||
| S.I.N. Implant System [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 87 | |||||
| S.I.N. Implant System [Member] | Customer Relationships and Lists [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 38 | |||||
| Weighted Average Useful Lives (in years) | 7 years | |||||
| S.I.N. Implant System [Member] | Trademarks and Tradenames [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 13 | |||||
| Weighted Average Useful Lives (in years) | 10 years | |||||
| S.I.N. Implant System [Member] | Product Development [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 36 | |||||
| Weighted Average Useful Lives (in years) | 8 years | |||||
| Biotech Dental [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 189 | |||||
| Biotech Dental [Member] | Customer Relationships and Lists [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 47 | |||||
| Weighted Average Useful Lives (in years) | 9 years | |||||
| Biotech Dental [Member] | Trademarks and Tradenames [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 18 | |||||
| Weighted Average Useful Lives (in years) | 7 years | |||||
| Biotech Dental [Member] | Product Development [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Assets Acquired | $ 124 | |||||
| Weighted Average Useful Lives (in years) | 10 years | |||||
| Series of Individually Immaterial Business Acquisitions [Member] | Minimum [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Weighted Average Useful Lives (in years) | 2 years | |||||
| Series of Individually Immaterial Business Acquisitions [Member] | Maximum [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Weighted Average Useful Lives (in years) | 10 years | |||||
| Series of Individually Immaterial Business Acquisitions [Member] | Product Development [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Weighted Average Useful Lives (in years) | 9 years | |||||
| Series of Individually Immaterial Business Acquisitions [Member] | Noncompete Agreements [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Weighted Average Useful Lives (in years) | 5 years | |||||
Inventory, Net (Narrative) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Inventories, Net [Abstract] | ||
| Inventory reserves | $ 131 | $ 132 |
Inventory, Net (Schedule of Inventory, Net) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Inventories, Net [Abstract] | ||
| Finished goods | $ 1,889 | $ 1,710 |
| Raw materials | 70 | 61 |
| Work-in process | 43 | 39 |
| Inventories, net | $ 2,002 | $ 1,810 |
Property and Equipment, Net (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | $ 1,380 | $ 1,201 | |
| Less accumulated depreciation and amortization | (759) | (670) | |
| Property and equipment related depreciation expense | 101 | 83 | $ 70 |
| Impairment of capitalized costs | 0 | 12 | $ 27 |
| Land [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | 22 | 20 | |
| Buildings and permanent improvements [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | $ 187 | 164 | |
| Property and equipment, average useful life (in years) | 40 years | ||
| Leasehold improvements [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | $ 125 | 109 | |
| Machinery and warehouse equipment [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | $ 307 | 257 | |
| Machinery and warehouse equipment [Member] | Minimum [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, average useful life (in years) | 5 years | ||
| Machinery and warehouse equipment [Member] | Maximum [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, average useful life (in years) | 15 years | ||
| Furniture, fixtures and other [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | $ 137 | 128 | |
| Furniture, fixtures and other [Member] | Minimum [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, average useful life (in years) | 3 years | ||
| Furniture, fixtures and other [Member] | Maximum [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, average useful life (in years) | 10 years | ||
| Computer equipment and software [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, gross | $ 602 | $ 523 | |
| Computer equipment and software [Member] | Minimum [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, average useful life (in years) | 3 years | ||
| Computer equipment and software [Member] | Maximum [Member] | |||
| Property, Plant and Equipment [Line Items] | |||
| Property and equipment, average useful life (in years) | 10 years | ||
Leases (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Lessee, Lease, Description [Line Items] | |||
| Gain on early lease termination | $ 4 | ||
| Impairment of right-of-use asset from operating lease | $ 0 | $ 3 | |
| Operating lease assets, Lease not yet commenced | 23 | ||
| Current operating lease liabilities | 78 | 75 | |
| Non-current operating lease liabilities | 251 | 259 | |
| Property Owned By Employees And Shareholders [Member] | |||
| Lessee, Lease, Description [Line Items] | |||
| Current operating lease liabilities | 5 | 6 | |
| Non-current operating lease liabilities | $ 22 | $ 20 | |
| Property Owned By Employees And Shareholders [Member] | Current Operating Lease Liabilities [Member] | Related Party Concentration Risk [Member] | |||
| Lessee, Lease, Description [Line Items] | |||
| Concentration risk percentage (as a percent) | 6.60% | 7.60% | |
| Property Owned By Employees And Shareholders [Member] | Non-Current Operating Lease Liabilities [Member] | Related Party Concentration Risk [Member] | |||
| Lessee, Lease, Description [Line Items] | |||
| Concentration risk percentage (as a percent) | 8.70% | 7.80% | |
| Maximum [Member] | |||
| Lessee, Lease, Description [Line Items] | |||
| Remaining lease term (in years) | 23 years | ||
| Lease option to extend (in years) | 10 years | ||
| Operating lease not yet commenced, term of contract | 10 years | ||
| Maximum [Member] | Property Owned By Employees And Shareholders [Member] | |||
| Lessee, Lease, Description [Line Items] | |||
| Remaining lease term (in years) | 12 years | ||
Leases (Components of Lease Expense) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Leases [Abstract] | |||
| Operating lease cost | $ 94 | $ 107 | $ 99 |
| Variable lease cost | 11 | 12 | 12 |
| Short-term lease cost | 10 | 11 | 10 |
| Total operating lease cost | 115 | 130 | 121 |
| Finance lease cost: | |||
| Finance lease cost | 3 | 4 | 5 |
| Total lease cost | 118 | 134 | 126 |
| Operating lease cost including restructuring and integration costs | $ 3 | $ 17 | $ 11 |
Leases (Supplemental Balance Sheet Information) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Operating Leases | ||
| Operating lease right-of-use assets | $ 301 | $ 293 |
| Current operating lease liabilities | 78 | 75 |
| Non-current operating lease liabilities | 251 | 259 |
| Total operating lease liabilities | 329 | 334 |
| Finance leases | ||
| Property and equipment, at cost | 14 | 16 |
| Accumulated depreciation | (7) | (9) |
| Property and equipment, net of accumulated depreciation | 7 | 7 |
| Current maturities of long-term debt | $ 3 | $ 3 |
| Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] | Long-term Debt and Capital Lease Obligations, Current | Long-term Debt and Capital Lease Obligations, Current |
| Long-term debt | $ 4 | $ 3 |
| Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | Long-Term Debt and Lease Obligation | Long-Term Debt and Lease Obligation |
| Total finance lease liabilities | $ 7 | $ 6 |
| Weighted Average Remaining Lease Term, in years, Operating Lease | 5 years 7 months 6 days | 5 years 10 months 24 days |
| Weighted Average Remaining Lease Term, in years, Finance Lease | 2 years 10 months 24 days | 2 years 8 months 12 days |
| Weighted Average Discount Rate, Percent, Operating Lease | 4.50% | 4.20% |
| Weighted Average Discount Rate, Percent, Finance Lease | 4.50% | 4.40% |
Leases (Supplemental Cash Flow Information) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Cash paid for amounts included in the measurement of lease liabilities | ||
| Operating cash flows for operating leases | $ 99 | $ 94 |
| Financing cash flows for finance leases | 3 | 4 |
| Right-of-use assets obtained in exchange for lease obligations: | ||
| Operating leases | 71 | 76 |
| Finance leases | $ 3 | $ 2 |
Leases (Maturities of Lease Liabilities) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Operating Leases | ||
| 2026 | $ 91 | |
| 2027 | 74 | |
| 2028 | 59 | |
| 2029 | 47 | |
| 2030 | 37 | |
| Thereafter | 63 | |
| Total future lease payments | 371 | |
| Less imputed interest | 42 | |
| Total operating lease liabilities | 329 | $ 334 |
| Finance Leases | ||
| 2026 | 3 | |
| 2027 | 2 | |
| 2028 | 1 | |
| 2029 | 1 | |
| 2030 | 0 | |
| Thereafter | 0 | |
| Total future lease payments | 7 | |
| Less imputed interest | 0 | |
| Total finance lease liabilities | $ 7 | $ 6 |
Goodwill and Other Intangibles, Net (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Goodwill and Intangible Assets [Line Items] | |||
| Goodwill impairment | $ 13 | ||
| Amortization of intangible assets | $ 180 | 185 | $ 152 |
| Impairment charge on intangible assets | 16 | 0 | 7 |
| Amortization expense expected to be recorded 2024 | 172 | ||
| Amortization expense expected to be recorded 2025 | 159 | ||
| Amortization expense expected to be recorded 2026 | 142 | ||
| Amortization expense expected to be recorded 2027 | 128 | ||
| Amortization expense expected to be recorded 2028 | 118 | ||
| Disposal of a Business [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | $ 0 | $ 14 | 12 |
| Trademarks and Trade Names [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Average useful life (in years) | 8 years | 8 years | |
| Customer Lists and Relationships [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Average useful life (in years) | 10 years | 10 years | |
| Product Development [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Average useful life (in years) | 9 years | 9 years | |
| Noncompete Agreements [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Average useful life (in years) | 5 years | 4 years | |
| Other Intangible Assets [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Average useful life (in years) | 15 years | 15 years | |
| Global Specialty Products [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Goodwill impairment | $ 11 | ||
| Global Specialty Products [Member] | Disposal of a Business [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Goodwill impairment | 11 | ||
| Global Distribution and Value-Added Services [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Goodwill impairment | 0 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | $ 16 | 4 | 19 |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Planned Exit of Business [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | 12 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Trade Names [Member] | Disposal of a Business [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | 2 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Trade Names [Member] | Business Integration [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | 1 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Trade Names and Non-Compete Agreements [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | 2 | $ 1 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | Customer Lists and Relationships [Member] | |||
| Goodwill and Intangible Assets [Line Items] | |||
| Impairment charge on intangible assets | $ 14 | $ 7 | |
Goodwill and Other Intangibles, Net (Changes in the Carrying Amount of Goodwill) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Goodwill [Roll Forward] | ||
| Beginning balance | $ 3,887 | $ 3,875 |
| Adjustments to goodwill: Acquisitions | 199 | 148 |
| Adjustments to goodwill: Impairment | (13) | |
| Adjustments to goodwill: Disposal | (3) | |
| Adjustments to goodwill: Foreign currency translation | 130 | (123) |
| Ending balance | 4,213 | 3,887 |
| Global Distribution and Value-Added Services [Member] | ||
| Goodwill [Roll Forward] | ||
| Beginning balance | 2,009 | 2,007 |
| Adjustments to goodwill: Acquisitions | 49 | 41 |
| Adjustments to goodwill: Impairment | 0 | |
| Adjustments to goodwill: Disposal | (1) | |
| Adjustments to goodwill: Foreign currency translation | 49 | (39) |
| Ending balance | 2,106 | 2,009 |
| Global Specialty Products [Member] | ||
| Goodwill [Roll Forward] | ||
| Beginning balance | 1,093 | 1,077 |
| Adjustments to goodwill: Acquisitions | 124 | 107 |
| Adjustments to goodwill: Impairment | (11) | |
| Adjustments to goodwill: Disposal | 0 | |
| Adjustments to goodwill: Foreign currency translation | 74 | (80) |
| Ending balance | 1,291 | 1,093 |
| Global Technology [Member] | ||
| Goodwill [Roll Forward] | ||
| Beginning balance | 785 | 791 |
| Adjustments to goodwill: Acquisitions | 26 | 0 |
| Adjustments to goodwill: Impairment | (2) | |
| Adjustments to goodwill: Disposal | (2) | |
| Adjustments to goodwill: Foreign currency translation | 7 | (4) |
| Ending balance | $ 816 | $ 785 |
Goodwill and Other Intangibles, Net (Other Intangible Assets - Finite-Lived) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Finite-Lived Intangible Assets, Net [Abstract] | ||
| Cost | $ 1,656 | $ 1,555 |
| Accumulated amortization | (638) | (532) |
| Net | 1,018 | 1,023 |
| Customer Relationships and Lists [Member] | ||
| Finite-Lived Intangible Assets, Net [Abstract] | ||
| Cost | 971 | 915 |
| Accumulated amortization | (408) | (356) |
| Net | $ 563 | $ 559 |
| Weighted Average Remaining Life (in years) | 10 years | 10 years |
| Trademarks and Trade Names [Member] | ||
| Finite-Lived Intangible Assets, Net [Abstract] | ||
| Cost | $ 205 | $ 188 |
| Accumulated amortization | (96) | (89) |
| Net | $ 109 | $ 99 |
| Weighted Average Remaining Life (in years) | 8 years | 8 years |
| Product Development [Member] | ||
| Finite-Lived Intangible Assets, Net [Abstract] | ||
| Cost | $ 438 | $ 403 |
| Accumulated amortization | (120) | (71) |
| Net | $ 318 | $ 332 |
| Weighted Average Remaining Life (in years) | 9 years | 9 years |
| Noncompete Agreements [Member] | ||
| Finite-Lived Intangible Assets, Net [Abstract] | ||
| Cost | $ 18 | $ 21 |
| Accumulated amortization | (5) | (6) |
| Net | $ 13 | $ 15 |
| Weighted Average Remaining Life (in years) | 5 years | 4 years |
| Other intangibles assets [Member] | ||
| Finite-Lived Intangible Assets, Net [Abstract] | ||
| Cost | $ 24 | $ 28 |
| Accumulated amortization | (9) | (10) |
| Net | $ 15 | $ 18 |
| Weighted Average Remaining Life (in years) | 15 years | 15 years |
Investments and Other (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Investments in unconsolidated affiliates | $ 174 | $ 170 | |
| Non-current deferred foreign, state and local income taxes | 92 | 47 | |
| Notes receivable | 56 | 63 | |
| Capitalized costs for software and cloud based applications for external use | 112 | 90 | |
| Security deposits | 4 | 4 | |
| Acquisition related indemnification assets | 39 | 39 | |
| Non-current pension assets | 11 | 9 | |
| Non-current inventory | 38 | 27 | |
| Other long-term assets | 72 | 52 | |
| Total | 598 | 501 | |
| Amortization of other long-term assets | 30 | 29 | $ 26 |
| Impairment of capitalized costs | $ 0 | 12 | $ 27 |
| Operating Segments [Member] | Global Technology [Member] | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Impairment of capitalized costs | $ 12 | ||
| Financing Receivable [Member] | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Latest maturity date of varying installments of long-term notes receivable | May 31, 2031 | ||
| Financing Receivable [Member] | Minimum [Member] | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Long-term notes receivable interest rate (as a percent) | 3.00% | ||
| Financing Receivable [Member] | Maximum [Member] | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Long-term notes receivable interest rate (as a percent) | 11.80% | ||
Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Change in fair value of contingent consideration in connection with business acquisitions | $ (2) | $ 45 |
| Business Acquisition 2025 [Member] | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Change in fair value of contingent consideration in connection with business acquisitions | 9 | |
| Business Acquisition 2023 [Member] | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Change in fair value of contingent consideration in connection with business acquisitions | (11) | 38 |
| Business Acquisition 2022 [Member] | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Change in fair value of contingent consideration in connection with business acquisitions | 7 | |
| Estimate of Fair Value Measurement [Member] | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Fair value of debt (including bank credit lines) | $ 3,107 | $ 2,536 |
Fair Value Measurements (Components of Change in Fair Value of Contingent Consideration) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Fair Value Measurements [Abstract] | ||
| Balance, beginning of period | $ 30 | $ 6 |
| Increase in contingent consideration due to business acquisitions and acquisitions of noncontrolling interests in subsidiaries | 103 | 10 |
| Decrease in contingent consideration due to payments | (19) | (31) |
| Change in fair value of contingent consideration in connection with business acquisitions | (2) | 45 |
| Change in fair value of contingent consideration in connection with changes in ownership in consolidated subsidiaries | (15) | 0 |
| Balance, end of period | $ 97 | $ 30 |
Fair Value Measurements (Assets and Liabilities Measured and Recognized on a Recurring Basis) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|---|---|
| Attributable To Redeemable Noncontrolling Interests [Abstract] | ||||
| Redeemable noncontrolling interests | $ 895 | $ 806 | $ 864 | $ 576 |
| Estimate of Fair Value Measurement [Member] | ||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
| Fair value of debt | 3,107 | 2,536 | ||
| Fair Value, Measurements, Recurring [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Total assets | 3 | 17 | ||
| Liabilities [Abstract] | ||||
| Contingent consideration | 97 | 30 | ||
| Total liabilities | 122 | 42 | ||
| Attributable To Redeemable Noncontrolling Interests [Abstract] | ||||
| Redeemable noncontrolling interests | 895 | 806 | ||
| Fair Value, Measurements, Recurring [Member] | Fair Value Measurement [Domain] | Total Return Swap [Member] | ||||
| Assets [Abstract] | ||||
| Total return swaps | 1 | |||
| Liabilities [Abstract] | ||||
| Total return swaps | 3 | |||
| Fair Value, Measurements, Recurring [Member] | Derivative Contracts Designated as Hedges [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 1 | 10 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 23 | 5 | ||
| Fair Value, Measurements, Recurring [Member] | Derivative Contracts Undesignated [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 1 | 7 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 2 | 4 | ||
| Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Total assets | 0 | 0 | ||
| Liabilities [Abstract] | ||||
| Contingent consideration | 0 | 0 | ||
| Total liabilities | 0 | 0 | ||
| Attributable To Redeemable Noncontrolling Interests [Abstract] | ||||
| Redeemable noncontrolling interests | 0 | 0 | ||
| Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Fair Value Measurement [Domain] | Total Return Swap [Member] | ||||
| Assets [Abstract] | ||||
| Total return swaps | 0 | |||
| Liabilities [Abstract] | ||||
| Total return swaps | 0 | |||
| Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Derivative Contracts Designated as Hedges [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 0 | 0 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 0 | 0 | ||
| Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Derivative Contracts Undesignated [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 0 | 0 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 0 | 0 | ||
| Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Total assets | 3 | 17 | ||
| Liabilities [Abstract] | ||||
| Contingent consideration | 0 | 0 | ||
| Total liabilities | 25 | 12 | ||
| Attributable To Redeemable Noncontrolling Interests [Abstract] | ||||
| Redeemable noncontrolling interests | 0 | 0 | ||
| Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Fair Value Measurement [Domain] | Total Return Swap [Member] | ||||
| Assets [Abstract] | ||||
| Total return swaps | 1 | |||
| Liabilities [Abstract] | ||||
| Total return swaps | 3 | |||
| Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Derivative Contracts Designated as Hedges [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 1 | 10 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 23 | 5 | ||
| Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Derivative Contracts Undesignated [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 1 | 7 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 2 | 4 | ||
| Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Total assets | 0 | 0 | ||
| Liabilities [Abstract] | ||||
| Contingent consideration | 97 | 30 | ||
| Total liabilities | 97 | 30 | ||
| Attributable To Redeemable Noncontrolling Interests [Abstract] | ||||
| Redeemable noncontrolling interests | 895 | 806 | ||
| Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Fair Value Measurement [Domain] | Total Return Swap [Member] | ||||
| Assets [Abstract] | ||||
| Total return swaps | 0 | |||
| Liabilities [Abstract] | ||||
| Total return swaps | 0 | |||
| Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Derivative Contracts Designated as Hedges [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 0 | 0 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | 0 | 0 | ||
| Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Derivative Contracts Undesignated [Member] | Fair Value Measurement [Domain] | ||||
| Assets [Abstract] | ||||
| Derivative contracts - assets | 0 | 0 | ||
| Liabilities [Abstract] | ||||
| Derivative contracts - liabilities | $ 0 | $ 0 |
Concentrations of Risk (Details) |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Top customer concentration risk [Member] | Sales revenue, net [Member] | Any single customer [Member] | Maximum [Member] | |||
| Concentration Risk [Line Items] | |||
| Concentration risk percentage (as a percent) | 2.00% | 2.00% | 2.00% |
| Supplier concentration risk [Member] | Purchases [Member] | Top 10 Distribution and Value-Added Services Suppliers [Member] | |||
| Concentration Risk [Line Items] | |||
| Concentration risk percentage (as a percent) | 24.00% | 25.00% | |
| Supplier concentration risk [Member] | Purchases [Member] | Single Largest Supplier [Member] | |||
| Concentration Risk [Line Items] | |||
| Concentration risk percentage (as a percent) | 4.00% | 4.00% | |
Derivatives and Hedging Activities (Narrative) (Details) € in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
|
Dec. 27, 2025
USD ($)
|
Dec. 28, 2024
USD ($)
|
Dec. 30, 2023
USD ($)
|
Dec. 27, 2025
EUR (€)
|
Dec. 27, 2025
USD ($)
|
Nov. 16, 2023
EUR (€)
|
Mar. 20, 2020
USD ($)
|
|
| Derivative [Line Items] | |||||||
| Notional amount | $ 1,239,000,000 | $ 1,254,000,000 | |||||
| Term Credit Agreement [Member] | |||||||
| Derivative [Line Items] | |||||||
| Derivative fixed interest rate | 5.69% | 5.69% | |||||
| Derivative variable interest rate | 5.01% | 5.01% | |||||
| Debt face amount | $ 750,000,000 | ||||||
| Debt term | 3 years | ||||||
| Interest Rate Swaps [Member] | Term Credit Agreement [Member] | |||||||
| Derivative [Line Items] | |||||||
| Derivative fixed interest rate | 6.04% | ||||||
| Other Comprehensive Income [Member] | Interest Rate Swaps [Member] | Term Credit Agreement [Member] | |||||||
| Derivative [Line Items] | |||||||
| Gain (loss) on derivative | $ (3,000,000) | $ (3,000,000) | |||||
| Forward Contracts [Member] | Other Comprehensive Income [Member] | |||||||
| Derivative [Line Items] | |||||||
| Gain (loss) on derivative | (33,000,000) | 10,000,000 | $ (32,000,000) | ||||
| Total Return Swap [Member] | SERP and DCP [Member] | |||||||
| Derivative [Line Items] | |||||||
| Notional amount | 117,000,000 | $ 43,000,000 | |||||
| Gain (loss) on derivative | $ 11,000,000 | $ 8,000,000 | $ 10,000,000 | ||||
| Inception date | Mar. 20, 2020 | ||||||
| Total Return Swap [Member] | SERP and DCP [Member] | Interest Rate Swaps [Member] | |||||||
| Derivative [Line Items] | |||||||
| Notional amount | $ 675,000,000 | ||||||
| Total Return Swap [Member] | Secured Overnight Financing Rate Sofr Overnight Index Swap Rate [Member] | SERP and DCP [Member] | |||||||
| Derivative [Line Items] | |||||||
| Derivative fixed interest rate | 3.79% | 3.79% | |||||
| Derivative basis spread on variable rate | 75.00% | 75.00% | |||||
| Derivative variable interest rate | 4.54% | 4.54% | |||||
| Net Investment Hedging [Member] | Foreign Exchange Forward [Member] | |||||||
| Derivative [Line Items] | |||||||
| Maturity date | Nov. 03, 2028 | Nov. 03, 2028 | |||||
| Notional amount | $ 336,000,000 | $ 365,000,000 | |||||
| Net Investment Hedging [Member] | Forward Contracts I [Member] | |||||||
| Derivative [Line Items] | |||||||
| Maturity date | Nov. 16, 2023 | ||||||
| Notional amount | € | € 200 | ||||||
| Net Investment Hedging [Member] | Forward Contracts II [Member] | |||||||
| Derivative [Line Items] | |||||||
| Maturity date | Nov. 03, 2028 | ||||||
| Notional amount | € | € 300 | ||||||
Derivatives and Hedging Activities (Summary of Terms and Fair Value of Derivative Instruments) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Derivatives Fair Value [Line Items] | ||
| Notional Amount | $ 1,254 | $ 1,239 |
| Fair Value | (21) | 3 |
| Cash Flow Hedging [Member] | Foreign Currency Forward [Member] | ||
| Derivatives Fair Value [Line Items] | ||
| Notional Amount | 98 | 84 |
| Fair Value | $ 0 | $ 0 |
| Maturity Date | Dec. 24, 2026 | Oct. 30, 2025 |
| Cash Flow Hedging [Member] | Interest Rate Swaps [Member] | ||
| Derivatives Fair Value [Line Items] | ||
| Notional Amount | $ 675 | $ 713 |
| Fair Value | $ (3) | $ (3) |
| Maturity Date | Jul. 13, 2026 | Jul. 13, 2026 |
| Net Investment Hedging [Member] | Foreign Currency Forward [Member] | ||
| Derivatives Fair Value [Line Items] | ||
| Notional Amount | $ 365 | $ 336 |
| Fair Value | $ (19) | $ 9 |
| Maturity Date | Nov. 03, 2028 | Nov. 03, 2028 |
| Undesignated Hedging [Member] | Total Return Swap [Member] | ||
| Derivatives Fair Value [Line Items] | ||
| Notional Amount | $ 116 | $ 106 |
| Fair Value | $ 1 | $ (3) |
| Maturity Date | Dec. 30, 2025 | Dec. 30, 2024 |
Derivatives and Hedging Activities (Summary of Effect of Cash Flow and Net Investment Hedges on Statements of Income) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Derivative Instruments And Hedging Activities Disclosures [Line Items] | |||
| Unrealized gain (loss) from hedging activities | $ (24) | $ 13 | $ (18) |
| Cash Flow Hedging [Member] | Foreign Currency Forward [Member] | |||
| Derivative Instruments And Hedging Activities Disclosures [Line Items] | |||
| Unrealized gain (loss) from hedging activities | 0 | 0 | (1) |
| Cash Flow Hedging [Member] | Interest Rate Swaps [Member] | |||
| Derivative Instruments And Hedging Activities Disclosures [Line Items] | |||
| Unrealized gain (loss) from hedging activities | 0 | 6 | (7) |
| Net Investment Hedging [Member] | Foreign Currency Forward [Member] | |||
| Derivative Instruments And Hedging Activities Disclosures [Line Items] | |||
| Unrealized gain (loss) from hedging activities | $ (24) | $ 7 | $ (10) |
Debt (Revolving Credit Agreement - Narrative) (Details) - Revolving Credit Facility [Member] - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Aug. 20, 2021 |
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Line of Credit Facility [Line Items] | |||
| Line of credit initiation date | Aug. 20, 2021 | Jul. 11, 2023 | |
| Credit facility borrowing capacity | $ 1,000,000,000.0 | ||
| Credit facility expiration date | Jul. 11, 2028 | ||
| Line of credit interest rate | 3.78% | 4.45% | |
| Debt instrument, basis spread on variable rate | 1.08% | 1.18% | |
| Debt Instrument Variable Interest Rate Type Extensible Enumeration | Secured Overnight Financing Rate Sofr [Member] | Secured Overnight Financing Rate Sofr [Member] | |
| Line of credit combined interest rate | 4.86% | 5.63% | |
| Borrowings | $ 100,000,000 | $ 0 | |
| Average outstanding balance under line of credit | 203,000,000 | ||
| Outstanding letters of credit provided to third parties | $ 10,000,000 | $ 11,000,000 | |
Debt (Other Short-Term Bank Credit Lines - Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Line of Credit Facility [Line Items] | ||
| Bank credit lines | $ 764 | $ 650 |
| Other Short-Term Credit Lines [Member] | ||
| Line of Credit Facility [Line Items] | ||
| Credit facility borrowing capacity | 787 | 790 |
| Bank credit lines | 664 | $ 650 |
| Average outstanding balance under line of credit | $ 680 | |
| Weighted average interest rate on borrowings under credit lines at period end | 4.68% | 5.35% |
Debt (Private Placement Facilities - Narrative) (Details) - Private Placement Facilities [Member] |
12 Months Ended | |
|---|---|---|
|
Dec. 27, 2025
USD ($)
number
|
Dec. 28, 2024 |
|
| Debt Instrument [Line Items] | ||
| Number of companies included in private placement facilities | number | 4 | |
| Debt instrument maximum borrowing capacity | $ | $ 1,500,000,000 | |
| Debt instrument, maturity date | Dec. 19, 2028 | |
| Average term of issuances under private placement facilities | 12 years | |
| Weighted average interest rate at period end | 3.93% | 3.70% |
| Minimum [Member] | ||
| Debt Instrument [Line Items] | ||
| Term of issuances under private placement facilities | 5 years | |
| Maximum [Member] | ||
| Debt Instrument [Line Items] | ||
| Term of issuances under private placement facilities | 15 years |
Debt (Term Loan - Narrative) (Details) - USD ($) |
5 Months Ended | 7 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Jun. 05, 2025 |
Dec. 27, 2025 |
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Term Credit Agreement [Member] | ||||
| Line of Credit Facility [Line Items] | ||||
| Debt term | 3 years | |||
| Debt face amount | $ 750,000,000 | $ 750,000,000 | ||
| Debt instrument, maturity date | Jul. 11, 2026 | Jun. 06, 2030 | ||
| Long-term debt | $ 749,000,000 | $ 749,000,000 | $ 712,000,000 | |
| Debt instrument, interest rate, stated percentage | 3.76% | 3.76% | 4.45% | |
| Debt instrument, basis spread on variable rate | 1.25% | 1.60% | ||
| Debt Instrument Variable Interest Rate Type Extensible Enumeration | Secured Overnight Financing Rate Sofr Overnight Index Swap Rate [Member] | Secured Overnight Financing Rate Sofr Overnight Index Swap Rate [Member] | ||
| Debt instrument, interest rate at period end | 5.01% | 5.01% | 6.05% | |
| Percentage of the notional amount hedged | 90.00% | 90.00% | ||
| Derivative fixed interest rate | 5.69% | 5.69% | ||
| Derivative variable interest rate | 5.01% | 5.01% | ||
| Derivative weighted average interest rate | 5.62% | 5.62% | ||
| Term Credit Agreement [Member] | Interest Rate Swaps [Member] | ||||
| Line of Credit Facility [Line Items] | ||||
| Derivative fixed interest rate | 6.04% | |||
| June 2026 through June 2027 [Member] | ||||
| Line of Credit Facility [Line Items] | ||||
| Quarterly payments | $ 5,000,000 | |||
| September 2027 through June 2030 [Member] | ||||
| Line of Credit Facility [Line Items] | ||||
| Quarterly payments | $ 9,000,000 | |||
Debt (U.S. Trade Accounts Receivable Securitization - Narrative) (Details) - U.S. Trade Accounts Receivable Securitization [Member] |
12 Months Ended | |
|---|---|---|
|
Dec. 27, 2025
USD ($)
number
|
Dec. 28, 2024
USD ($)
|
|
| Debt Instrument [Line Items] | ||
| Pricing commitment period | 3 years | |
| Debt instrument, maturity date | Dec. 06, 2027 | Dec. 15, 2025 |
| Debt instrument maximum borrowing capacity | $ 450,000,000 | |
| Number of banks as agents for debt instrument | number | 2 | |
| Long-term debt | $ 390,000,000 | $ 150,000,000 |
| Debt instrument, interest rate, stated percentage | 4.06% | 4.73% |
| Debt instrument, basis spread on variable rate | 0.75% | 0.75% |
| Debt Instrument Variable Interest Rate Type Extensible Enumeration | ||
| Debt instrument, variable rate basis at period end | 4.81% | 5.48% |
| Minimum [Member] | ||
| Debt Instrument [Line Items] | ||
| Commitment fee basis points depending upon program utilization | 0.0030 | |
| Maximum [Member] | ||
| Debt Instrument [Line Items] | ||
| Commitment fee basis points depending upon program utilization | 0.0035 | |
Debt (Bank Credit Lines) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Line of Credit Facility [Line Items] | ||
| Bank credit lines | $ 764 | $ 650 |
| Revolving Credit Facility [Member] | ||
| Line of Credit Facility [Line Items] | ||
| Bank credit lines | 100 | 0 |
| Other Short-Term Credit Lines [Member] | ||
| Line of Credit Facility [Line Items] | ||
| Bank credit lines | $ 664 | $ 650 |
Debt (Schedule of Long-term Debt) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
||
|---|---|---|---|---|
| Debt Instrument [Line Items] | ||||
| Finance lease obligations | $ 7 | $ 6 | ||
| Total Long-term debt | 2,343 | 1,886 | ||
| Less current maturities | (33) | (56) | ||
| Total long-term debt | [1] | 2,310 | 1,830 | |
| Term Credit Agreement [Member] | ||||
| Debt Instrument [Line Items] | ||||
| Long-term debt | $ 749 | $ 712 | ||
| Borrowing Rate | 3.76% | 4.45% | ||
| Private Placement Facilities [Member] | ||||
| Debt Instrument [Line Items] | ||||
| Long-term debt | $ 1,149 | $ 975 | ||
| U.S. Trade Accounts Receivable Securitization [Member] | ||||
| Debt Instrument [Line Items] | ||||
| Long-term debt | $ 390 | $ 150 | ||
| Borrowing Rate | 4.06% | 4.73% | ||
| Various Collateralized and Uncollateralized Long-Term Loans Payable with Interest, in Varying Installments [Member] | ||||
| Debt Instrument [Line Items] | ||||
| Long-term debt | $ 48 | $ 43 | ||
| Various Collateralized and Uncollateralized Long-Term Loans Payable with Interest, in Varying Installments [Member] | Minimum [Member] | ||||
| Debt Instrument [Line Items] | ||||
| Borrowing Rate | 0.00% | 0.00% | ||
| Various Collateralized and Uncollateralized Long-Term Loans Payable with Interest, in Varying Installments [Member] | Maximum [Member] | ||||
| Debt Instrument [Line Items] | ||||
| Borrowing Rate | 6.75% | 9.42% | ||
| ||||
Debt (Schedule of Long-Term Debt Maturities) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Maturities of Long-term Debt [Abstract] | ||
| 2026 | $ 33 | |
| 2027 | 534 | |
| 2028 | 221 | |
| 2029 | 143 | |
| 2030 | 810 | |
| Thereafter | 602 | |
| Total Long-term debt | $ 2,343 | $ 1,886 |
Debt (Schedule of Private Placement Facilities) (Details) - Private Placement Facilities [Member] - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
|
| Debt Instrument [Line Items] | ||
| Less: Deferred debt issuance costs | $ (1) | |
| Total Long-term debt | $ 1,149 | $ 975 |
| Due Date | Dec. 19, 2028 | |
| Private Placement Facilities June 16, 2017 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Jun. 16, 2017 | Jun. 16, 2017 |
| Amount of borrowing outstanding | $ 100 | $ 100 |
| Borrowing Rate | 3.42% | 3.42% |
| Due Date | Jun. 16, 2027 | Jun. 16, 2027 |
| Private Placement Facilities September 15, 2017 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Sep. 15, 2017 | Sep. 15, 2017 |
| Amount of borrowing outstanding | $ 100 | $ 100 |
| Borrowing Rate | 3.52% | 3.52% |
| Due Date | Sep. 15, 2029 | Sep. 15, 2029 |
| Private Placement Facilities January 2, 2018 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Jan. 02, 2018 | Jan. 02, 2018 |
| Amount of borrowing outstanding | $ 100 | $ 100 |
| Borrowing Rate | 3.32% | 3.32% |
| Due Date | Jan. 02, 2028 | Jan. 02, 2028 |
| Private Placement Facilities September 2, 2020 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Sep. 02, 2020 | Sep. 02, 2020 |
| Amount of borrowing outstanding | $ 100 | $ 100 |
| Borrowing Rate | 2.35% | 2.35% |
| Due Date | Sep. 02, 2030 | Sep. 02, 2030 |
| Private Placement Facilities June 2, 2021 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Jun. 02, 2021 | Jun. 02, 2021 |
| Amount of borrowing outstanding | $ 100 | $ 100 |
| Borrowing Rate | 2.48% | 2.48% |
| Due Date | Jun. 02, 2031 | Jun. 02, 2031 |
| Private Placement Facilities June 2, 2021 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Jun. 02, 2021 | Jun. 02, 2021 |
| Amount of borrowing outstanding | $ 100 | $ 100 |
| Borrowing Rate | 2.58% | 2.58% |
| Due Date | Jun. 02, 2033 | Jun. 02, 2033 |
| Private Placement Facilities May 4, 2023 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | May 04, 2023 | May 04, 2023 |
| Amount of borrowing outstanding | $ 75 | $ 75 |
| Borrowing Rate | 4.79% | 4.79% |
| Due Date | May 04, 2028 | May 04, 2028 |
| Private Placement Facilities May 4, 2023 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | May 04, 2023 | May 04, 2023 |
| Amount of borrowing outstanding | $ 75 | $ 75 |
| Borrowing Rate | 4.84% | 4.84% |
| Due Date | May 04, 2030 | May 04, 2030 |
| Private Placement Facilities May 4, 2023 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | May 04, 2023 | May 04, 2023 |
| Amount of borrowing outstanding | $ 75 | $ 75 |
| Borrowing Rate | 4.96% | 4.96% |
| Due Date | May 04, 2033 | May 04, 2033 |
| Private Placement Facilities May 4, 2023 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | May 04, 2023 | May 04, 2023 |
| Amount of borrowing outstanding | $ 150 | $ 150 |
| Borrowing Rate | 4.94% | 4.94% |
| Due Date | May 04, 2033 | May 04, 2033 |
| Private Placement Facilities December 15, 2025 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Dec. 15, 2025 | |
| Amount of borrowing outstanding | $ 100 | |
| Borrowing Rate | 5.23% | |
| Due Date | Dec. 15, 2032 | |
| Private Placement Facilities December 15, 2025 [Member] | ||
| Debt Instrument [Line Items] | ||
| Date of borrowing | Dec. 15, 2025 | |
| Amount of borrowing outstanding | $ 75 | |
| Borrowing Rate | 5.28% | |
| Due Date | Dec. 15, 2032 | |
Income Taxes (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
Dec. 31, 2022 |
|
| Income Tax Examination [Line Items] | ||||
| Effective tax rate (as a percent) | 23.70% | 24.90% | 22.10% | |
| Corporate tax rate | 21.00% | |||
| Unrecognized tax benefits | $ 90 | $ 89 | $ 98 | $ 82 |
| Amount of tax interest expense included as a component of the provision for taxes | 4 | 2 | $ 4 | |
| Other Liabilities [Member] | ||||
| Income Tax Examination [Line Items] | ||||
| Unrecognized tax benefits including accrued interest | 112 | 108 | ||
| Unrecognized tax benefits that would affect the effective tax rate if recognized | 104 | 100 | ||
| Interest accrued | 22 | $ 18 | ||
| Federal Tax Authority [Member] | ||||
| Income Tax Examination [Line Items] | ||||
| Operating loss carryforwards | 86 | |||
| Net operating loss carryforwards not subject to expiration | 86 | |||
| State and Local Jurisdiction [Member] | ||||
| Income Tax Examination [Line Items] | ||||
| Operating loss carryforwards | 62 | |||
| Net operating loss carryforwards not subject to expiration | 21 | |||
| Foreign Tax Authority [Member] | ||||
| Income Tax Examination [Line Items] | ||||
| Operating loss carryforwards | 366 | |||
| Net operating loss carryforwards not subject to expiration | $ 358 | |||
Income Taxes (Income Before Taxes and Equity in Earnings of Affiliates) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Income before equity method investments, income taxes and loss on sale of equity investment [Abstract] | |||
| Domestic | $ 384 | $ 338 | $ 424 |
| Foreign | 149 | 175 | 118 |
| Income before taxes, equity in earnings of affiliates and noncontrolling interests | $ 533 | $ 513 | $ 542 |
Income Taxes (Provision for Income Taxes Attributable to Continuing Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Current income tax expense: | |||
| U.S. Federal | $ 42 | $ 100 | $ 72 |
| State and local | 15 | 33 | 28 |
| Foreign | 64 | 56 | 40 |
| Total current | 121 | 189 | 140 |
| Deferred income tax expense (benefit): | |||
| U.S. Federal | 33 | (29) | 9 |
| State and local | 3 | (12) | (3) |
| Foreign | (31) | (20) | (26) |
| Total deferred | 5 | (61) | (20) |
| Total income tax provision | $ 126 | $ 128 | $ 120 |
Income Taxes (Tax Effects of Temporary Differences to Deferred Income Tax Asset (Liability)) (Details) - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Deferred income tax asset: | ||
| Net operating losses | $ 105 | $ 91 |
| Other carryforwards | 52 | 37 |
| Inventory, premium coupon redemptions and accounts receivable valuation allowances | 38 | 37 |
| Operating lease liability | 75 | 76 |
| Capitalization of research and Development costs | 10 | 27 |
| Other asset | 62 | 49 |
| Total deferred income tax asset | 342 | 317 |
| Valuation allowance for deferred tax assets | (53) | (38) |
| Net deferred income tax asset | 289 | 279 |
| Deferred income tax liability | ||
| Intangibles amortization | (266) | (260) |
| Operating lease right-of-use asset | (70) | (67) |
| Property and equipment | (7) | (7) |
| Total deferred tax liability | (343) | (334) |
| Net deferred income tax asset (liability) | $ (54) | $ (55) |
Income Taxes (Reconciliation of Income Tax Provision at Federal Statutory Rate to Total Income Tax Provision) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||
| Income tax provision at federal statutory rate | $ 112 | $ 108 | $ 114 |
| State income tax provision, net of federal income tax effect | 10 | 11 | 15 |
| Foreign tax provisions | 10 | 5 | |
| Pass through noncontrolling interest | 1 | (8) | |
| Effects of changes in tax laws or rate enacted in current period | 0 | ||
| Cross border tax laws | 1 | 12 | 7 |
| Tax credits | (2) | ||
| Changes in valuation allowance | 3 | 6 | (3) |
| Nontaxable and nondeductible items | 3 | ||
| Worldwide changes in unrecognized tax benefits | 4 | ||
| Previously held non-controlling equity investment | (9) | ||
| Unrecognized tax benefits and audit settlements | 5 | 9 | |
| Interest expense related to loans | (14) | (13) | |
| Other | (10) | (11) | (6) |
| Total income tax provision | $ 126 | $ 128 | $ 120 |
| Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract] | |||
| Income tax provision at federal statutory rate (as a percent) | 21.00% | ||
| State income tax provision, net of federal income tax effect (as a percent) | 2.00% | ||
| Effects of changes in tax laws or rate enacted in current period (as a percent) | 0.00% | ||
| Cross border tax laws (as a percent) | 0.10% | ||
| Tax credits (as a percent) | (0.40%) | ||
| Changes in valuation allowance (as a percent) | 0.60% | ||
| Nontaxable and nondeductible items (as a percent) | 0.50% | ||
| Worldwide changes in unrecognized tax benefits (as a percent) | 0.70% | ||
| Previously held non-controlling equity investment (as a percent) | (1.70%) | ||
| Other (as a percent) | (1.80%) | ||
| Effective tax rate (as a percent) | 23.70% | 24.90% | 22.10% |
| Cayman Islands Tax Information Authority [Member] | |||
| Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||
| Foreign partnership loss | $ 8 | ||
| Other | $ (1) | ||
| Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract] | |||
| Foreign partnership loss (as a percent) | 1.50% | ||
| Other (as a percent) | (0.10%) | ||
| Foreign Tax Jurisdiction, Other [Member] | |||
| Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||
| Equity investment remeasurement gain | $ (6) | ||
| Notional interest deductioin | (6) | ||
| Other | $ 19 | ||
| Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract] | |||
| Equity investment remeasurement gain (as a percent) | (1.10%) | ||
| Notional interest deduction (as a percent) | (1.10%) | ||
| Other (as a percent) | 3.50% | ||
Income Taxes (Reconciliation of Unrecognized Tax Benefits Excluding the Effect of Deferred Taxes) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
| Balance, beginning of period | $ 89 | $ 98 | $ 82 |
| Additions based on current year tax positions | 5 | 5 | 9 |
| Additions based on prior year tax positions | 5 | 10 | 26 |
| Reductions based on prior year tax positions | (2) | (14) | (2) |
| Reductions resulting from settlements with taxing authorities | 0 | 0 | (3) |
| Reductions resulting from lapse in statutes of limitations | (7) | (10) | (14) |
| Balance, end of period | $ 90 | $ 89 | $ 98 |
Plans of Restructuring and Related Costs (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 105 | $ 110 | |
| Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration | Selling, General and Administrative Expense | Selling, General and Administrative Expense | |
| Impairment charge on intangible assets | $ 16 | $ 0 | $ 7 |
| Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Impairment charge on intangible assets | 0 | 14 | 12 |
| 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 105 | 73 | |
| 2024 Plan [Member] | Global Distribution and Value-Added Services [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 1 | ||
| 2024 Plan [Member] | Global Specialty Products [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 12 | ||
| Goodwill and intangible asset imapirment | 13 | ||
| 2024 Plan [Member] | Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 8 | 15 | |
| 2022 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 0 | 37 | 80 |
| 2022 Plan [Member] | Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 0 | 13 | |
| 2022 Plan [Member] | Disposal of a Business [Member] | Global Specialty Products [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Impairment charge on intangible assets | $ 12 | ||
Plans of Restructuring and Related Costs (Schedule of Restructuring Costs) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 105 | $ 110 | |
| Total | $ 105 | $ 110 | $ 80 |
| Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration | Selling, General and Administrative Expense | Selling, General and Administrative Expense | |
| 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 105 | $ 73 | |
| 2024 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 86 | 44 | |
| 2024 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 2 | 12 | |
| 2024 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 9 | 2 | |
| 2024 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 8 | 15 | |
| 2022 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 37 | 80 |
| 2022 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 24 | 46 | |
| 2022 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 15 | ||
| 2022 Plan [Member] | Accelerated Depreciation and Amortization [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 7 | ||
| 2022 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 6 | 6 | |
| 2022 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 13 | |
| Global Distribution and Value-Added Services [Member] | 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 1 | ||
| Global Specialty Products [Member] | 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 12 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 68 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 43 | 38 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2024 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 40 | 31 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2024 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | (3) | 5 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2024 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 5 | 2 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2024 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 1 | 0 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2022 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 30 | 45 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2022 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 18 | 29 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2022 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 13 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2022 Plan [Member] | Accelerated Depreciation and Amortization [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 10 | ||
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2022 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 2 | 3 | |
| Operating Segments [Member] | Global Distribution and Value-Added Services [Member] | 2022 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 0 | |
| Operating Segments [Member] | Global Specialty Products [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 30 | ||
| Operating Segments [Member] | Global Specialty Products [Member] | 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 44 | 23 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2024 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 22 | 5 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2024 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 6 | 3 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2024 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 4 | 0 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2024 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 12 | 15 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2022 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 7 | 19 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2022 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 5 | 5 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2022 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | ||
| Operating Segments [Member] | Global Specialty Products [Member] | 2022 Plan [Member] | Accelerated Depreciation and Amortization [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | ||
| Operating Segments [Member] | Global Specialty Products [Member] | 2022 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 2 | 1 | |
| Operating Segments [Member] | Global Specialty Products [Member] | 2022 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 13 | |
| Operating Segments [Member] | Global Technology [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 11 | ||
| Operating Segments [Member] | Global Technology [Member] | 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | (2) | 10 | |
| Operating Segments [Member] | Global Technology [Member] | 2024 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 4 | 6 | |
| Operating Segments [Member] | Global Technology [Member] | 2024 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | (1) | 4 | |
| Operating Segments [Member] | Global Technology [Member] | 2024 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 0 | |
| Operating Segments [Member] | Global Technology [Member] | 2024 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | (5) | 0 | |
| Operating Segments [Member] | Global Technology [Member] | 2022 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 1 | 7 | |
| Operating Segments [Member] | Global Technology [Member] | 2022 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 1 | 5 | |
| Operating Segments [Member] | Global Technology [Member] | 2022 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 2 | ||
| Operating Segments [Member] | Global Technology [Member] | 2022 Plan [Member] | Accelerated Depreciation and Amortization [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | ||
| Operating Segments [Member] | Global Technology [Member] | 2022 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 0 | |
| Operating Segments [Member] | Global Technology [Member] | 2022 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 0 | |
| Corporate Nonsegment [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 1 | ||
| Corporate Nonsegment [Member] | 2024 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 20 | 2 | |
| Corporate Nonsegment [Member] | 2024 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 20 | 2 | |
| Corporate Nonsegment [Member] | 2024 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 0 | |
| Corporate Nonsegment [Member] | 2024 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 0 | |
| Corporate Nonsegment [Member] | 2024 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 0 | 0 | |
| Corporate Nonsegment [Member] | 2022 Plan [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | (1) | 9 | |
| Corporate Nonsegment [Member] | 2022 Plan [Member] | Severance and Employee Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | 7 | |
| Corporate Nonsegment [Member] | 2022 Plan [Member] | Impairment and Accelerated Depreciation and Amortization of Right-of-Use Lease Assets and Other Long Long-Lived Assets [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 0 | ||
| Corporate Nonsegment [Member] | 2022 Plan [Member] | Accelerated Depreciation and Amortization [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | (3) | ||
| Corporate Nonsegment [Member] | 2022 Plan [Member] | Exit and Other Related Costs [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | 2 | 2 | |
| Corporate Nonsegment [Member] | 2022 Plan [Member] | Loss on Disposal of a Business [Member] | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring and related costs | $ 0 | $ 0 | |
Plans of Restructuring and Related Costs (Schedule of Restructuring Reserve Activity) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Restructuring Reserve [Roll Forward] | |||
| Balance, beginning | $ 40 | $ 23 | |
| Restructuring and related costs | 105 | 110 | |
| Non-cash asset impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets | (2) | (19) | |
| Non-cash impairment on disposal of a business | (6) | (13) | |
| Cash payments and other adjustments | (88) | (61) | |
| Balance, ending | $ 49 | $ 40 | $ 23 |
| Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration | Selling, General and Administrative Expense | Selling, General and Administrative Expense | |
| 2022 Plan [Member] | |||
| Restructuring Reserve [Roll Forward] | |||
| Balance, beginning | $ 12 | $ 23 | |
| Restructuring and related costs | 0 | 37 | 80 |
| Non-cash asset impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets | 0 | (7) | |
| Non-cash impairment on disposal of a business | 0 | 0 | |
| Cash payments and other adjustments | (11) | (41) | |
| Balance, ending | 1 | 12 | 23 |
| 2024 Plan [Member] | |||
| Restructuring Reserve [Roll Forward] | |||
| Balance, beginning | 28 | 0 | |
| Restructuring and related costs | 105 | 73 | |
| Non-cash asset impairment and accelerated depreciation and amortization of right-of-use lease assets and other long-lived assets | (2) | (12) | |
| Non-cash impairment on disposal of a business | (6) | (13) | |
| Cash payments and other adjustments | (77) | (20) | |
| Balance, ending | $ 48 | $ 28 | $ 0 |
Commitments and Contingencies (Other Commitments - Narrative) (Details) |
12 Months Ended |
|---|---|
|
Dec. 27, 2025
USD ($)
| |
| Employment, consulting and non-compete agreements [Member] | |
| Other Commitment, Fiscal Year Maturity [Abstract] | |
| 2026 | $ 13,000,000 |
| 2027 | 3,000,000 |
| 2028 | 0 |
| 2029 | 0 |
| 2030 | 0 |
| Thereafter | 0 |
| Life-time consulting agreement [Member] | |
| Other Commitment, Fiscal Year Maturity [Abstract] | |
| Current compensation paid under lifetime consulting agreement | $ 400,000 |
Commitments and Contingencies (Litigation - Narrative) (Details) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 27, 2025
USD ($)
|
Dec. 28, 2024
USD ($)
|
Dec. 30, 2023
USD ($)
|
|
| Loss Contingency, Information about Litigation Matters [Abstract] | |||
| Revenue from Contract with Customer, Excluding Assessed Tax | $ 13,184 | $ 12,673 | $ 12,339 |
| Maximum [Member] | |||
| Loss Contingency, Information about Litigation Matters [Abstract] | |||
| Number of pending claims | 10 | ||
| Actions consolidated in the MultiDistrict Litigation [Member] | Maximum [Member] | |||
| Loss Contingency, Information about Litigation Matters [Abstract] | |||
| Maximum sales of opioids in North America during the year, percentage | 0.40% | ||
| Actions consolidated in the MultiDistrict Litigation [Member] | Continuing Operations [Member] | |||
| Loss Contingency, Information about Litigation Matters [Abstract] | |||
| Revenue from Contract with Customer, Excluding Assessed Tax | $ 13,200 | ||
Commitments and Contingencies (Purchase Commitments) (Details) $ in Millions |
Dec. 27, 2025
USD ($)
|
|---|---|
| Unrecorded Unconditional Purchase Obligation [Abstract] | |
| 2026 | $ 8 |
| 2027 | 1 |
| 2028 | 0 |
| 2029 | 0 |
| 2030 | 0 |
| Thereafter | 0 |
| Total minimum inventory purchase commitment payments | $ 9 |
Stock Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Pre-tax share-based compensation expense | $ 39 | $ 39 | $ 39 |
| Total unrecognized compensation cost related to non-vested awards | $ 63 | ||
| Weighted-average period of recognition for unrecognized compensation costs on nonvested awards (in years) | 2 years 6 months | ||
| Options granted in period | 0 | ||
| Restricted Stock/Units [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Weighted-average grant date fair value of stock-based awards granted before forfeitures (in dollars per share) | $ 75.78 | $ 75.12 | $ 76.43 |
| Time-Based Restricted Stock/Units [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Weighted-average grant date fair value of stock-based awards granted before forfeitures (in dollars per share) | $ 75.18 | ||
| Fair value of awards that vested | $ 38 | $ 21 | $ 27 |
| Time-Based Restricted Stock/Units [Member] | Chief Executive Officer [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 4 years | ||
| Awards issued, allocation percentage | 35.00% | ||
| Time-Based Restricted Stock/Units [Member] | Executive Management Committee [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 4 years | ||
| Awards issued, allocation percentage | 50.00% | ||
| Time-Based Restricted Stock/Units [Member] | Vice President [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Awards issued, allocation percentage | 80.00% | ||
| Time-Based Restricted Stock/Units [Member] | Share Based Compensation Award Tranche One [Member] | Vice President [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Vesting percentage | 50.00% | ||
| Time-Based Restricted Stock/Units [Member] | Share Based Compensation Award Tranche One [Member] | Director [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Vesting percentage | 50.00% | ||
| Time-Based Restricted Stock/Units [Member] | Share Based Compensation Award Tranche Two [Member] | Vice President [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Vesting percentage | 50.00% | ||
| Time-Based Restricted Stock/Units [Member] | Share Based Compensation Award Tranche Two [Member] | Director [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Vesting percentage | 50.00% | ||
| Performance-Based Restricted Stock/Units [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Weighted-average grant date fair value of stock-based awards granted before forfeitures (in dollars per share) | $ 75.30 | ||
| Fair value of awards that vested | $ 1 | $ 1 | $ 38 |
| Performance-Based Restricted Stock/Units [Member] | Chief Executive Officer [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 3 years | ||
| Awards issued, allocation percentage | 65.00% | ||
| Performance-Based Restricted Stock/Units [Member] | Executive Management Committee [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 3 years | ||
| Awards issued, allocation percentage | 50.00% | ||
| Performance-Based Restricted Stock/Units [Member] | Vice President [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 3 years | ||
| Awards issued, allocation percentage | 20.00% | ||
| Stock Options [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 3 years | ||
| Expiration period (in years) | 10 years | ||
| 2020 Stock Incentive Plan [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Shares authorized to be granted (in shares) | 75,742,657 | ||
| Shares available to be granted (in shares) | 9,081,164 | ||
| Non-Employee Director Stock Incentive Plan [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Shares authorized to be granted (in shares) | 2,075,000 | ||
| Shares available to be granted (in shares) | 324,753 | ||
| Non-Employee Director Stock Incentive Plan [Member] | Time-Based Restricted Stock/Units [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Number of years for full vesting (in years) | 12 months | ||
Stock Based Compensation (Summary of Stock Option Activity Under the Plans) (Details) $ / shares in Units, $ in Millions |
12 Months Ended |
|---|---|
|
Dec. 27, 2025
USD ($)
$ / shares
shares
| |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | |
| Outstanding at beginning of year (in shares) | shares | 963,491 |
| Granted (in shares) | shares | 0 |
| Exercised (in shares) | shares | (24,945) |
| Forfeited (in shares) | shares | (15,831) |
| Outstanding at end of year (in shares) | shares | 922,715 |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | |
| Outstanding at beginning of year (in dollars per share) | $ / shares | $ 72.16 |
| Granted (in dollars per share) | $ / shares | 0 |
| Exercised (in dollars per share) | $ / shares | 62.71 |
| Forfeited (in dollars per share) | $ / shares | 81.75 |
| Outstanding at end of year (in dollars per share) | $ / shares | $ 72.26 |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | |
| Options exercisable at end of year (in shares) | shares | 922,715 |
| Options exercisable at end of year (in dollars per share) | $ / shares | $ 72.26 |
| Outstanding at end of year, Weighted Average Remaining Contractual Life in Years | 5 years 7 months 6 days |
| Outstanding at end of year, Aggregate Intrinsic Value | $ | $ 7 |
| Options exercisable at end of year, Weighted Average Remaining Contractual Life in Years | 5 years 7 months 6 days |
| Options exercisable at end of year, Aggregate Intrinsic Value | $ | $ 7 |
Stock Based Compensation (Status of Non-Vested Restricted Shares/Units) (Details) |
12 Months Ended |
|---|---|
|
Dec. 27, 2025
$ / shares
shares
| |
| Time-Based Restricted Stock/Units [Member] | |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
| Beginning balance outstanding (in shares) | shares | 1,685,550 |
| Granted (in shares) | shares | 592,716 |
| Vested (in shares) | shares | (564,037) |
| Forfeited (in shares) | shares | (107,687) |
| Ending balance outstanding (in shares) | shares | 1,606,542 |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | |
| Beginning balance outstanding (in dollars per share) | $ / shares | $ 72.90 |
| Granted (in dollars per share) | $ / shares | 75.18 |
| Vested (in dollars per share) | $ / shares | 66.54 |
| Forfeited (in dollars per share) | $ / shares | 77.10 |
| Ending balance outstanding (in dollars per share) | $ / shares | $ 75.69 |
| Performance-Based Restricted Stock/Units [Member] | |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
| Beginning balance outstanding (in shares) | shares | 389,111 |
| Granted (in shares) | shares | 251,287 |
| Performance adjustment (in shares) | shares | 31,313 |
| Vested (in shares) | shares | (14,499) |
| Forfeited (in shares) | shares | (206,626) |
| Ending balance outstanding (in shares) | shares | 387,960 |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | |
| Beginning balance outstanding (in dollars per share) | $ / shares | $ 75.98 |
| Granted (in dollars per share) | $ / shares | 75.30 |
| Performance adjustment (in dollars per share) | $ / shares | 76.20 |
| Vested (in dollars per share) | $ / shares | 84.04 |
| Forfeited (in dollars per share) | $ / shares | 77.33 |
| Ending balance outstanding (in dollars per share) | $ / shares | $ 75.89 |
Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Defined Contribution Plan Disclosure [Line Items] | |||
| Accumulated benefit obligations | $ 142 | $ 125 | |
| Funded Plan [Member] | |||
| Defined Contribution Plan Disclosure [Line Items] | |||
| Status of plan | 8 | 8 | |
| Management [Member] | Deferred compensation bonus and commission plan [Member] | |||
| Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] | |||
| Deferred compensation plan fair market value amount charged (credited) to operations | $ 12 | 12 | $ 12 |
| Qualified 401K plan [Member] | |||
| Defined Contribution Plan Disclosure [Line Items] | |||
| Maximum matching contributions as a percentage of participants' contributions (as a percent) | 100.00% | ||
| Maximum participants' contributions as a percentage of their base compensation (as a percent) | 5.00% | ||
| Allowable maximum percentage of contributions allocated to Henry Schein Stock Fund (as a percent) | 20.00% | ||
| Amounts charged (credited) to operations | $ 42 | 48 | 50 |
| Qualified 401K plan [Member] | Selling General And Administrative Expenses [Member] | |||
| Defined Contribution Plan Disclosure [Line Items] | |||
| Amounts charged (credited) to operations | 36 | 40 | 42 |
| Qualified 401K plan [Member] | Cost of Goods Sold [Member] | |||
| Defined Contribution Plan Disclosure [Line Items] | |||
| Amounts charged (credited) to operations | 6 | 8 | 8 |
| Supplemental executive retirement plan [Member] | |||
| Defined Contribution Plan Disclosure [Line Items] | |||
| Amounts charged (credited) to operations | $ 3 | $ 2 | $ 3 |
Employee Benefit Plans (Obligation and Funded Status) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Funded Plan [Member] | |||
| Defined Benefit Plan Change In Fair Value Of Plan Assets [Roll Forward] | |||
| Unfunded status at end of period | $ 8 | $ 8 | |
| Pension Plans Defined Benefit [Member] | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Balance | 129 | 125 | |
| Service costs | 4 | 4 | $ 3 |
| Interest cost | 3 | 3 | 3 |
| Past service cost (credit) | 0 | (1) | |
| Actuarial gain (loss) | (2) | 6 | |
| Benefits paid | 1 | 0 | |
| Participant contributions | 2 | 2 | |
| Settlements and curtailments | (7) | (1) | |
| Effect of foreign currency translation | 16 | (9) | |
| Balance | 146 | 129 | 125 |
| Defined Benefit Plan Change In Fair Value Of Plan Assets [Roll Forward] | |||
| Fair value of plan assets at beginning of period | 90 | 86 | |
| Actual return on plan assets | 1 | 3 | |
| Employer contributions | 3 | 3 | |
| Plan participant contributions | 2 | 2 | |
| Expected return on plan assets | 3 | 3 | |
| Benefit received | 4 | 1 | |
| Settlements | (6) | (2) | |
| Effect of foreign currency translation | 9 | (6) | |
| Fair value of plan assets at end of period | 106 | 90 | $ 86 |
| Pension Plans Defined Benefit [Member] | Unfunded Plan [Member] | |||
| Defined Benefit Plan Change In Fair Value Of Plan Assets [Roll Forward] | |||
| Unfunded status at end of period | $ 40 | $ 39 | |
Employee Benefit Plans (Balance Sheet) (Details) - Pension Plans Defined Benefit [Member] - USD ($) $ in Millions |
Dec. 27, 2025 |
Dec. 28, 2024 |
|---|---|---|
| Defined Benefit Plan Disclosure [Line Items] | ||
| Non-current assets | $ 37 | $ 28 |
| Current liabilities | (1) | (1) |
| Non-current liabilities | (76) | (68) |
| Accumulated other comprehensive loss, pre-tax | $ 8 | $ 10 |
Employee Benefit Plans (Net Periodic Pension Cost) (Details) - Pension Plans Defined Benefit [Member] - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Defined Benefit Plan Disclosure [Line Items] | |||
| Service costs | $ 4 | $ 4 | $ 3 |
| Interest cost | 3 | 3 | 3 |
| Expected return on plan assets | (3) | (3) | (3) |
| Employee contributions | (1) | (1) | (1) |
| Settlements | (1) | 0 | 0 |
| Total | $ 2 | $ 3 | $ 2 |
Employee Benefit Plans (Assumptions) (Details) - Pension Plans Defined Benefit [Member] |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate | 2.75% | 2.23% | |
| Defined Benefit Plan Weighted Average Assumptions Used In Calculating Net Periodic Benefit Cost [Abstract] | |||
| Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate | 2.05% | 1.70% | 1.50% |
| Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets | 0.92% | 1.13% | 0.51% |
| Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase | 2.00% | 1.98% | 1.64% |
| Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Rate | 0.74% | 0.63% | 0.80% |
Employee Benefit Plans (Estimated Payments) (Details) - Pension Plans Defined Benefit [Member] $ in Millions |
Dec. 27, 2025
USD ($)
|
|---|---|
| Defined Benefit Plan Disclosure [Line Items] | |
| 2026 | $ 8 |
| 2027 | 9 |
| 2028 | 9 |
| 2029 | 7 |
| 2030 | 8 |
| 2031 to 2035 | 52 |
| Total | $ 93 |
Redeemable Noncontrolling Interests (Change in Fair Value of Redeemable Noncontrolling Interests) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Components of the change in the redeemable noncontrolling interests [Abstract] | |||
| Balance, beginning of period | $ 806 | $ 864 | $ 576 |
| Decrease in redeemable noncontrolling interests due to acquisitions of noncontrolling interests in subsidiaries | (76) | (273) | (19) |
| Increase in redeemable noncontrolling interests due to business acquisitions | 86 | 171 | 326 |
| Net income attributable to redeemable noncontrolling interests | (5) | (1) | 6 |
| Distributions declared, net of capital contributions | (18) | (50) | (19) |
| Effect of foreign currency translation gain (loss) attributable to redeemable noncontrolling interests | 30 | (24) | 5 |
| Change in fair value of redeemable securities | 72 | 119 | (11) |
| Balance, end of period | $ 895 | $ 806 | $ 864 |
Comprehensive Income (Accumulated Other Comprehensive Income and Comprehensive Income Components) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Attributable to redeemable noncontrolling interests: | |||
| Foreign currency translation adjustment | $ (26) | $ (56) | $ (32) |
| Attributable to noncontrolling interests: | |||
| Foreign currency translation adjustment | 1 | (1) | (1) |
| Attributable to Henry Schein, Inc.: | |||
| Foreign currency translation adjustment | (196) | (371) | (188) |
| Unrealized gain (loss) from hedging activities | (24) | 0 | (13) |
| Pension adjustment loss | (6) | (8) | (5) |
| Accumulated other comprehensive loss | (226) | (379) | (206) |
| Total Accumulated other comprehensive loss | (251) | (436) | (239) |
| Components of comprehensive income [Abstract] | |||
| Net Income | 419 | 398 | 436 |
| Foreign currency translation gain (loss) | 207 | (207) | 53 |
| Tax effect | 0 | 0 | 0 |
| Foreign currency translation gain (loss) | 207 | (207) | 53 |
| Unrealized gain (loss) from hedging activities | (33) | 18 | (25) |
| Tax effect | 9 | (5) | 7 |
| Unrealized gain (loss) from hedging activities | (24) | 13 | (18) |
| Pension adjustment gain (loss) | 5 | (5) | (3) |
| Tax effect | (3) | 2 | 0 |
| Pension adjustment gain (loss) | 2 | (3) | (3) |
| Comprehensive income | $ 604 | $ 201 | $ 468 |
Comprehensive Income (Total Comprehensive Income) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Comprehensive Income Net Of Applicable Taxes [Abstract] | |||
| Comprehensive income attributable to Henry Schein, Inc. | $ 551 | $ 217 | $ 443 |
| Comprehensive income attributable to noncontrolling interests | 28 | 9 | 14 |
| Comprehensive income attributable to Redeemable noncontrolling interests | 25 | (25) | 11 |
| Comprehensive income | $ 604 | $ 201 | $ 468 |
Earnings Per Share (Reconciliation of Shares used in Calculating Earnings per Share Basic and Diluted) (Details) - shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Weighted-average common shares outstanding: | |||
| Basic (in shares) | 120,813,977 | 126,788,997 | 130,618,990 |
| Effect of dilutive securities: | |||
| Stock options, restricted stock and restricted stock units (in shares) | 903,899 | 990,231 | 1,129,181 |
| Diluted (in shares) | 121,717,876 | 127,779,228 | 131,748,171 |
Earnings Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details) - shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Anti-dilutive securities excluded from earnings per share | 402,252 | 415,963 | 439,735 |
| Stock Options [Member] | |||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Anti-dilutive securities excluded from earnings per share | 396,052 | 406,676 | 424,695 |
| Restricted Stock/Units [Member] | |||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Anti-dilutive securities excluded from earnings per share | 6,200 | 9,287 | 15,040 |
Supplemental Cash Flow Information (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Supplemental Cash Flow Elements [Abstract] | |||
| Unrealized gain (loss) from hedging activities | $ (33) | $ 18 | $ (25) |
| Debt assumed as part of acquisitions | $ 3 | $ 0 | $ 143 |
Supplemental Cash Flow Information (Cash Paid for Interest and Income Taxes) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
|
| Supplemental Cash Flow Information [Line Items] | |||
| Cash paid for interest | $ 151 | $ 132 | $ 84 |
| Cash paid for income taxes, net of refunds | 128 | ||
| Cash paid during the period for income taxes (prior to ASU 2023-09) | $ 144 | $ 218 | |
| U.S. Federal [Member] | |||
| Supplemental Cash Flow Information [Line Items] | |||
| Cash paid for income taxes, net of refunds | 67 | ||
| U.S. State and Local [Member] | |||
| Supplemental Cash Flow Information [Line Items] | |||
| Cash paid for income taxes, net of refunds | 15 | ||
| Switzerland [Member] | |||
| Supplemental Cash Flow Information [Line Items] | |||
| Cash paid for income taxes, net of refunds | 8 | ||
| Other [Member] | |||
| Supplemental Cash Flow Information [Line Items] | |||
| Cash paid for income taxes, net of refunds | $ 38 | ||
Related Party Transactions (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 27, 2025 |
Dec. 28, 2024 |
Dec. 30, 2023 |
Apr. 03, 2018 |
|
| Related Party Transaction [Line Items] | ||||
| Selling, general and administrative | $ 3,084 | $ 3,034 | $ 2,956 | |
| Current operating lease liabilities | 78 | 75 | ||
| Non-current operating lease liabilities | 251 | 259 | ||
| Equity Method Investee [Member] | ||||
| Related Party Transaction [Line Items] | ||||
| Other liabilities | 6 | 6 | ||
| Due from related party | 39 | 35 | ||
| Revenues | 56 | 52 | 47 | |
| Purchases from related party | $ 19 | 10 | 10 | |
| Internet Brands Inc [Member] | Co Venturer [Member] | ||||
| Related Party Transaction [Line Items] | ||||
| Extend time-based trigger and pause exercise of put option, period (in years) | 4 years | |||
| Internet Brands Inc [Member] | Co Venturer [Member] | Royalty Agreements [Member] | ||||
| Related Party Transaction [Line Items] | ||||
| Period covered by agreement | 10 years | |||
| Related party agreement amount | $ 31 | |||
| Selling, general and administrative | $ 31 | 31 | $ 31 | |
| Internet Brands Inc [Member] | Henry Schein One LLC [Member] | ||||
| Related Party Transaction [Line Items] | ||||
| Minority interest ownership percentage | 33.60% | 26.00% | ||
| Henry Schein One LLC [Member] | Internet Brands Inc [Member] | Affiliated Entity [Member] | ||||
| Related Party Transaction [Line Items] | ||||
| Other liabilities | $ 9 | $ 1 | ||
KKR Investment and Accelerated Share Repurchase Program (Narrative) (Details) $ / shares in Units, $ in Millions |
1 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
|
May 16, 2025
USD ($)
$ / shares
shares
|
Jul. 31, 2025
USD ($)
shares
|
May 31, 2025
USD ($)
shares
|
Dec. 27, 2025
number
|
Nov. 04, 2025 |
Nov. 03, 2025 |
May 19, 2025
USD ($)
|
|
| Accelerated Share Repurchases [Line Items] | |||||||
| Accelerated share repurchase program authorized amount | $ 250 | ||||||
| Stock repurchased during the period (in shares) | shares | 368,651 | 3,122,832 | |||||
| Stock repurchased during the period | $ 26 | $ 224 | |||||
| KKR Investor [Member] | |||||||
| Related Party Transaction [Line Items] | |||||||
| Related party agreement amount | $ 250 | ||||||
| Issue new shares of common stock - shares | shares | 3,285,151 | ||||||
| Issue new shares of common stock - price per share | $ / shares | $ 76.10 | ||||||
| Number of independent directors to join Board of Directors upon investment | number | 2 | ||||||
| KKR Investor [Member] | Maximum [Member] | |||||||
| Related Party Transaction [Line Items] | |||||||
| Equity to purchase by KKR via open market (as a percent) | 19.90% | 14.90% | |||||